<!doctype html>
<style>
@charset "utf-8";
body {
	height: 100%;
	margin: 0;
	padding: 0;
}

.banner {
	position: fixed;
	top: 0;
	width: 100%;
	height: 65px;
	background: gray;
	line-height: 65px;
}
.spacer {
	height: 10px;
}

.main-content {
	padding: 5%;
}

.collapse_ACT {
	cursor: pointer;
	display: block;
	color: black;
	height: 30px;
	line-height: 30px;
	border-style: none solid none none;
	border-color: #B4045F;
	border-width: thick;
	background: #DCDCDC;
}
.collapse_ACT + input{
	display: none;
}
.collapse_ACT + input + div{
	display: none;
}
.collapse_ACT + input:checked + div{
	display: block;
}
.ACT {
	text-align: justify;
	text-justify: inter-word;
}
.ACT_collapse_similarity {
	cursor: pointer;
	display: block;
	color: black;
	background: white;
	border-style: none none none solid;
	border-color: #B4045F;
}
.ACT_collapse_similarity:hover{
	background: #e5d3dc;
}
.ACT_collapse_similarity + input {
	display: none;
}
.ACT_collapse_similarity + input + div{
	display: none;
}

.ACT_collapse_similarity + input:checked + div{
	display: block;
}
.ACT_collapse_similarity > a {
	text-decoration: none;
	color: gray;
}
.ACT_collapse_similarity {
	cursor: pointer;
	display: block;
	color: black;
	background: white;
	border-style: none none none solid;
	border-color: #B4045F;
	padding-left: 5px;
}
.ACT_collapse_similarity:hover{
	background: #e5d3dc;
}
.ACT_collapse_similarity + input {
	display: none;
}
.ACT_collapse_similarity + input + div{
	display: none;
}
.ACT_collapse_similarity + input:checked + div{
	display: block;
}
.ACT_collapse_similarity > a {
	text-decoration: none;
	color: gray;
}
.ACT_similar {
	padding-left: 2%;
	text-align: justify;
	text-justify: inter-word;
	border-style: none none none solid;
	border-color: #B4045F;
}
.ACT_similar > a {
	text-decoration: none;
	color: gray;
}

.collapse_DOM {
	cursor: pointer;
	display: block;
	color: black;
	height: 30px;
	line-height: 30px;
	border-style: none solid none none;
	border-color: #B404AE;
	border-width: thick;
	background: #DCDCDC;
}
.collapse_DOM + input{
	display: none;
}
.collapse_DOM + input + div{
	display: none;
}
.collapse_DOM + input:checked + div{
	display: block;
}
.DOM {
	text-align: justify;
	text-justify: inter-word;
}
.DOM_collapse_similarity {
	cursor: pointer;
	display: block;
	color: black;
	background: white;
	border-style: none none none solid;
	border-color: #B404AE;
	padding-left: 5px;
}
.DOM_collapse_similarity:hover{
	background: #e8d7e7;
}
.DOM_collapse_similarity + input {
	display: none;
}
.DOM_collapse_similarity + input + div{
	display: none;
}
.DOM_collapse_similarity + input:checked + div{
	display: block;
}
.DOM_collapse_similarity > a {
	text-decoration: none;
	color: gray;
}.DOM_similar {
	padding-left: 2%;
	text-align: justify;
	text-justify: inter-word;
	border-style: none none none solid;
	border-color: #B404AE;
}
.DOM_similar > a {
	text-decoration: none;
	color: gray;
}

.collapse_EVO {
	cursor: pointer;
	display: block;
	color: black;
	height: 30px;
	line-height: 30px;
	border-color: #7401DF;
	border-style: none solid none none;
	border-width: thick;
	background: #DCDCDC;
}
.collapse_EVO + input{
	display: none;
}
.collapse_EVO + input + div{
	display: none;
}
.collapse_EVO + input:checked + div{
	display: block;
}
.EVO {
	text-align: justify;
	text-justify: inter-word;
}
.EVO_collapse_similarity {
	cursor: pointer;
	display: block;
	color: black;
	background: white;
	border-style: none none none solid;
	border-color: #7401DF;
	padding-left: 5px;
}
.EVO_collapse_similarity:hover{
	background: #e2d7ed;
}
.EVO_collapse_similarity + input {
	display: none;
}
.EVO_collapse_similarity + input + div{
	display: none;
}
.EVO_collapse_similarity + input:checked + div{
	display: block;
}
.EVO_collapse_similarity > a {
	text-decoration: none;
	color: gray;
}
.EVO_similar {
	padding-left: 2%;
	text-align: justify;
	text-justify: inter-word;
	border-style: none none none solid;
	border-color: #7401DF;
}
.EVO_similar > a {
	text-decoration: none;
	color: gray;
}

.collapse_RP {
	cursor: pointer;
	display: block;
	color: black;
	height: 30px;
	line-height: 30px;
	border-color: #0174DF;
	border-style: none solid none none;
	border-width: thick;
	background: #DCDCDC;
}
.collapse_RP + input{
	display: none;
}
.collapse_RP + input + div{
	display: none;
}
.collapse_RP + input:checked + div{
	display: block;
}
.RP {
	text-align: justify;
	text-justify: inter-word;
}
.RP_collapse_similarity {
	cursor: pointer;
	display: block;
	color: black;
	background: white;
	border-style: none none none solid;
	border-color: #0174DF;
	padding-left: 5px;
}
.RP_collapse_similarity:hover{
	background: #c9d7e2;
}
.RP_collapse_similarity + input {
	display: none;
}
.RP_collapse_similarity + input + div{
	display: none;
}
.RP_collapse_similarity + input:checked + div{
	display: block;
}
.RP_collapse_similarity > a {
	text-decoration: none;
	color: gray;
}
.RP_similar {
	padding-left: 2%;
	text-align: justify;
	text-justify: inter-word;
	border-style: none none none solid;
	border-color: #0174DF;
}
.RP_similar > a {
	text-decoration: none;
	color: gray;
}

.collapse_SIT {
	cursor: pointer;
	display: block;
	color: black;
	height: 30px;
	line-height: 30px;
	border-color: #0489B1;
	border-style: none solid none none;
	border-width: thick;
	background: #DCDCDC;
}
.collapse_SIT + input{
	display: none;
}
.collapse_SIT + input + div{
	display: none;
}
.collapse_SIT + input:checked + div{
	display: block;
}
.SIT {
	text-align: justify;
	text-justify: inter-word;
}
.SIT_collapse_similarity {
	cursor: pointer;
	display: block;
	color: black;
	background: white;
	border-style: none none none solid;
	border-color: #0489B1;
	padding-left: 5px;
}
.SIT_collapse_similarity:hover{
	background: #d0dfe2;
}
.SIT_collapse_similarity + input {
	display: none;
}
.SIT_collapse_similarity + input + div{
	display: none;
}
.SIT_collapse_similarity + input:checked + div{
	display: block;
}
.SIT_collapse_similarity > a {
	text-decoration: none;
	color: gray;
}
.SIT_similar {
	padding-left: 2%;
	text-align: justify;
	text-justify: inter-word;
	border-style: none none none solid;
	border-color: #0489B1;
}
.SIT_similar > a {
	text-decoration: none;
	color: gray;
}

.collapse_TU {
	cursor: pointer;
	display: block;
	color: black;
	height: 30px;
	line-height: 30px;
	border-color: #04B486;
	border-style: none solid none none;
	border-width: thick;
	background: #DCDCDC;
}
.collapse_TU + input{
	display: none;
}
.collapse_TU + input + div{
	display: none;
}
.collapse_TU + input:checked + div{
	display: block;
}
.TU {
	text-align: justify;
	text-justify: inter-word;
}
.TU_collapse_similarity {
	cursor: pointer;
	display: block;
	color: black;
	background: white;
	border-style: none none none solid;
	border-color: #04B486;
	padding-left: 5px;
}
.TU_collapse_similarity:hover{
	background: #d0e2de;
}
.TU_collapse_similarity + input {
	display: none;
}
.TU_collapse_similarity + input + div{
	display: none;
}
.TU_collapse_similarity + input:checked + div{
	display: block;
}
.TU_collapse_similarity > a {
	text-decoration: none;
	color: gray;
}
.TU_similar {
	padding-left: 2%;
	text-align: justify;
	text-justify: inter-word;
	border-style: none none none solid;
	border-color: #04B486;
}
.TU_similar > a {
	text-decoration: none;
	color: gray;
}

ul { 
	list-style-type: none;
	padding: 0;
	margin: 0;
}
ul li > a {
	text-decoration: none;
	color: gray;
}
ul li:hover, ul li:focus {
	background: #F0F0F0;
}

ul li:first-child span {
  border-left:none;  
}

</style>
<html>
<head>
<meta charset="utf-8">
<title>TF properties - MalT</title>
<meta name="theme-color" content="#ffffff">
</head>
<body>
	<div class="banner">
		<center><font color="white" size="16px" face="arial">MalT</font></center>
	</div>
	<div align="center" class="main-content">
		<div class="spacer">
	</div><br>			<label class="collapse_ACT" for="_1"><font size="5px">MalT transcriptional activity</font></label>
				<input id="_1" type="checkbox">
				<div class="ACT"><br><ul><li>This regulation depends on the binding of CAMP-CRP to malTp and results in the pH , modulation of basal and induced activity of MalTMalTJMalT , equilibrium and pH,-dependent dependent promoters ( malKp , malEp , malPp and expression of malK malSp ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9884223" target="_blank">9884223</a>]<br></li>
<li>) 1,2 139 CRP cytR 0 1 p 1,2 142 CRP deop2 1 1 p 1,2 142 , 162 CRP galpi 1 1 0 1,2 60 CRP glpD 0 1 0 2,4 174 CRP glnApl 1 1 0 4 119 CRP ilvB 0 0 0 4 39 CRP lac 0 1 0 1,2 87 CRP malT 0 0 0 1,2 88 CRP melR 0 0 0 1,2 169 CRP nagB 1 0 0 4 108 CRP nagE 1 0 0 4 108 CRP pBRp4 0 0 0 2,4 113 CRP putA 1 1 0 4 47 CRP rpoHpS 1 0 0 4 99 CRP tnaA 0 0 0 2,4 27 CRP tsx 0 1 p 4 142 , 165 FNR dmsA 0 0 0 4 35 FNR fdrA 0 0 0 1,4 35 , 61 FNR , Y gipA 0 0 0 4 35 FNR , Y narG 0 0 0 1,4 35 , 75 FNR nirB 0 1 0 1,4 35 , 61 , 62 FNR PFLp6 1 0 0 4 133 FNR PFLp7 1 0 0 4 75 , 133 IlvY ilvC 1 0 p 3 170 MalT malE 1 1 R 1,2 114 , 115 MalT malK 1 1 R 1,2 114 , 115 MalT malPQ 0 0 0 1,4 138 MetR metE 1 1 0 1,3 161 MetR metH 0 0 0 4 160 , 161 OmpR ompC 0 0 p 1,2 80 , 81 , 154 OmpR ompF 0 0 p 1,2 38 , 116 , 154 OxyR ahpC 0 0 0 3 146 OxyR katG 0 0 0 3 146 , 149 PapB papB 1 1 R 1,2 37 , 41 PhoB phoA 0 0 0 4 84 PhoB phoB 0 0 0 1,4 84 , 154 PhoB phoE 0 0 P ( ?	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=1943993" target="_blank">1943993</a>]<br></li>
<li>It can be structural , as found in the araBAD promoter , in which case a CRP-induced DNA bend acts to disrupt a repressive DNA loop , or steric , as in the malK promoter , in which case CRP induces a repositioning of the MalT activator into an activating register .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=7592420" target="_blank">7592420</a>]<br></li>
				<label class="ACT_collapse_similarity" for="act_similarity_4">
Richet , E. , and Søgaard-Andersen , L. ( 1994 ) CRP induces the repositioning of MalT at Escherichia coli malKp promoter primarily through DNA bending .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10027963" target="_blank">10027963</a>]<br></label>
<input id="act_similarity_4", type="checkbox">
<div class="ACT_similar">
<li>Richet , E. , and Sogaard-Andersen , L. ( 1994 ) CRP induces the repositioning of MalT at the Escherichia coli malKp promoter primarily through DNA bending .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9484902" target="_blank">9484902</a>]<br></li>
<li>Richet , E. , and Sogaard , A.L. ( 1994 ) CRP induces the repositioning of MalT at the Escherichia coli malKp promoter primarily through DNA bending .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9822819" target="_blank">9822819</a>]<br></li>
<li>CRP induces the repositioning of MalT at the Escherichia coli malKp promoter primarily through DNA bending .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9000616" target="_blank">9000616</a>, <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9440505" target="_blank">9440505</a>, <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11073923" target="_blank">11073923</a>, <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10852886" target="_blank">10852886</a>, <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=20966094" target="_blank">20966094</a>, <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9529892" target="_blank">9529892</a>, <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=16980449" target="_blank">16980449</a>, <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=7551052" target="_blank">7551052</a>, <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9401025" target="_blank">9401025</a>, <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9512707" target="_blank">9512707</a>, <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=16166533" target="_blank">16166533</a>]<br></li>
<li>CRP induces the repositioning of MalT at the Escherichia col malKp promoter primarily through DNA bending .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10512697" target="_blank">10512697</a>]<br></li>
<li>CRP induces the repositioning of MalT at the Escherichi coli malKp promoter primarily through DNA bending .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=14529615" target="_blank">14529615</a>]<br></li></div>
<li>7 1996 Academic Press Limited Keywords : MalT ; CRP ; Escherichia coli ; transcription activation ; DNA loops Unité de Génétique Moléculaire URA CNRS 1149 Institut Pasteur 25 rue du Dr. Roux 75724 Paris Cedex 15 France Introduction Prokaryotic transcriptional-activators act either alone or synergistically , depending on the promoter .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9000616" target="_blank">9000616</a>]<br></li>
				<label class="ACT_collapse_similarity" for="act_similarity_11">
Synergistic transcription activation : a dual role for CRP in the activation of an Escherichia coli promoter depending on MalT and CRP .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=20966094" target="_blank">20966094</a>]<br></label>
<input id="act_similarity_11", type="checkbox">
<div class="ACT_similar">
<li>Richet , E. ( 2000 ) Synergistic transcription activation : a dual role for CRP in the activation of an Escherichia coli promoter depending on MalT and CRP .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15066032" target="_blank">15066032</a>, <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=24335284" target="_blank">24335284</a>]<br></li></div>
<li>62 , No. 1 Maltose/Maltodextrin System of Escherichia coli : Transport , Metabolism , and Regulation WINFRIED BOOS1 * AND HOWARD SHUMAN2 Department of Biology , University of Konstanz , D-78457 Konstanz , Germany ,1 and Department of Microbiology , Columbia University , College of Physicians & Surgeons , New York , New York 100322 I NTRODUCTION AND SCOPE ... 2 ALTOSE GENES AND THEIR PRODUCTS ... 2 OSITIVE TRANSCRIPTIONAL ACTIVATOR , MalT ... 2 malT , Its Product , and Regulation of Its Expression ... 2 MalT Box ... 2 ALTOSE/MALTODEXTRIN TRANSPORT SYSTEM ... 2 Periplasmic Substrate Recognition Site and Its Interaction with Membrane Components ... 2 Membrane-Spanning Subunits MalF and MalG of the Transport System ... 2 MalK , the Energy-Coupling Protein of the Transport System ... 2 Role of the Lambda Receptor ( Maltoporin ) in the Diffusion of Maltose and Maltodextrins through the Outer Membrane ... 2 NZYMES OF THE MALTOSE SYSTEM ... 2 Amylomaltase ... 2 Maltodextrin Phosphorylase ... 2 Maltodextrin Glucosidase , an Enzyme of Unclear Function ... 2 Role of Glucokinase and Phosphoglucomutase in Maltose/Maltodextrin Metabolism ... 2 Periplasmic a-Amylase ... 2 Maltose Utilization in Other Bacteria ... 2 ONCLASSICAL REGULATORY PHENOMENA ... 2 MalK , the ATP-Hydrolyzing Subunit , as a Sensor for mal Expression ... 2 MalY as a mal Repressor ... 2 Aes as a mal Repressor ... 2 Effect of Phosphorylated PhoP on mal Expression ... 2 NDOGENOUS INDUCER OF THE MALTOSE SYSTEM ... 2 Glycogen as a Source of Maltotriose ... 2 Second Pathway for Maltotriose Formation ... 2 Elevated Expression of the mal Genes during Glucose Starvation ... 2 Role of Glucose in Internal Induction of the Maltose System ... 2 Osmoregulation of the Maltose System ... 2 NTERCONNECTION BETWEEN THE MALTOSE AND TREHALOSE SYSTEMS ... 2 Trehalose as an Inducer of the Maltose System ... 2 Transport of Maltose and Trehalose in the Archaeon Thermococcus litoralis ... 2 INAL CONSIDERATIONS ... 2 CKNOWLEDGMENTS ... 2 EFERENCES ... 2 04 05 05 05 09 10 10 12 13 M P M 14 15 15 16 17 17 17 18 18 18 19 20 20 20 20 21 21 21 21 22 22 23 23 23 23 E N E I F A R INTRODUCTION AND SCOPE Historically , some of the earliest work on Escherichia coli genetics and physiology in the Jacob and Monod groups concentrated on the maltose system , but it was rapidly overshadowed by the spectacular success in understanding the lactose operon .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9529892" target="_blank">9529892</a>]<br></li>
<li>Most of the MalT protein sedimented in 1 h at 20 000 g. All strains previously shown to produce increased amounts of MalT protein expressed the maltose operons constitutively , at levels that depended upon the actual concentration of MaWT 37 Table H. Effect of the malTp mutations on the expression of ( maT-IacZ ) and lacY in malT-lac hybrid operons , B-galactosidase f,-galactoside permease crp + permease x 1000 , B-galactosidase crp + Acrp39 crp Gly 110 Glu + cAMP 110 Gly 2 8 Glu 10 Glu 40 Gly 18 malT + maITpl 330 140 not done 14 4 4 6 malTp7 malTpJ malTp7 13 The specific activities of ( 1-galactosidase ( units/mg of protein ) and ( 3-galactoside permease ( nmols of [ 14C ] thiomethyl , B-galactoside transported in 20 min by 108 cells ) were determined in strains where the $ ( malT-IacZ ) 542-1 ( Hyb ) hybrid gene had been introduced in a cis position to the malTp mutation ( see Table I ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=6325162" target="_blank">6325162</a>]<br></li>
<li>All of the amino acid substitutions altering the DT3 H10/HT11 area speciﬁcally affect MalT repression by MalK To quantify the effect of the DT3 up mutations on the activity of MalT , we measured the amount of b-galactosidase synthesized by two isogenic reporter strains when transformed with pOM181 or variants thereof and grown in minimal medium supplemented with glycerol : the DmalT malK C strain used above ( pop7191 ) , in which MalT was repressed by MalK , and an isogenic DmalT DmalK strain ( pop7190 ) , in which the activity of MalT was unrepressed .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li>
<li>This is the case for TyrR ,23 MalT ,24 BirA ,25 and NtrC .26 For eukaryotic nuclear receptors , including the vitamin D and retinoic acid receptors , regulatory ligands determine not only the oligomeric state of the receptor but als in ¯ uence the assembly of heterodimers of mixed receptor type , processes that have consequences for target site selection .27,28 In general , these effectorlinked assembly processes provide an indirect means of regulating DNA target-site occupancy , and ultimately transcriptional activity , via small changes in ligand concentration .25 One of the most interesting aspects of the Lrp regulon is the different regulatory patterns that relate to Lrp-leucine interactions .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11575919" target="_blank">11575919</a>]<br></li>
<li>Binding of proteins to immobilized ligands Crude extracts prepared from E. coli strains expressing MalT -- BCCP , MalE -- BCCP , or MalT1 ( Con ) - BCCP from plasmids pCP80 or pRP137 , pMALcr.1-BCCP and pCP101 , respectively , were incubated with streptavidin-agarose beads ( 0.02 ml ) for 30 min at room temperature to immobilize the fusion proteins on the resin .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9822819" target="_blank">9822819</a>]<br></li>
<li>To determine which proteins interact with the biotinylated MalT proteins , extracts prepared from E. coli strains expressing MalKþ , MalTþ , His-6 -- MalK or His-6 -- FabI from plasmids pMR10 , pOM2 , pCP97 and pCK204 , respectively , were then added and allowed to mix with the immobilized proteins for 1 h. Proteins remaining bound to the beads after four washes with PBST were eluted with gel loading buffer .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9822819" target="_blank">9822819</a>]<br></li>
<li>The N Terminus of the Escherichia coli Transcription Activator MalT Is the Domain of Interaction with MalY Anja Schlegel ,1 Olivier Danot ,2 Evelyne Richet ,2 Thomas Ferenci ,3 and Winfried Boos1 * Department of Biology , University of Konstanz , 78457 Konstanz , Germany1 ; Unité de Génétique Moléculaire , Institut Pasteur , FRE CNRS 2364 , 75724 Paris Cedex 15 , France2 ; and Department of Microbiology G08 , University of Sydney , Sydney , New South Wales 2006 , Australia3 Received 26 December 2001/Accepted 1 March 2002 The maltose system of Escherichia coli consists of a number of genes encoding proteins involved in the uptake and metabolism of maltose and maltodextrins .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=12003949" target="_blank">12003949</a>]<br></li>
<li>169 , No. 7 Maltotriose Is the Inducer of the Maltose Regulon of Escherichia coli OLIVIER RAIBAUD * AND EVELYNE RICHET Unite ' de Genetique Moleculaire , Institut Pasteur , 75724 Paris Cedex 15 , France Received 20 January 1987/Accepted 13 April 1987 In a cell-free system programmed with a plasmid bearing a malP ' - ` lacZ gene fusion under the control of malPp , I-galactosidase synthesis was strictly dependent on the presence of both the MalT activator protein and the inducer of the Escherichia coli maltose regulon .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=3298211" target="_blank">3298211</a>]<br></li>
<li>The EMBO Journal vol .8 no. 3 pp. 981 - 987 , 1 989 MalT , the regulatory protein of the Escherichia coli maltose system , is an ATP-dependent transcriptional-activator Evelyne Richet and Olivier Raibaud Unite de Genetique Moleculaire , Institut Pasteur , 28 rue du Dr. Roux , 75015 Paris Cedex 15 , France Communicated by M.Schwartz We show that MalT , the transcriptional-activator of the Escherichia coli maltose regulon , specifically binds ATP and dATP with a high affinity ( Kd = 0.4 , uM ) and exhibits a weak ATPase activity .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>( 1991 ) 218 , 529-542 Supercoiling is Essential for the Formation and Stability Initiation Complex at the Divergent malEp and malKp Promoters of the Evelyne Richet and Olivier Raibaud Unite ' de Ge 'n e ' tique Mole ' culaire A 1149 du CNRS , Institut Pasteur , 25 rue du Dr. Roux 75724 Paris Cedex 15 , France UR ( Received 5 July 1990 ; accepted 2 January 1991 ) m , alEp and malKp are divergent and partially overlapping promoters of the Escherichia coli maltose regulon , whose activity depends on the presence of two transcriptional-activators , MalT and CRP ( CAMP receptor protein ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2016744" target="_blank">2016744</a>]<br></li>
<li>Self-association of the Escherichia coli Transcription Activator MalT in the Presence of Maltotriose and ATP * ( Received for publication , June 1 , 1999 , and in revised form , August 23 , 1999 ) Valérie Schreiber and Evelyne Richet ‡ From the Unité de Génétique Moléculaire , URA CNRS 1773 , Institut Pasteur , 25 rue du D 75724 Paris Cedex 15 , France r. Roux , the DNA-binding fold ( 11 , 12 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10559195" target="_blank">10559195</a>]<br></li>
<li>The Aes Protein Directly Controls the Activity of MalT , the Central Transcriptional Activator of the Escherichia coli Maltose Regulon * Received for publication , January 30 , 2002 , and in revised form , February 21 , 2002 Published , JBC Papers in Press , February 26 , 2002 , DOI 10.1074 / jbc.M200991200 Nicolas Joly ‡ § , Olivier Danot ‡ , Anja Schlegel ¶ , Winfried Boos ¶ , and Evelyne Richet ‡ From the ‡ Unité de Génétique Moléculaire , FRE CNRS 2364 , Institut Pasteur , 25 rue de Dr. Roux , 75724 Paris Cedex 15 , France and ¶ Department of Biology , University of Konstanz , 78457 Konstanz , Germany MalT , the transcriptional-activator of the maltose regulon from Escherichia coli , is the prototype of a new family of transcription factors .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>( 2005 ) 347 , 1 -- 10 Two Domains o s f MalT , the Activator of the E cherichia egulon , Bear Determinants Essential for by MalK Maltose R coli Anti-activation Evelyne Richet * , Nicolas Joly and Olivier Danot Unité de Génétique Moléculaire URA CNRS 2172 , Institut Pasteur , 25 , rue de Dr. Roux 75724 Paris Cedex 15 , France MalT , the dedicated transcriptional-activator of the maltose regulon in Escherichia coli , is subject to multiple controls .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li>
<li>MalK , the ATP-binding Cassette Component of the Escherichia coli Maltodextrin Transporter , Inhibits the Transcriptional Activator MalT by Antagonizing Inducer Binding * Received for publication , April 1 , 2004 , and in revised form , June 2 , 2004 Published , JBC Papers in Press , June 4 , 2004 , DOI 10.1074 / jbc.M403615200 Nicolas Joly ‡ § , Alex Böhm ¶ , Winfried Boos ¶ , and Evelyne Richet ‡ From the ‡ Unité de Génétique Moléculaire , URA CNRS 2172 , Institut Pasteur , 25 rue du Dr. Roux , 75724 Paris Cedex 15 , France and the ¶ Department of Biology , University of Konstanz , Universitätstrasse 10 , 78457 Konstanz , Germany MalK , the ATP-binding cassette component of the Escherichia coli maltodextrin transporter , has long been known to control negatively the activity of MalT , a transcriptional-activator dedicated to the maltose regulon .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>Thus , it is possible that the positive regulatory protein , MalT , binding to maltose may be also pressure-sensitive , so this might be one cause of the high pressure effect leading to repression of the malB region .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=8598266" target="_blank">8598266</a>]<br></li>
<li>Discussion MalT , an ATP binding protein We have shown here that MalT , the transcriptional-activator of the maltose regulon , specifically binds ATP and dATP with high affinity ( Kd = 0.4 jtM ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>Discussion MalT is specific DNA ( a ) a binding protein around which DNA can wrap In this paper we present direct evidence that MalT , the transcriptional-activator of the E. coli maltose regulon , specifically binds to the hexa-nucleotide 5 ' - GGAT/GGA -3 ' , which has previously been genetically defined as the site of action of MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2538630" target="_blank">2538630</a>]<br></li>
<li>By using a biochemical approach , we demonstrate here that ( i ) Aes controls MalT activity through direct pro-tein-protein interaction , ( ii ) Aes competes with maltotri-ose for MalT binding , ( iii ) ATP and ADP differentially affect the competition between Aes and the inducer , and ( iv ) part , if not all , of the Aes binding site is located in DT1 , the N-terminal domain of the activator , which also contains the ATP binding site .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>In both cases , the inhibitory protein is a negative effector of MalT that competes with the inducer for MalT binding and whose binding site is located on the N-terminal domain of the activator .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>It establishes that MalY is a negative effector of MalT , the transcriptional-activator of the regulon , and that it downregulates-the-activity of MalT through direct protein ± protein interaction and by preventing inducer binding .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>The induction of the maltose system is controlled on one hand by the inducer maltotriose-activating MalT , the transcriptional-activator of the system ( 49 ) , and by MalK , the ATP-hydrolyzing ABC subunit of the transporter inactivating MalT ( 31 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=16321936" target="_blank">16321936</a>]<br></li>
<li>MalK , the ABC component of the Escherichia coli maltodextrin transport system , inhibits the transcriptional-activator MalT by antagonizing inducer binding .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15491603" target="_blank">15491603</a>]<br></li>
				<label class="ACT_collapse_similarity" for="act_similarity_35">
279 ( 2004 ) 33123 -- 33130 MalK , the ATP-binding cassette component of the Escherichia coli maltodextrin transporter , inhibits the transcriptional-activator MalT by antagonizing inducer binding .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></label>
<input id="act_similarity_35", type="checkbox">
<div class="ACT_similar">
<li>MalK , the ATP-binding cassette component of the Escherichia coli maltodextrin transporter , inhibits the transcriptional-activator MalT by antagonizing inducer binding .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=16321936" target="_blank">16321936</a>, <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li></div>
<li>Molecular Microbiology ( 1998 ) 30 ( 3 ) , 535 -- 546 transpor ter MalK antagonizes MalT , the activator o scherichia coli m l f t e maltose he ATP-binding cassette subunit o h T f the E a regulon Cynthia H. Panagiotidis ,1 Winfried Boos2 and Howard A. Shuman1 * 1Department of Microbiology , College of Physicians and Surgeons , Columbia University , 701 West 168th Street , New York , NY 10032 , USA .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9822819" target="_blank">9822819</a>]<br></li>
<li>Discussion The results presented here document the functional and physical interaction between the ATP-binding cassette subunit of the maltose transporter , MalK , and the transcriptional-activator , MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9822819" target="_blank">9822819</a>]<br></li>
<li>The model system is the Escherichia coli maltodextrin transporter , whose ATP-binding cassette component , the MalK protein , down-regulates-the-activity of MalT , a transcriptional-activator that controls the expression of the maltose regulon ( 4 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
				<label class="ACT_collapse_similarity" for="act_similarity_40">
Panagiotidis , C.H. , Boos , W. , and Shuman , H.A. ( 1998 ) The ATP-binding cassette subunit of the maltose transporter MalK antagonizes MalT , the activator of the Escherichia coli mal regulon .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10411743" target="_blank">10411743</a>, <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></label>
<input id="act_similarity_40", type="checkbox">
<div class="ACT_similar">
<li>Panagiotidis , C.H. , Boos , W. and Shuman , H.A. ( 1998 ) The ATP-binding cassette subunit of the maltose transporter MalK antagonizes MalT , the activator of the Escherichia coli mal regulon .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11157755" target="_blank">11157755</a>]<br></li></div>
<li>This indicates that Aes interacts directly with MalT , rendering it inactive as a transcriptional-activator .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9401025" target="_blank">9401025</a>]<br></li>
<li>We speculate that a structural motif present in all three proteins , but not recognizable by sequence , interacts with MalT , thus inactivating the function of MalT as a transcriptional-activator .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9401025" target="_blank">9401025</a>]<br></li>
<li>For most speci ® c transcriptional-regulators , the co-activator or inducer is a low-molecular-weight metabolite related to the products of the regulated genes , e.g. for the mal regulon , the co-activator of MalT is maltotriose ( Raibaud and Richet , 1987 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10411743" target="_blank">10411743</a>]<br></li>
<li>Like all mal genes , malZ is under the control of MalT , the central activator , with maltotriose being the inducer ( 37 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=21421758" target="_blank">21421758</a>]<br></li>
<li>All mal genes are controlled by MalT , a transcriptional-activator that is exclusively activated by maltotriose .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=16321936" target="_blank">16321936</a>]<br></li>
<li>All these operons are under direct positive control of MalT , the transcriptional-activator ( 2 , 3 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=1918057" target="_blank">1918057</a>]<br></li>
<li>MalT , the transcriptional-activator of the system , is necessary for the transcription of all mal genes .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9484893" target="_blank">9484893</a>]<br></li>
<li>To our knowledge , MalT is the first ATP-dependent transcriptional-activator so far described in prokaryotes .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>In addition to the positive effectors , maltotriose and ATP , three proteins are known to be able to interact with MalT , curbing its activity as a transcriptional-activator .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=12003949" target="_blank">12003949</a>]<br></li>
<li>171 , No. 9 MalI , a Novel Protein Involved in Regulation of the Maltose System of Escherichia coli , Is Highly Homologous to the Repressor Proteins GalR , CytR , and Lacl JOACHIM REIDL , KARIN ROMISCH , MICHAEL EHRMANN , AND WINFRIED BOOS * Department of Biology , University of Konstanz , D-7750 Konstanz , Federal Republic of Germany Received 13 March 1989/Accepted 10 June 1989 The maltose regulon of Escherichia coli comprises several operons that are under common regulatory control of the MalT activator protein .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2670898" target="_blank">2670898</a>]<br></li>
<li>Oligomeric assemblies of the Escherichia coli MalT transcriptional-activator revealed by cryoelectron microcopy and image processing .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li>
<li>Summary Transcription of the mal regulon of Escherichia coli K-12 is regulated by the positive activator , MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9822819" target="_blank">9822819</a>]<br></li>
<li>DISCUSSION MalT , the transcriptional-activator of the E. coli maltose system , exhibits the peculiar property of interacting with ﬁv effectors that either increase or decrease its transcriptional activity .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=12003949" target="_blank">12003949</a>]<br></li>
<li>J Gen Microbiol 130 : 83 -- 88 Joly N , Danot O , Schlegel A , Boos W , Richet E ( 2002 ) The Aes protein directly controls-the-activity of MalT , the central transcriptional-activator of the Escherichia coli maltose regulon .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15616579" target="_blank">15616579</a>]<br></li>
<li>The Aes protein directly controls-the-activity of MalT , the central transcriptional-activator of the Escherichia coli maltose regulon .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=12003949" target="_blank">12003949</a>, <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15491603" target="_blank">15491603</a>, <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li>
<li>The transcriptional-activators MalT and CRP regulate the expression of the E. coli malt.ose regulon ( Schwartz , 1987 ) with regard to the availability of maltodextrins and of some other sugars such as glucose , respectively .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2016744" target="_blank">2016744</a>]<br></li>
<li>The activation of these genes depends on the action of the maltose regulon activator MalT and the global activator cyclic AMP receptor protein .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9829919" target="_blank">9829919</a>]<br></li>
<li>The central MalT activator protein regulates expression from at least five ` maltose Received 13 July , 1994 ; revised 23 November , 1994 ; accepted 9 December , 1994 , ' ^ For correspondence .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=7651130" target="_blank">7651130</a>]<br></li>
<li>The expression of mal2 is positively controlled by the presence of MalT , the transcriptional-activator of the mal regulon .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=1918057" target="_blank">1918057</a>]<br></li>
<li>The regulation of the maltose system is speciﬁcally controlled by MalT acting as an inducer-dependent mal gene activator ( 50 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=16321936" target="_blank">16321936</a>]<br></li>
<li>The regulon is controlled by MalT , the central activator of the system , and consists of 10 coordinately regulated genes that are geared for the utilization of maltose and maltodextrins .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=16321936" target="_blank">16321936</a>]<br></li>
<li>fr The Escherichiacoli maltose regulon consists of five operons under the control of the MalT transcriptional-activator .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9884223" target="_blank">9884223</a>]<br></li>
<li>The system is positively regulated by MalT , its transcriptional-activator .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=12003949" target="_blank">12003949</a>]<br></li>
<li>The system is regulated by MalT , a transcriptional-activator that is needed together with the inducer for the expression of all maltose-regulated genes ( 54 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=1856179" target="_blank">1856179</a>]<br></li>
<li>POSITIVE TRANSCRIPTIONAL ACTIVATOR , MalT malT , Its Product , and Regulation of Its Expression MALTOSE GENES AND THEIR PRODUCTS Table 1 summarizes all known mal genes in E. coli .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9529892" target="_blank">9529892</a>]<br></li>
<li>Expression of the mal genes is induced by maltose and maltodextrins and is dependent on a specific positive regulator , the MalT protein , as well as on the cyclic AMP-catabolite gene activator protein complex .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2423504" target="_blank">2423504</a>]<br></li>
<li>Expression of the mal genes is dependent upon the positive transcriptional-regulator MalT , and the malT gene is itself negatively regulated by Mlc ( Decker et al. , 1998 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9767573" target="_blank">9767573</a>]<br></li>
<li>Although autoregulation of several transcriptional-regulators has been observed previously , e.g. CytR ( Pedersen et al. , 1992 ) , TyrR ( Pittard and Davidson , 1991 ) and GalS ( Weickert and Adhya , 1993 ) , in this case , the positive transcriptional-regulator of the maltose regulon , MalT , is subject to negative regulation by a second regulator , Mlc .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9484893" target="_blank">9484893</a>]<br></li>
<li>Until now , these sugars were thought to be inducers of the maltose regulon and to act as positive effectors of the MalT protein .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=3298211" target="_blank">3298211</a>]<br></li>
<li>In contrast , expression of the malKpromoter of the maltose regulon requires two activator proteins , MalT and the cAMP receptor protein ( CRP ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=8087856" target="_blank">8087856</a>]<br></li>
<li>Alone or together with CRP ( cAMP receptor protein ) MalT activates the promoters of all of the operons comprising the maltose regulon ( 1 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10559195" target="_blank">10559195</a>]<br></li>
<li>Alone or in synergy with CRP ( cAMP receptor protein ) , MalT activates all the operons comprising the Escherichia coli maltose regulon , which encodes proteins involved in the uptake and degradation of maltodextrins ( Boos and Shuman , 1998 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>Their activation depends on the synergistic action of MalT , the activator of the maltose regulon ( Schwartz , 1987 ) , and CRP , a global regulator controlling the utilization of carbon sources ( Kolb et al. , 1993 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9000616" target="_blank">9000616</a>]<br></li>
<li>Two examples are provided by the arabinose and maltose regulons in Escherichia coli , both of which include promoters that are positively controlled by two proteins : the CAMP receptor protein ( CRPt ) and an activator specific of the regulon ( AraC and MalT , respectively : Schleif , 1987 ; Lichenstein et al. , 1987 ; Schwartz , 1987 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2016744" target="_blank">2016744</a>]<br></li>
<li>DhaLHADP is then repho-sphorylated by DhaM , a multiphosphoryl protein of the PTS negatively control the transcriptional-activator MalT of the E. coli maltose regulon ( Boos and Shuman , 1998 ; Schreiber et al , 2000 ; Joly et al , 2002 ; Schlegel et al , 2002 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15616579" target="_blank">15616579</a>]<br></li>
<li>Our results suggest that the H-NS and StpA proteins stimulate MalT translation and hence play a positive role in the control of the maltose regulon .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9829919" target="_blank">9829919</a>]<br></li>
<li>Besides the outer membrane porins , other genes ( 49 ) -- those encoding the tripeptide permease TppB of Salmonella typhimurium , the outer membrane protease Opr , the PhoA and PhoE proteins of the Pho regulon , and the positive regulator MalT of the maltose operon -- are known to be regulated by EnvZ and OmpR .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=7642497" target="_blank">7642497</a>]<br></li>
<li>Treha-lose is not transported by the maltose system , nor does treha-lose or trehalose-6-phosphate stimulate MalT ; also , MalT does not regulate any of the genes involved in the degradation of trehalose , since malT mutants grow well on trehalose .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9529892" target="_blank">9529892</a>]<br></li>
<li>Indeed , malT expression results in the synthesis of a MalT ' , protein with an does not depend on medium osmolarity and only the increased affinity for the inducer and some activity in the basal expression of maltose genes is osmodependent .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9884223" target="_blank">9884223</a>]<br></li>
<li>With respect to the latter , this may be equivalent to the suppression by overproduction of MalT of the effectson maltose regulon expression that are caused by catabolite repression ( Chapon , 1982 ) or the fact that maltose-regulon expression is maltose-independent in E. coli strains carrying multiple copies of malT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2693596" target="_blank">2693596</a>]<br></li>
<li>Thus , all genes regulated by MalT belong to the maltose regulon , while the expression of malT itself is independent of MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9529892" target="_blank">9529892</a>]<br></li>
				<label class="ACT_collapse_similarity" for="act_similarity_83">
All values represent the average of assays performed in duplicate and are corrected for the background level ( 60 cpm ) measured in the absence of MalT and MalK .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></label>
<input id="act_similarity_83", type="checkbox">
<div class="ACT_similar">
<li>All values represent the average of assays performed in duplicate and are corrected for the background level ( 40 cpm ) measured in the absence of MalT and Aes .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>All values represent the average of assays performed in duplicate and are corrected for the background level ( 119 c.p.m. ) measured in the absence of MalT and MalY .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li></div>
<li>Pro-27 vided that our model is correct , the propensity of MalT to self-associate might cause the extension of the homo-oligomer speciﬁcally assembled upon recognition of the MalT sites at high MalT concentration , and lead to the formation of a curved homopolymer similar to those revealed by our cryo-EM analyses and around which the DNA fragment might wrap .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15491603" target="_blank">15491603</a>]<br></li>
<li>However , it is worth noting that , were this hypothesis correct , formation of unproductive aggregates might be consequential to the artiﬁcially high concentrations of active MalT needed to achieve saturation of malEpD64 ; hence some of the stimulatory effects observed under these conditions might not exist under normal conditions .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9000616" target="_blank">9000616</a>]<br></li>
<li>Under standard conditions used to observe n complementation , it produces white plaques when plated on pop2539 , a maiT ^ derivative of strain TGI , and dark-blue plaques when plated on pop2540 , a derivative of pop2539 overexpressing MalT ( Danot and Raibaud , 1994 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=7830577" target="_blank">7830577</a>]<br></li>
<li>Backgrounds of 12Umg '' ' -LCB- matTp * strains ) or 19Umg '' ' ( malTp7 strains ) , and 2Umg ' were subtracted trom the values obtained under inducing and non-inducing growth conditions , respectively experiments at a lower but stiil saturating concentration of MalT ( 150 nM ) : this gave the same resuit ( Fig. 7 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=7830577" target="_blank">7830577</a>]<br></li>
				<label class="ACT_collapse_similarity" for="act_similarity_90">
Note that for each combination of ligand concentrations and MalT variant used in this work , we determined the response curve , i.e. the amount of open complexes formed , as a function of MalT concentration .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></label>
<input id="act_similarity_90", type="checkbox">
<div class="ACT_similar">
<li>Therefore , for each combination of effectors and MalT variant used in this work , we determined an individual response curve , i.e. the amount of open complexes formed as a function of MalT concentration .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li></div>
<li>Note also that malPp response to increasing concentrations of MalT is sigmoidal , and that the concentration of MalT used was that eliciting about half of the maximum respons 8 under the assay conditions .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li>
<li>As before , the concentration of MalT was adjusted to elicit half of the maximum response under the chosen concentrations of ligands .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>It is therefore tempting to speculate that MalT might activate transcription initiation by a mechanism different from that used by CI or CRP to activate PR or lacZp ( de Crombrugghe et al. , 1984 ; Ptashne , 1986 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>It specifically binds DNA at different sites in the promoters whose activity it controls , recognizing a short , asymmetric motif called the MalT box ( 5 ' - GGAT/GGA -3 ' ) ( Raibaud et al. , 1989 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>It binds to specific sites in the promoters whose activities it controls , recognizing a short asymmetric motif called the MalT box ( 12 , 43 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2670898" target="_blank">2670898</a>]<br></li>
<li>The end points of the malEp upstream deletions malEpD64 and malEpD92 ( Raibaud et al. , 1989 ) are indicated Results Each set of three MalT sites ( 3/4/5 and 3 ' / 4 ' / 5 ' ) forms a functional unit to which MalT binds cooperatively ( Danot & Raibaud , 1994 ; Richet et al. , 1991 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9000616" target="_blank">9000616</a>]<br></li>
<li>The sensitivity of higher-order structure formation to the phasing between the proximal and distal sets of MalT sites is essentially determined by MalT Previous studies lead us to propose that formation of the higher-order structure at malEpmalKp is sensitive to the phasing between MalT sites 1/2 and the distal set of sites , and only occurs when MalT occupies sites 3 ' / 4 ' / 5 ' ( Richet et al. , 1991 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9000616" target="_blank">9000616</a>]<br></li>
<li>Elegant studies by Raibaud , Richet and colleagues have shown that CRP serves to reposition MalT to an alternative set of T boxes that results in activation ( Richet et al. , 1991 ; Richet and Sogaard , 1994 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9822819" target="_blank">9822819</a>]<br></li>
<li>CRP bound to site 1 plays a speciﬁc role in malEp + activation The observation that CRP site 1 still strongly stimulated malEp in the absence of any distal MalT sites ( Raibaud et al. , 1989 ; Vidal-Ingigliardi et al. , 1991 ) suggested that the CRP molecule bound to site 1 might play an active role in malEp activation , besides its structural role in the assembly of the active complex .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9000616" target="_blank">9000616</a>]<br></li>
<li>Discussion A unique nucleoprotein assembly activates malEp and malKp The MalT sites 1 and 2 , as well as the CRP sites 1 , 2 and 3 had all been shown to play a role in malEp activation ( Vidal-Ingigliardi & Raibaud , 1991 ; Vidal-Ingigliardi et al. , 1991 ) , but so far it was not clear which of the MalT sites present in the distal region are involved in promoter activation .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9000616" target="_blank">9000616</a>]<br></li>
<li>In contrast , the promoter of the malPQ operon , which is as strong as malEp and malKp , apparently depends only on , MalT for its activity ( Chapon , 1982 ; Raibaud et al. , 1985 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2016744" target="_blank">2016744</a>]<br></li>
<li>In contrast to other maltose operon promoters , which are regulated only by MalT : malEp and malKp are also positively controlled by CRP , a pleiotropic regulator involved in the control of carbon source utilization ( De Crombrugghe et al. , 1984 ; Chapon , 1982 ; Richet & Raibaud , 1987 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2538630" target="_blank">2538630</a>]<br></li>
<li>While the requirement for MalT is absolute ( Bedouelle , 1983 ) , the dependence on CRP is less stringent : malEp and malKp still work at 20 % and lo % , respectively , in the presence of MalT alone ( Raibaud et al. , 1989 ; Vidal-Ingigliardi & Raibaud , 1991 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2016744" target="_blank">2016744</a>]<br></li>
<li>However , it should be pointed out that MalT binding to the malEp - malKp region , which contains five MalT boxes , appears to be highly cooperative ( Raibaud et al. , 1989 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>One should recall that the nucleoprotein assembly formed at , malEp-malKp is thought to involve wrapping of the DNA around a core formed by the bound molecules of CRP and MalT ( Raibaud et al. , 1989 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2016744" target="_blank">2016744</a>]<br></li>
<li>Genetic data strongly suggest that this sequence is part of the MalT binding site ( Bedouelle , 1983 ; Gutierrez & Raibaud , 1984 ; Raibaud et al. , 1985 ) , but direct evidence that MalT binds to the `` MalT box '' is so far lacking .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2538630" target="_blank">2538630</a>]<br></li>
<li>Two other specific DNA-binding proteins that have been shown to alter their DNA contacts in response to environmental signals are the AraC and MalT proteins of E. coil ( Lobell and Schleif , 1990 ; Richet et al. , 1991 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=8087856" target="_blank">8087856</a>]<br></li>
<li>As a result , the speciﬁc inactivation of one site within a given unit is generally sufﬁcient to reduce MalT binding to this unit without precluding MalT binding to the overlapping set of MalT sites ( Richet et al. , 1991 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9000616" target="_blank">9000616</a>]<br></li>
<li>Indeed , the presence of the biotinylation domain ( BCCP ) attached to the C-terminus of MalT for protein immobilization renders MalT inactive in vivo ( Panagiotidis et al. , 1998 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>As shown in controlled by MalT ( Raibaud et al. , 1985 ) , depends only on the presence of ApA and CTP as substrates .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>As shown ( Raibaud et al. , 1989 ) , the afinity of MalT for its DNA binding sites is rather weak in the presence of chloride salts , which was a limiting factor for in vitro studies .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2016744" target="_blank">2016744</a>]<br></li>
<li>The minimal features establishing a gene as MalT dependent are the presence of a MalT box at ¹ 38 , replacing the usual ¹ 35 region of a standard promoter , plus two MalT boxes in tandem orientation further upstream on the same side of the DNA helix ( Vidal-Ingigliardi et al. , 1991 ; Danot and Raibaud , 1994 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9484893" target="_blank">9484893</a>]<br></li>
<li>In the presence of these two ligands , MalT binds to a degenerate decanucleotide sequence , 58-GGGGA ( T/G ) GAGG-38 ( T box ) , that is found in various permutations upstream of all mal promoters ( Richet and Raibaud , 1989 ; Vidal-Ingigliardi et al. , 1991 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9822819" target="_blank">9822819</a>]<br></li>
<li>Two observations indicate that MalT binds the mal promoters as an oligomer : ( i ) like MalT oligomerization , promoter binding depends on the presence of both effectors ( Raibaud and Richet , 1987 ; Richet and Raibaud , 1989 ; Schreiber and Richet , 1999 ) ; and ( ii ) MalT binds cooperatively to the MalT sites present in the promoters ( Vidal-Ingigliardi et al. , 1991 ; Danot and Raibaud , 1994 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>We tried the highest MalT concentration possible in order to fiil in all the non-mutated sites in the malPpW , malPp20 and malPp30 variants but we were iimited by the fact that above 500 nM and in the absence of RNA polymerase MalT seemed to slowly aggregate on the promoter and reverslbly inactivated it .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=7830577" target="_blank">7830577</a>]<br></li>
<li>However , the ﬁnding that the 3/4/5 set of sites stimulates malEp to some extent provided that the concentration of active MalT protein is high + enough ( i.e. in an induced malT strain ) indicates that the oligomeric structure built by MalT when occupying sites 1/2 and 3 ' / 4 ' / 5 ' can also form when MalT occupies sites 1/2 and 3/4/5 , albeit less efﬁciently .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9000616" target="_blank">9000616</a>]<br></li>
<li>malEpD64 was most active in the malTp1 malTp7 malPQ + strain in which protection of th MalT sites 1 and 2 was complete .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9000616" target="_blank">9000616</a>]<br></li>
<li>Interestingly , malEpD64 and malEpD92 displayed similar partial occupancy of MalT sites 1 and 2 when present in the malPQ − overproducing strain , while malEpD92 was 14-fold more active than malEpD64 .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9000616" target="_blank">9000616</a>]<br></li>
<li>Occupation of MalT sites 1 and 2 in malEpD64 in strains containing increasing amounts of active MalT protein .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9000616" target="_blank">9000616</a>]<br></li>
<li>Occupation of MalT sites 1 and 2 in the malEpD92 and malEpKp1 ,2,3 , I3 variants in strains containing increasing amounts of active MalT protein .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9000616" target="_blank">9000616</a>]<br></li>
<li>The role ( s ) that this structure or elements thereof play in the activation of malEp is analysed by monitoring both the occupancy of the proximal MalT sites ( sites 1 and 2 ) and the activity of different malEp variants in strains containing increasing amounts of active MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9000616" target="_blank">9000616</a>]<br></li>
<li>Role of the regulatory elements involved in malEp activation Promoter activity assays combined with analysis of the occupancy of MalT sites 1 and 2 of different malEp variants in strains producing increasing amounts of active MalT protein proved to be a successful approach to deﬁne the role of the multiple regulatory elements involved in malEp activation .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9000616" target="_blank">9000616</a>]<br></li>
<li>This simpie model is supported by the observation that the concentration of MalT is limiting for the activation of the promotere of the maltose reguion ( Hatfield et al. .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=7830577" target="_blank">7830577</a>]<br></li>
<li>Second , they exhibit the same sigmoidal responses to increasing concentration of MalT in vitro ( Richet & Raibaud , 1991 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9000616" target="_blank">9000616</a>]<br></li>
<li>This inference is further supported by the observation that , in vitro , malEp and malKp exhibit superimposable sigmoidal responses to increasing concentration of MalT ( Richet & Raibaud , 1991 ) , which indicates that the same event of cooperative binding underlies the two activation processes .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9000616" target="_blank">9000616</a>]<br></li>
<li>The in vivo DMS protection pattern of MalT sites 1 and 2 in malEp + is qualitatively similar to that obtained in vitro ( Richet & Raibaud , 1991 ) , although it is weaker than that observed in vitro under saturating conditions , which suggests that the MalT sites 1 and 2 of malEp + are only partially occupied in vivo , even under conditions of full induction .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9000616" target="_blank">9000616</a>]<br></li>
<li>Indeed , the 3 ' / 4 ' / 5 ' set of sites is clearly the most efﬁcient of the two sets of MalT sites in stimulating malEp at a saturating concentration of MalT , while only the sites 3 ' / 4 ' / 5 ' have the capacity to stimulate malEp when the MalT concentration becomes limiting .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9000616" target="_blank">9000616</a>]<br></li>
<li>Strikingly , MalT at a concentration which was too low to protect the maIPp MalT sites in the absence of RNA poiymerase was sufficient to give nearly full protection in its presence 0 O. Danot and O. Raibaud 0 1 2 0 1 2 0 1 2 - ao .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=7830577" target="_blank">7830577</a>]<br></li>
<li>The relative ability of the two sets of MalT sites to activate malEp was also examined under conditions in which the concentration of active MalT was limiting , i.e. in the presence of glycerol as the sole carbon source ( Vidal-Ingigliardi & Raibaud , 1991 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9000616" target="_blank">9000616</a>]<br></li>
<li>The fact that the concentration of MalT at which half-protection was observed was not changed in the presence of a fivefold excess of unlabelled DNA fragment indicates that active MalT protein was present in excess in t ' hese experiment , s. Therefore , the relatively high concentration required to achieve protection probably reflects the low affinity of the protein for its DNA binding sites .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2538630" target="_blank">2538630</a>]<br></li>
<li>This reduction of MgCl , concentration results in a 2-fold increase of MalT affinity for its DNA binding sites .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2538630" target="_blank">2538630</a>]<br></li>
<li>The above observations argue against a strict DNA loop model ( Hochschild & Ptashne , 1986 ) and are more consistent with a scenario whereby MalT binding to malEp-malKp results in the wrapping of the int , ervening DNA around a core of MalT proteins , this phenomenon occurring whether or not one set of MalT binding sites is missing .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2538630" target="_blank">2538630</a>]<br></li>
<li>The observation that the function of these sites is sensitive to the phase of the DNA helix has led to a model in which the DNA is wrapped around the complex composed of MalT and cAMP / CAP ( 199 , 206 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9529892" target="_blank">9529892</a>]<br></li>
<li>The simplest interpretation of these observations is that the oligomeric assembly resulting from the cooperative binding of MalT onto sites 1/2 and sites 3 ' / 4 ' / 5 ' can also form when MalT occupies sites 1/2 and 3/4/5 , albeit less easily , and that both types of complex can activate malEp ( see Discussion ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9000616" target="_blank">9000616</a>]<br></li>
<li>The sigmoidicity of the curve reflects the cooperative binding of MalT to the three MalT operator sites involved in malPp activation ( 15 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>The curve representing the response to increasing concentrations of MalT in the absence of MalY is sigmoidal as a result of co-operative binding of the activator to the three MalT sites present in malPp ( Danot and Raibaud , 1994 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>Recent studies revealed that the unliganded form of the protein is monomeric and that the function of both of these effectors is to induce MalT selfassociation , thought to play a critical role in promoter binding ( 4 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>Although the precise mechanism of how MalT interacts with and stimulates RNA polymerase is still unknown , there is considerable information about the structural requirements for MalT binding to DNA as well as its ability to form a nucleoprotein complex with the catabolite activator protein ( CAP ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9529892" target="_blank">9529892</a>]<br></li>
<li>Truncated forms of MalT lacking its C-terminal DNA binding domain are negatively dominant over the function of the wild-type protein , indicating that the protein interacts with itself when binding to DNA ( 40 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9529892" target="_blank">9529892</a>]<br></li>
<li>position function of the Sfsl protein is as a kind of DNA binding protein or interacting protein with an activating protein such as MalT or CRP .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2013578" target="_blank">2013578</a>]<br></li>
<li>Taken together , the results presented in Figs 5 and 6 and in Table 1 demonstrate that MalT binding to maIPp is a cooperative process which involves interactions between the MalT molecules bound to the different sites .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=7830577" target="_blank">7830577</a>]<br></li>
<li>Indeed , our results make it unlikely that MalT binding to target promoters implicates a discrete high-order multimer involving both isologous and heterologous interactions between protomers , as proposed by Raibaud , to account for cooperative 25 binding of MalT to diversely orientated MalT sites .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15491603" target="_blank">15491603</a>]<br></li>
<li>Therefore , one can not exclude the alternative scenario in which one ligand affects the interaction of the MalT monomer with a MalT box whereas the binding of the other ligand promotes interactions between different MalT monomers , thereby stabilizing the nucleoprotein complex .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>Thirdly , CAP may reposition UhpA bound to uhpTp rather than stabilize binding of the activator , as is seen with CAP and MalT interaction at the malK promoter ( 32 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=7896692" target="_blank">7896692</a>]<br></li>
<li>Finally , an attractive possibility is that MalT in fact exists as an oligomer , e.g. a tetramer , in which nucleotide binding to one protomer prevents binding to the other protomers through anticooperative effects .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>After binding the inducer , MalT activates the transcription of all mal operons .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2670898" target="_blank">2670898</a>]<br></li>
<li>All of these 12 effectors modulate directly or indirectly MalT selfassociation , a key step in promoter binding .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15491603" target="_blank">15491603</a>]<br></li>
<li>This hypottiesis was sfrengthened by the characterization of the binding of MalT to maIPp variants carrying the mutations malPpiO , malPp20 and malPp30 .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=7830577" target="_blank">7830577</a>]<br></li>
<li>MalT binding to nalEp-malKp .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>Both observations suggested co-operative binding of MalT molecules to sites 1 - 3 .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=7830577" target="_blank">7830577</a>]<br></li>
<li>More attractively , this phenomenon may be directly related to a crucial role that supercoiling might play in the formation and stability of a functional pre-initiation complex involving MalT , CRP and malEp-malKp .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2016744" target="_blank">2016744</a>]<br></li>
<li>These curves represent , true kine-tics of active complex formation and not slow steps preceding this process , since a longer preincubation of MalT and CRP with the template did not change the rate at which active complexes appeared .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2016744" target="_blank">2016744</a>]<br></li>
<li>Indeed , the presenceof a large number of MalT molecules in the overproducing cells would be expected to result in the substitution by MalT of the CRP molecules bound to the malEp-malKp regulatory region , leading to the formation of the less active nucleoprotein complex containing only MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2538630" target="_blank">2538630</a>]<br></li>
<li>Under these conditions the formation of active complexes at malEp and malKp could be easily followed as a function of time after addition of polymerase to the template that had been preincubated for 20 minutes with MalT and CRP ( Fig. 2 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2016744" target="_blank">2016744</a>]<br></li>
<li>Furthermore , no transcripts were observed for malEp and malKp even when active complex formation was allowed to proceed for 30 minutes or , as tested for malKp , when MalT and CRP concentrations were simultaneously increased four - and 2 + fold , respectively .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2016744" target="_blank">2016744</a>]<br></li>
<li>Rather , we could explain these observations by suggesting the formation of a nucleoprotein complex in which the proteins form a scaffold for wrapping the regulatory DNA in a way somewhat similar to the structure adopted by the interspersed bound MalT and CRP proteins responsible for malK promoter activation Table !! .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=7748925" target="_blank">7748925</a>]<br></li>
<li>Most of the in vivo properties malKp promoters can be explained by this model if we assumethat the integrity of these nucleoprotein structures , i.e. the anchorage points on both sides and the correct wrapping of the DNA , is essential for transcription activation by this complex and if we assume that the complex involving both MalT and CRP is the most active species.Deletions of the distal MalT boxes destroy the anchorage points .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2538630" target="_blank">2538630</a>]<br></li>
<li>It should be noted that we have presented the simplest model accounting for our present results and that this model relies on the assumption that the complex MalT forms in vitro with malEp-malKp is closely related to the structure actually responsible for transcription activation in vivo .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2538630" target="_blank">2538630</a>]<br></li>
<li>First , in vitro , MalT repositioning onto sites 3 ' / 4 ' / 5 ' , i.e. , formation of a higher-order structure based on sites 1/2 and 3 ' / 4 ' / 5 ' , is correlated with an increase in the afﬁnity of MalT for sites 1 and 2 ( E.R. , unpublished results ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9000616" target="_blank">9000616</a>]<br></li>
<li>Finally , the possibility that the enhanced occupation of MalT sites 1 and 2 observed in the malEp + context results from a local effect , e.g. , from a direct interaction with CRP bound to the adjacent CRP 1 site , rather than from the formation of the higher-order structure is excluded by the observation that in vivo ( this work ) and in vitro ( unpublished results ) CRP binding to site 1 does not signiﬁcantly increase the afﬁnity of MalT for sites 1 and 2 in malEpD92 .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9000616" target="_blank">9000616</a>]<br></li>
<li>In addition , a variant in which both functional units ( 3/4/5 and 3 ' / 4 ' / 5 ' ) had been inactivated by the destruction of sites 3 , 4 , 3 ' and 4 ' displays the same level of activity as malEpD92 ( Figure 2 ( a ) ) , thereby excluding the possibility that the malEp stimulation still observed when either set of distal MalT sites is inactivated is due to some other sequence element and not to the remaining set .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9000616" target="_blank">9000616</a>]<br></li>
<li>To ensure that the occupation of MalT sites 1 and 2 observed with malEp + was not due to a stabilizing effect of RNA polymerase bound at malEp and/or malKp , I veriﬁed that MalT sites 1 and 2 were similarly occupied in the absence of functional − 10 sequences .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9000616" target="_blank">9000616</a>]<br></li>
<li>The mechanism of activation by CRP is clearly different from that occurring at the divergent malEp-malKp promoters , which are simultaneously controlled by an array of three binding sites for CRP , all located at distal positions in between ( 36 ) , and forming a high-order structure responsible for activation , assisting direct activation by the MalT primary regulator .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9573142" target="_blank">9573142</a>]<br></li>
<li>The binding of MalT and CRP to this region is known to result in the formation of a higher-order structure that is responsible for malKp activation .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9000616" target="_blank">9000616</a>]<br></li>
<li>This stabilizing effect most likely results from the assembly of the higher-order structure formed by MalT and CRP at malEp-malKp .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9000616" target="_blank">9000616</a>]<br></li>
<li>Some elements of this structure , namely the CRP site 1 , located at − 76.5 , and the distal MalT sites , seem to play a direct role in malEp activation besides their participation in the assembly of the higher-order structure .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9000616" target="_blank">9000616</a>]<br></li>
<li>Hence , this suggests that malEpD64 might actually represent a minimal MalT-dependent promoter that is inactive because of a too low occupation of MalT sites 1 and 2 , and that the role of the upstream elements in malEp activation might simply be to ensure high occupation of MalT sites 1 and 2 through the assembly of a higher-order structure with MalT and CRP .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9000616" target="_blank">9000616</a>]<br></li>
<li>Formation of this structure is disfavored when MalT is present alone and the role of CRP in malKp activation is to facilitate the repositioning of MalT onto sites 3 ' / 4 ' / 5 ' by stabilizing this higher-order structure .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9000616" target="_blank">9000616</a>]<br></li>
<li>Hence , malEp activation primarily relies on MalT sites 1/2 , 3 ' / 4 ' / 5 ' and on the CRP sites 1/2/3 , i.e. on the same set of regulatory elements as malKp activation .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9000616" target="_blank">9000616</a>]<br></li>
<li>However , occupation of this series of sites is prevented by MalT binding to the overlapping 3/4/5 set of sites for which MalT has a higher intrinsic afﬁnity , and whose occupation does not lead to promoter activation because it is incorrectly located with respect to the promoter − 35 / − 10 elements .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9000616" target="_blank">9000616</a>]<br></li>
<li>This study indeed revealed the following : ( 1 ) occupation of MalT sites 1 and 2 is sufﬁcient to promote malEp activation ; ( 2 ) in vivo , under conditions of full induction , the activity of the truncated malEpD64 promoter is severely limited by the degree of occupancy of MalT sites 1 and 2 ; ( 3 ) one role of the upstream regulatory elements is to stabilize MalT at sites 1 and 2 ; ( 4 ) full occupation of these sites is not sufﬁcient , however , to ensure full promoter activity ; ( 5 ) CRP site 1 and the upstream MalT sites can independently increase the capacity of MalT bound to sites 1 and 2 to stimulate malEp ; and ( 6 ) this effect of CRP bound to site 1 does not involve stabilization of MalT at sites 1 and 2 .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9000616" target="_blank">9000616</a>]<br></li>
<li>Hence , when MalT is limiting , malEp activation critically depends on the 3 ' / 4 ' / 5 ' set of sites .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9000616" target="_blank">9000616</a>]<br></li>
<li>This indicates that the distal set of MalT sites plays an additional role in malEp activation besides aiding MalT to-bind to sites 1 and 2 .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9000616" target="_blank">9000616</a>]<br></li>
<li>The role of the upstream sets of MalT sites in malEp activation was assessed by examining in vivo the effect of mutations speciﬁcally inactivating either set of sites on promoter activity .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9000616" target="_blank">9000616</a>]<br></li>
<li>The fact that complete occupation of MalT sites 1 and 2 only partially reactivates malEpD64 indeed strongly suggests that some of the upstream elements play a speciﬁc role in malEp activation .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9000616" target="_blank">9000616</a>]<br></li>
<li>The location of Fis site I at nt 41 is analo-D 2 gous to the positions of other activators , such as the l repressor , MalT , AraC , and CRP ( in some cases ) , in which direct contact with s70 has been implicated ( 7 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=7545153" target="_blank">7545153</a>]<br></li>
<li>The data presented here clearly establish that occupation of MalT site 1 and 2 is indeed not sufﬁcient to fully activate malEp , and that both the CRP site 1 and the distal MalT sites further stimulate malEp , 14 and ﬁvefold , respectively , when the proximal MalT sites are similarly occupied .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9000616" target="_blank">9000616</a>]<br></li>
<li>The absence of any cooperativity in the binding of MalT and CRP to sites 1/2 and 1 , respectively , as revealed by the in vivo footprinting experiments makes it unlikely that contact with MalT bound to site 2 mediates this stimulatory effect of CRP , and lends support to the hypothesis of an interaction with the polymerase .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9000616" target="_blank">9000616</a>]<br></li>
<li>In particular , we verified that the activity of each promoter in vitro depended on the presence of the distal MalT binding sites , and that the promoters were also specifically sensitive to insertions in the central region that change the relative orientation of the distal and proximal moieties of the regulatory region .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2016744" target="_blank">2016744</a>]<br></li>
<li>The EcoRI-EcoRI DNA fragments of were transferred in both orientations in front of the mulPQ maZEp and of malKp promoter was then measured by assaying ( d ) DNase I footprint of MalT bound to malEpmalKp ( c ) Effect of deletions and insertions in the absence of CRP To determine whether the involvement of the distal MalT binding sites depended on the presence of CRP and to study their role in the DNA-turn dependence , we examined the effect of deletions and insertions on promoter activity in the absence of CRP .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2538630" target="_blank">2538630</a>]<br></li>
<li>The fact that the insertions have the same qualitative effect on malKp activity whether or not CRP is present suggests that in the presence of CRP the distal MalT binding sites have also to be stereoaligned with some downstream regulatory elements .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2538630" target="_blank">2538630</a>]<br></li>
<li>In this system , malEp and malKp are active only in the presence of both MalT and CRP , and various mutations in the MalT or CRP binding sites affect the promoters in the same way as they do in vivo .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2016744" target="_blank">2016744</a>]<br></li>
<li>( ( a ) malEp and malKp function in vitro as in vivo To ensure tha.t our in oitro system really mimics events occ * urring in , z ' iz > o , we examined whether malflp and malKp activity depended on the pre-sence of the distal MalT binding sites and on the presence of the same set of CRP binding sites as in Gvo .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2016744" target="_blank">2016744</a>]<br></li>
<li>Moreover , inactivation of both distal sets of MalT sites together with the three CRP sites abolishes promoter activity as efﬁciently as deletion malEpD64 ( Figure 2 ( b ) ) , thereby indicating that , in the absence of functional CRP sites , malEp activity is fully dependent on the presence of either set of distal MalT sites .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9000616" target="_blank">9000616</a>]<br></li>
<li>To determine whether the higher efﬁciency of the 3 ' / 4 ' / 5 ' set of sites in promoting assembly of a higher-order structure depended on the presence of CRP , I measured the effect of the distal sets of MalT sites on malEp in the absence of functional CRP sites .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9000616" target="_blank">9000616</a>]<br></li>
<li>The observations that the 3 ' / 4 ' / 5 ' set of sites has a stronger stimulatory effect on malEp than the 3/4/5 sites regardless of the presence of functional CRP sites and that CRP similarly enhances the stimulatory effect of both sets of MalT sites , indicates that the sensitivity to the phasing is actually essentially determined by MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9000616" target="_blank">9000616</a>]<br></li>
<li>The distal MalT sites play an additional role in malEp activation The possibility that the MalT molecules bound to either set of distal sites might play a direct role in malEp activation was tested by examining whether , when achieved in the presence of the distal MalT sites , full occupation of the proximal MalT sites would restore promoter activity to a higher level than that observed with malEpD64 .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9000616" target="_blank">9000616</a>]<br></li>
<li>The hypothesis of a direct role for CRP site 1 was tested by examining whether occupation of MalT sites 1 and 2 in the presence of CRP site 1 increased malEp activity to a higher level than that observed with malEpD64 .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9000616" target="_blank">9000616</a>]<br></li>
<li>However , the fact that in pop2226 , the malEpKp1 ,2,3 , I3 variant is only 29 % as active as the wild-type promoter , while displaying similar occupation of MalT sites 1 and 2 , suggests that complete occupation of MalT sites 1 and 2 in the presence of the distal MalT sites is not sufﬁcient to restore malEp activity fully and that one of the CRP sites also plays a direct role in promoter activation .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9000616" target="_blank">9000616</a>]<br></li>
<li>The fact that in the malPQ − overproducing strain , malEpD92 was almost as active as malEp + in pop2226 for a similar occupancy of MalT sites 1 and 2 , indicates that ﬁlling MalT sites 1 and 2 in the presence of CRP site 1 efﬁciently restores promoter activity .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9000616" target="_blank">9000616</a>]<br></li>
<li>Even when the defect in MalT synthesis in the absence of CRP was counteracted the of by presence a mutation in the malTp promoter that renders its activity CRP-independent , some problems persisted that impeded any quantitative assessment of the role played by CRP in the activation of the promoters of the three mal operons , malPQ , malEFG , and malK-lamB-malM ( 5 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=1824723" target="_blank">1824723</a>]<br></li>
<li>Mutations inactivating either MalT site 4 or the CRP site -LCB- malPp40 and malPpSO ) had no effect at all on the uninduced or induced activity of the promoter , clearly demonstrating the absence of any functional role for these two sites .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=7830577" target="_blank">7830577</a>]<br></li>
<li>The activity of the Ep92 promoter still depends on MalT ; its dependence on CRP has not been tested .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2538630" target="_blank">2538630</a>]<br></li>
<li>malEp and malKp are inactive in the absence of CRP , but their activity can be partially restored by overproducing MalT ( Chapon , 1982 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2538630" target="_blank">2538630</a>]<br></li>
<li>In both cases , deletion of the distal MalTbinding sites impaired promoter function to about the same extent as in a crp ' strain ( compare Kp228 to Kp240 , and Epl99 to Ep236 ) , showing that in the absence of CRP MalT boxes located between positions -200 and - 240 upstream from the transcription start site are still involved in transcription activation .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2538630" target="_blank">2538630</a>]<br></li>
<li>In vitro run-off transcription assays have revealed no significant transcription initiation in either direction from this site , either in the presence or absence of MalT and CRP .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2538630" target="_blank">2538630</a>]<br></li>
<li>In the absence of either MalT or CRP , less than 10 % and 5 ?	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2016744" target="_blank">2016744</a>]<br></li>
				<label class="ACT_collapse_similarity" for="act_similarity_199">
In the absence of CRP , MalT binds to three sites from which it can not activate transcription .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=16166533" target="_blank">16166533</a>]<br></label>
<input id="act_similarity_199", type="checkbox">
<div class="ACT_similar">
<li>In the absence of CRP , MalT binds three high affinity sites but is unable to activate transcription .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=8087856" target="_blank">8087856</a>]<br></li></div>
<li>In the absence of cAMP/CAP , MalT binds with high afﬁnity to the three MalT boxes upstream of the malK transcriptional start site ( identiﬁed previously ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9529892" target="_blank">9529892</a>]<br></li>
<li>In the absence of MalQ , the higher amount of endogenous inducer available leads to an increase in the amount of MalT , .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9884223" target="_blank">9884223</a>]<br></li>
<li>In the absence of inducer , it interacts with MalT to cause repression .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9529892" target="_blank">9529892</a>]<br></li>
<li>This model is compatible with the known properties of CRP , since the direction of the bend induced by the binding of CRP to its recognition site ( Liu-Johnson et al. , 1986 ) is the same as the one resulting from DNA wrapping around MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2538630" target="_blank">2538630</a>]<br></li>
<li>One of its function is architectural : via binding to the three CRP binding sites and bending the DNA , it facilitates cooperative binding of MalT onto sites 1/2 and the distal sites ( Richet & Sogaard-Andersen , 1994 ) , thereby ensuring high occupancy of the critical MalT sites 1 and 2 .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9000616" target="_blank">9000616</a>]<br></li>
<li>CRP binding to these sites bends the DNA and causes MalT to shift 3 bp downstream to-binding sites from which MalT can activate transcription ( 24 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=16166533" target="_blank">16166533</a>]<br></li>
<li>Is the sensitivity to the relative angular orientation of the proximal and distal sets of MalT sites a property intrinsic to MalT or is it due to the increased torsional stiffness of the intervening DNA resulting from CRP binding ?	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9000616" target="_blank">9000616</a>]<br></li>
<li>Therefore , it is difﬁcult to conclude whether the DNA and the MalT oligomers speciﬁcally interact via MalT recognition sites .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15491603" target="_blank">15491603</a>]<br></li>
<li>Third , some G residues that were protected by MalT on supercoiled DNA were more reactive when MalT was added to relaxed DNA , and viceversa .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2016744" target="_blank">2016744</a>]<br></li>
<li>However , a constant consequence of MalT -- DNA interaction is the strong reduction in the radius of curvature of the MalT oligomers .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15491603" target="_blank">15491603</a>]<br></li>
<li>In addition , dimethylsulphate protection experiments provide evidence that the nucleoprotein complexes formed by CRP and MalT bound to malEp and TmalKp on supercoiled and relaxed DNA are different .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2016744" target="_blank">2016744</a>]<br></li>
<li>In this structure , the DNA appears to be wrapped around a core of proteins made up of MalT molecules ( when CRP is omitted ) or of a mixture of MalT and CRP molecules .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2664421" target="_blank">2664421</a>]<br></li>
<li>This indicates that in the malEpD92 context , CRP does not cause increased transcription by stabilizing MalT at sites 1 and 2 .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9000616" target="_blank">9000616</a>]<br></li>
<li>In contrast , the mechanism whereby MalT and CRP coactivate malEp remains elusive .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9000616" target="_blank">9000616</a>]<br></li>
<li>To conclude , it is important to stress the complexity of the mechanism by which MalT and CRP coactivate malEp .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9000616" target="_blank">9000616</a>]<br></li>
<li>These results indicated that overexpression of Sfsl could induce amylomaltase in a CRP * and MalT + host .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2013578" target="_blank">2013578</a>]<br></li>
<li>However , it is worth noting that a 20 minute preincubation of MalT , CRP and the template was necessary .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2016744" target="_blank">2016744</a>]<br></li>
<li>CRP and MalT act alone or in combination , depending on the promoter .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2016744" target="_blank">2016744</a>]<br></li>
<li>MalT MalT , CRP malK 4 .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=1943993" target="_blank">1943993</a>]<br></li>
<li>and malKlam & maEM operons are controlled by both MalT and CRP .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2016744" target="_blank">2016744</a>]<br></li>
<li>As mentioned in the Introduction , the MalT protomer bound to the most proximal MalT site is thought to contact RNA polymerase ( Danot et al. , 1996 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9000616" target="_blank">9000616</a>]<br></li>
<li>One possibility is that the CRP molecule bound to site 1 or/and one of the MalT protomers distally bound facilitate the initiation process , either by directly contacting the polymerase or by aiding one of the MalT protomers bound downstream to interact with the enzyme .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9000616" target="_blank">9000616</a>]<br></li>
<li>One could also imagine that the CRP molecule bound to site 1 contacts the polymerase even though its binding site is not at a permissive location ( Choy et al. , 1995 ) , and that the MalT protomers bound downstream transform this contact into a productive one .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9000616" target="_blank">9000616</a>]<br></li>
<li>We can not be sure that the nucleoprotein complex formed by maIPp and MalT involves only three active MalT mole-cules bound to sites 1 - 3 , However , for the purposes of this discussion , we will make this supposition as a working hypothesis .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=7830577" target="_blank">7830577</a>]<br></li>
<li>We interpret these results as meaning that ' this segment is now wrapped around the core formed by the MalT proteins bound to the malEp side .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2538630" target="_blank">2538630</a>]<br></li>
<li>This core could consist only of MalT monomers bound to their recognition sites or it could be formed of additional MalT proteins whose aggregation is nucleated by those bound to the MalT boxes .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2538630" target="_blank">2538630</a>]<br></li>
<li>The arrays of MalT sites in the mal promoters might be bound by a MalT multimer present in solution .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10559195" target="_blank">10559195</a>]<br></li>
<li>The primary activator is MalT which activates malKp when bound to the 3 ' / 4 ' / 5 ' set of sites present in the promoter proximal region .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9000616" target="_blank">9000616</a>]<br></li>
<li>One role of the higher-order structure formed by MalT and CRP when bound to the entire regulatory region is to ensure high occupation of MalT sites 1 and 2 , but it is not its only function .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9000616" target="_blank">9000616</a>]<br></li>
<li>So far , it was unclear why the higher-order structure preferentially assembles when MalT is bound to sites 1/2 and 3 ' / 4 ' / 5 ' .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9000616" target="_blank">9000616</a>]<br></li>
<li>Whaf is the functional role of MalT bound to sites 2 and 3 ?	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=7830577" target="_blank">7830577</a>]<br></li>
<li>MalT activates transcription only when bound at the correct sites .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10715008" target="_blank">10715008</a>]<br></li>
<li>DNase I footprints of MalT bound to the Ep236 , Ep225 , Ep204 or Ep193 fragments , whic present different deletions on the malKp side , are consistent with the notion that MalT individually recognizes MalT boxes 2/3 , 4 and 5 ( Fig. 6 ( a ) ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2538630" target="_blank">2538630</a>]<br></li>
<li>Second , the DNase I , hydroxyl radical and DMS footprints of MalT bound to matPp demonstrate that the major groove section corresponding to base pair - 3 3 is opposite the face of the DNA heiix contacted by MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=7830577" target="_blank">7830577</a>]<br></li>
<li>DMS footprints of MalT bound to maiPp in supercoiled DNA ( s.c. ) or linear DNA ( 1 .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=7830577" target="_blank">7830577</a>]<br></li>
<li>DNase I footprint of MalT and RNA polymerase bound to malPp .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=7830577" target="_blank">7830577</a>]<br></li>
<li>DNase I footprints of MalT bound to different mutated malPp .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=7830577" target="_blank">7830577</a>]<br></li>
<li>B , DMS footprints of MalT bound to malPp .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=7830577" target="_blank">7830577</a>, <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=7830577" target="_blank">7830577</a>]<br></li>
<li>Dimethylsulphate footprints of MalT and CRP bound to malEp-wdKp .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2016744" target="_blank">2016744</a>]<br></li>
<li>DPu'ase I footprint of MalT bound to the mulEp-malKp region .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2538630" target="_blank">2538630</a>]<br></li>
<li>When filtered alone , MalT and MalY eluted at the positions of < 110 kDa and 70 kDa globular proteins , respectively , consistent with the fact that MalT ( 103 kDa ) is essentially monomeric under these conditions ( Schreiber and Richet , 1999 ) and that MalY is a dimer of 2 43.5 kDa ( T. Clausen et al. , unpublished ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>When filtered alone under these conditions , MalY eluted at the position of an < 70 kDa protein , as above , whereas MalT eluted as an < 300 kDa globular protein ( Fig. 4D ) , consistent with the fact that MalT is known to multimerize in the presence of both its effectors ( Schreiber and Richet , 1999 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>In the protein concentration range examined ( from 2.1 mM MalY/4 .6 mM MalT to 10 mM MalY/20 mM MalT ) , the apparent molecular weight of the complex , as measured by gel filtration , increases from 165 to 230 kDa , thereby suggesting that the MalY ± MalT complex is not a stable species but is in rapid equilibrium with dissociated forms of MalY and MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>This suggests that the MalT-Aes complex is actually in rapid equilibrium with dissociated MalT and Aes forms , with the fraction of the complexed proteins increasing with the concentration of the proteins , and the position of the peak reflecting the weighted average Stokes radius of the species in equilibrium .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>This strongly suggests that the MalY/MalT complex is actually in rapid equilibrium on the timescale of the chromato-graphy with dissociated MalT and MalY forms , the fraction of material in the associated form increasing with protein concentrations .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>In the presence of both effectors , MalT binds to the asymmetric 5 ' - GGAT/GGA nucleotide sequence which is present in several copies in the mal promoters ( 32 ) and , by an unknown mechanism , increases the rate of open complex formation at these promoters ( 30 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2180908" target="_blank">2180908</a>]<br></li>
<li>As shown in Fig. 1 , MalK strongly depressed malPp activation by MalT in the absence of maltotriose ; the amount of open complexes formed was reduced by 80 % in the presence of 8 M MalK .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>( i ) Purified MalK is able to prevent open complex formation at the malPp promoter in the presence of RNA polymerase in a purified transcription system ; ( ii ) as shown by affinity chromatography , MalK specifically interacts with MalT ; and ( iii ) MalK inhibits maltotriose binding .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>The ATP-free MalT preparation ( 0.8 ml , containing ' 7 mg/ml protein ) was at least 90 % active as determined by using an abortive initiation assay monitoring the ability of the protein to activate open complex formation at the malPp promoter ( 18 ) ( The activity routinely displayed by MalT after purification in the presence of ATP is considered to correspond to 100 % activity ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10559195" target="_blank">10559195</a>]<br></li>
<li>MalT was incubated with malPp DNA and AMP-PNP2 in the presence or absence of MalK before adding RNA polymerase and allowing open complex formation .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>RESULTS Aes Inhibits Transcription Activation by MalT in Vitro -- MalT inhibition by Aes was assessed in vitro by measuring the ability of MalT to activate open complex formation at , a malPp MalT-dependent promoter , in the presence of Aes .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>The effect of MalK on MalT was assessed by monitoring the ability of MalT to activate open complex formation in the presence of MalK at malPp , a promoter whose activity depends strictly on MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li>
<li>MalT activity was assayed by monitoring its ability to activate open complex formation at malPp , a MalT-dependent promoter , in the presence of RNA polymerase .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>Indeed , both ATP and ADP can promote MalT multimerization or inhibitory complex formation , but ATP is more effective in driving MalT self-association , whereas ADP is more effective in promoting the formation of an inhib-itory complex ( 16 , 19 , 20 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>MalT displays weak ATPase activity whose function remains elusive : protein self-association , promo-ter binding and open complex formation do not require ATP hydrolysis ( Richet and Raibaud , 1989 ; Schreiber and Richet , 1999 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>Although MalT displays a weak ATPase activity , ATP hydrolysis is not required for promoter binding and activation of open complex formation ( 18 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10559195" target="_blank">10559195</a>]<br></li>
<li>MalT is endowed with a weak ATPase activity whose role is thus far elusive ; activation of open complex formation does not require ATP hydrolysis ( 5 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>The conclusion that ATP hydrolysis is not needed at least up to formation of the open complex is further strengthened by the observation that the MalT-ADP form was fully competent for activation provided that MalT concentration was high enough .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>0 0.1 0.2 03 0.6 MalT ( PM ) ATP hydrolysis is not required for activation of open complex formation As shown in Figures 4 and 5 , AMP-PNP , a non-hydrolysable analogue of ATP , was as effective as ATP for activation of open complex formation by MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>As clearly shown here , activation of open complex formation by MalT does not require ATP hydrolysis .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>As shown in Figure 3 ( a ) , 10 activation of open complex formation by MalTN637T is not depressed by MalK at a concentration that reduced activation by wild-type MalT by 70 % .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li>
<li>MalT-N637T was about 80 % as active as wild-type MalT , when activation of open complex formation at malPp was assayed ( see below ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li>
<li>Transcription activation by MalT 1 involves MalT self-association , cooperative bind-2 ing to copies of the MalT recognition motif that are present in target promoters , and stimulation of 3 -- 5 open complex formation by RNA polymerase .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li>
<li>Transcription activation by MalT involves MalT self-association , cooperative binding to an array of MalT sites located in the target promoters , and stimulation of open complex formation by the RNA polymerase ( 14 -- 16 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>Effect of different adenine nucleotides on activation of open complex form.ation by MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>MalT binding to DNA shows the same specificity for maltodextrins and nucleotides as MalT activation of open complex formation .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>Data obtained in the presence be fitted by the equation : as in the absence of CRP-cAMP could Table I. Activities of the malT and Px promoters MalT In the presence of Px Px In the presence of malT Alone Alone Template 214 bp 214 bp cut by HIphIl 214 bp 214 bp cut by HaeIll Product ApUpU ApUpU CpUpUpU ApUpC CpUpUpU ApUpC - CRP 38 49 16 7 12 6 19 i 9 12 6 + CRP 71 74 2 I 1 1 I1 1 1 +1 The activities or tum-over numbers of the two promoters are expressed as the amount of mols of UMP incorporated/mol of template/min with SD 20 % unless otherwise indicated .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2832158" target="_blank">2832158</a>]<br></li>
<li>In contrast , these mutations caused a 5 -- 14 times increase in the activity of malEpD92 in the presence of MalK , which resulted in a dramatic decrease in the repression by MalK from 12.5 for wild-type MalT to 1.0 -- 1.9 for the mutants .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li>
<li>In conclusion , all of the substitutions altering residues R634 , E636 , N637 , L638 , L639 , G640 and R656 enhance MalT activity under conditions of repression by MalK but have no signiﬁcant effect o MalT activity in the absence of repressor or in the presence of MalY or , in the cases of residues 634 , 636 , 637 and 639 , in the presence of Aes .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li>
<li>Therefore , the effect of MalY and MalK on the activity of MalT depends on the amount of MalT and on the presence of inducer .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9529892" target="_blank">9529892</a>]<br></li>
<li>Also , to ensure that inhibition by MalY , if any , would be detected , the assays were performed in the presence of a limiting concentration of MalT , i.e. a concentration giving about half of the maximum response under the chosen ligand concentration conditions ( see the inset in Fig. 1 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>As above , the effect of MalY was examined in the presence of MalT concentrations that were limiting under the ligand concentration conditions chosen ( see insets in Fig. 7A and B ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>The concentration of MalT that was used to test the effect of MalK was that eliciting about half of the maximum response under the chosen conditions .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>The assays were performed in the presence of a limiting concentration of MalT to ensure that inhibition by MalK , if any , would be detected .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li>
<li>The presence of a limiting concentration of MalT in the assay ensures that MalT inhibition by MalK can be readily detected .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>However , because the comparative assays reported here were performed in the presence of a saturating concentration of MalT , a differential effect of CRP might have been overlooked , and the possibility remains that CRP may also increase the bias toward the 1/2 -3 ' / 4 ' / 5 ' looped structures via an increase in the torsional rigidity of the DNA in the central region .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9000616" target="_blank">9000616</a>]<br></li>
<li>DNase I footprints of MalT bound to its recognition site are often characterized by the presence of two bands in the middle of t ' he protected area which result either from an enhanced cutting or from a partial protection ( see boxes 213 and 4 in Fig. 4 ( a ) ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2538630" target="_blank">2538630</a>]<br></li>
<li>To assess the occupancy of MalT sites 1 and 2 in malEpD64 , I performed in vivo dimethyl sulphate ( DMS ) protection experiments on isogenic DmalT and malT + strains harbouring pOM82 or pOM82malEpD64 and grown in the presence of glycerol and maltose as for promoter assays .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9000616" target="_blank">9000616</a>]<br></li>
<li>For this purpose , DMS footprinting experiments were perfomied as described for the experiment presented in Fig. 4 except that the MalT concentration was varied , and the occupancy of each site was quantified from the percentage of protection of the G residues whose reactivity decreased in the presence of MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=7830577" target="_blank">7830577</a>]<br></li>
<li>DBase I protection experiments were carried out in the presence of 1 PM-MalT and IO mM-MgCl , , with E'coRI - BamHI Kpx fragments 3 ' end-labelled at the BamHI extremity ( upper strand in Fig. 5 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2538630" target="_blank">2538630</a>]<br></li>
<li>We also performed footprinting experiments on maIPp in the presence of several MalT concentrations and RNA polymerase .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=7830577" target="_blank">7830577</a>]<br></li>
<li>DNase I , DMS and hydroxyl radicai footprinting experiments Footprinting experiments in the presence of MalT alone were performed with SamHI-Smal and BglW-Nde \ fragments containing maIPp or maiPp vamr \ ts and purified from pOM22 or from its derivatives on polyacrylamide gels .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=7830577" target="_blank">7830577</a>]<br></li>
<li>diagrammatically represented in Quantitative analysis of Ma/T interaction with sites 1-3 in maIPp and maIPp variants MalT interaction with DNA fragments canving maIPp or maIPp variants was quantitatively analysed by measuring the percentage of protection of each site in DNase I footprinting experiments perfomied in the presence of various MalT concentrations .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=7830577" target="_blank">7830577</a>]<br></li>
<li>DNase I protection experiments were carried out with an end-labelled malEp - malKp DNA fragment in the presence of MalT and various combinations of effectors .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>A. DNase I footprints were perfomied in the presence of various MalT concentrations with matPp carried by ttie SamHl-Smal Iragment labelled at the SamHI extremity .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=7830577" target="_blank">7830577</a>]<br></li>
<li>B. DMS footprints were performed with maiPp carried by tha supercoiied replicative form of M13malPl DNA in the presence of various MalT concentrations .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=7830577" target="_blank">7830577</a>]<br></li>
<li>Figure 4 shows the footprints obtained for each DNA strand in the presence of various concentrations of MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2538630" target="_blank">2538630</a>]<br></li>
<li>( b ) Abortive initiation performed malPp in the assays were on presence of 0.28 MM MalT and 10 MM of the indicated nucleotide as described in Materials and methods .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>The DBase I protection experiments were carried out as described in Materials and Methods in the presence of the indicated concentrations of MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2538630" target="_blank">2538630</a>]<br></li>
<li>The assays were carried out in the presence of the indicated concentrations of MalT as described in Materials and Methods , except that the concentration of MgCl , was 1 mnr .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2538630" target="_blank">2538630</a>]<br></li>
<li>Because low temperature and citrate anions were known to stabilize MalT in the absence of ATP ( 18 ) , gel filtration was performed at 6 ° C in the presence of a buffer containing 33 mM tri-potassium citrate .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10559195" target="_blank">10559195</a>]<br></li>
<li>Because of the low affinity of MalT for Ep47 , the assays involving this fragment were performed in the presence of 75 % polyethylene glycol 6000 ( Zimmerman & Harrison , 1987 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2538630" target="_blank">2538630</a>]<br></li>
<li>SDS ± PAGE analysis confirmed that both proteins were present in the peak fractions and indicated that observed trailing is most probably caused by the presence of free MalT ( Fig. 4C ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>Second , the presence of MalT decreased th / ^ Pp40 PpSO A TCG f ^ iO Pp15 Pp19 CTC A T L GAG GAG TGGTTGAGATCAC : : ACCAACTCmGTG TTCCTTfeCTCATCCCC SCAACTCCTCCCI3CCTAATCCCCCG : AGGATGAG , GG GAGTAGGGG ^ GTTTGAGGAGGGfl ; GGATTAGGGGGC JTCCTACTC - ao 3 5 -50 ^ ^ ¬ .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=7830577" target="_blank">7830577</a>]<br></li>
<li>These basal activities were totally MalT-dependent ( 25 ) and probably resulted from the presence of an internal inducer or from a weak activity of MalT without inducer .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=1824723" target="_blank">1824723</a>]<br></li>
<li>When assayed in the absence of ATP , 1.1 tM of MalT gave the same signal as 0.07 gM MalT tested in the presence of a saturating concentration of ATP , indicating that ATP stimulates MalT activity at least 16-fold .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>Indeed , the loss of promoter activity resulting from these mutations can not be offset by a 15-fold increase in MalT concentration ( presence of malTp7 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=7830577" target="_blank">7830577</a>]<br></li>
<li>Crosses symbolize the malEpKp1 , -2 and -3 mutations , which correspond to 3 bp substitutions and which inactivate the CRP sites 1 , 2 and 3 , respectively ( Vidal-Ingigliardi & Raibaud , 1991 ) Occupation of MalT sites 1 and 2 requires the presence of upstream regulatory elements As mentioned above , the truncated malEpD64 promoter , which comprises only MalT sites 1 and 2 , is inactive .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9000616" target="_blank">9000616</a>]<br></li>
<li>Altogether , these dat demonstrate that occupation of MalT sites 1 and 2 depends on the presence of upstream regulatory elements .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9000616" target="_blank">9000616</a>]<br></li>
<li>In the presence of both MalT and CRP , CRP molecules bind to their recognition sites , replacing several of the MalT monomers which nonspecifically contacted the DNA .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2538630" target="_blank">2538630</a>]<br></li>
<li>In the presence of CRP , MalT is repositioned to three adjacent sites of lower affinity and is thereby properly aligned to activate malK expression .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=8087856" target="_blank">8087856</a>]<br></li>
<li>Both promoters show some activity in the presence of MalT alone while they are completely inactive in the presence of CRP alone .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9000616" target="_blank">9000616</a>]<br></li>
<li>Figure 3 shows the response of malEp and malKp to inczreasing concent , rations of MalT in the presence of a saturating concentration of CRP .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2016744" target="_blank">2016744</a>]<br></li>
<li>mal & and malKp depended on the presence of both MalT and CRP , as observed in vivo .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2016744" target="_blank">2016744</a>]<br></li>
<li>the activities of mdEp and malKp depend on the presence of both CRP and MalT as they do in viva .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2016744" target="_blank">2016744</a>]<br></li>
<li>The studies reported here , which consist of DNase I footprinting of MalT bound to DNA fragments containing various segments of malEpmulKp , clearly indicate a close correlation between MalT binding and the presence of this hexa-nucleotide .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2538630" target="_blank">2538630</a>]<br></li>
<li>Intriguingly , the presence of malPp DNA causes the MalT polymers to undergo a dramatic conformational change .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15491603" target="_blank">15491603</a>]<br></li>
<li>Therefore , we do not know whether the conformational change that occurs in the presence of malPp involves non-speciﬁc MalT -- DNA interactions or MalT binding to the cognate sites present on the fragment .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15491603" target="_blank">15491603</a>]<br></li>
<li>In the presence of cAMP/CAP , MalT binding is shifted by three nucleotides toward the Pribnow box of the malK promoter .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9529892" target="_blank">9529892</a>]<br></li>
<li>Therefore , the presence of MalT site 4 and of the CRP-binding site in maIPp remains unexplained .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=7830577" target="_blank">7830577</a>]<br></li>
<li>1969 and this work : compare maIPp activity in the presence of malTp * and malTp7 ) and by the observation that the binding of MalT to maIPp is co-operative .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=7830577" target="_blank">7830577</a>]<br></li>
<li>We verified that , in all cases , ApApC synthesis was proportional to time for at least 40 min after the initiation of the reaction and that it was strictly dependent on the presence of MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=7830577" target="_blank">7830577</a>]<br></li>
<li>confimied that the three-nucleotide substitution introduced in each site strongiy inactivated it , since protection of the mutate site could not be detected even in the presence of 1 \ M MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=7830577" target="_blank">7830577</a>]<br></li>
<li>These polypeptides probably corresponded to proteolytic fragments of MalT and MalTc , since all of the strains are isogenic except for the presence of the different alleles of malT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2180908" target="_blank">2180908</a>]<br></li>
<li>Cryo-electron microscopy of the nucleoprotein complexes formed by MalT in the presence of malPp500 promoter .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15491603" target="_blank">15491603</a>]<br></li>
<li>These modifications of the pattern of DMS reactivity in the presence of MalT have been found reproducibly in three independent experiments .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=7830577" target="_blank">7830577</a>]<br></li>
<li>maiPp20 and maiPp30 in the presence of 0 ( lane 0 ) , 0,2 nM ( iane 1 ) and 1 pM ( lane 2 ) MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=7830577" target="_blank">7830577</a>]<br></li>
<li>In the presence of a DNA fragment containing a MalT-controlled promoter , malPp500 , MalT forms homopolymers with a much smaller radius of curvature and a different conformation .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15491603" target="_blank">15491603</a>]<br></li>
<li>In the presence of MalT '' ( maZTCmutation ) or without MalQ ( malQ mutation ) , malK expression more or less depends on pH , .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9884223" target="_blank">9884223</a>]<br></li>
<li>In this test , pOM34 , a plasmid carrying a gene fusion between malP and lacZ , was incubated in a cell extract in the presence of various amounts of MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2180908" target="_blank">2180908</a>]<br></li>
<li>Second , the poly dispersion of the homopolymers revealed by cryo ¬ EM is consistent with ﬁltration data , indicating that , in the presence of both an adenine trinucleotide and maltotriose , MalT does not form discrete size multimers , but self-associates into rapidly equilibrating species whose average size monotonically increases with the concentration of the protein .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15491603" target="_blank">15491603</a>]<br></li>
<li>Activities of MalT , MalTc22 , and MalTC26 as a function of protein concentration in the presence or absence of maltotriose .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2180908" target="_blank">2180908</a>]<br></li>
<li>Activities of MalT , MalTc22 , and MalTc26 as a function of maltotriose concentration at limiting protein concentrations .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2180908" target="_blank">2180908</a>]<br></li>
<li>That MalT is actually monomeric at 1 mM in the presence of maltotriose is consistent with the observation that at low concentration , MalT has a sedimentation coefficient s20 , w of 5.9 S , which corresponds to that of an ' 110-kDa globular protein ( Fig. 3B ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10559195" target="_blank">10559195</a>]<br></li>
<li>( Because we could not decrease the concentration of the protein below 2 mM , we do not know whether MalT is dimeric or monomeric at low concentrations in the presence of both maltotriose and AMP-PNP .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10559195" target="_blank">10559195</a>]<br></li>
<li>The presence of a wild-type malPQ + operon , which encodes enzymes involved in the catabolism of maltodextrins , further increases the concentration of active MalT in a malTp1 malTp7 background ( see below ) , possibly through an effect on the production of maltotriose ( the true inducer ) from maltose .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9000616" target="_blank">9000616</a>]<br></li>
<li>When a plasmid bearing a malP-lacZ gene fusion was incubated in a coupled transcription-translation system in the presence of wild-type MalT protein , the activation of transcription at malPp and , consequently , the synthesis of the hybrid MalP-LacZ protein were specifically and totally dependent on the presence of maltotriose ( 25 ) ( Fig. 5 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2180908" target="_blank">2180908</a>]<br></li>
<li>In the presence of maltotriose , the activities of the three proteins were very similar to the activity of wild-type MalT ; half-maximal MalP-LacZ synthesis was reached at about the same MalT concentration ( taking into account the lower degree of purity of MalTc22 ) , and , at a saturating protein concentration , the same amount of MalP-LacZ was synthesized ( Fig. 5 ) ( since all of the properties of MalTC25 and -26 are identical , only the experimental data obtained for MalTC26 are shown in Fig. 5 and 7 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2180908" target="_blank">2180908</a>]<br></li>
<li>Whereas wild-type MalT activity was absolutely dependent upon the presence of maltotriose , even at high protein concentrations , both mutated proteins were partially active in the absence of this sugar .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2180908" target="_blank">2180908</a>]<br></li>
<li>In the absence of maltotriose , however , wild-type MalT was totally inactive , whereas MalTC22 and -26 were as active as they were in the presence of maltotri-ose , although a higher concentration of protein was required to reach the plateau ( Fig. 5 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2180908" target="_blank">2180908</a>]<br></li>
<li>Therefore , although t ' he MalT protein is overproduced , the concentration of active MalT protein in the absence of inducer is similar to that found in a partly induced wild type st ' rain .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=6379197" target="_blank">6379197</a>]<br></li>
<li>Whereas in an in vitro assay the wild-type MalT protein is inactive in the absence of maltotriose , the MalT ( Con ) proteins are active in the absence of maltotriose but still bind maltotriose with an increased afﬁnity .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9529892" target="_blank">9529892</a>]<br></li>
<li>The variant assayed is MalT 26 , C which has been characterized previously and shown to be active in vitro in the absence of maltotriose and to display higher affinity for the inducer than the wild-type protein ( Dardonville and Raibaud , 1990 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>MalTC26 , but not MalT , was active in the absence of maltotriose ( Fig. 6 ) , confirming the result obtained in the coupled transcription-translation assay .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2180908" target="_blank">2180908</a>]<br></li>
<li>The in vitro properties of the MalTC proteins described in this paper are also consistent with the second , more classical hypothesis , since the maW7 ` mutations seem to lock MalT in a conformation in which the proteins are active even in the absence of maltotriose .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2180908" target="_blank">2180908</a>]<br></li>
<li>The MalT-Aes complex is in rapid equilibrium with free MalT and Aes on the time scale of the chromatography , and the apparent molecular mass of the complex increases with increasing concentrations of the partners without reaching a limit value within the protein concentration range used .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>The progressive increase of the apparent mo-lecular mass of the peak of MalT multimers suggests the presence of several multimeric species in rapid equilibrium on the time scale of the chromatography , the position of the peak reflecting the weighted average Stokes radius of the species in equilibrium .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10559195" target="_blank">10559195</a>]<br></li>
<li>The continuous shift of the peak position is best explained by the presence of several species in rapid equilibrium , e.g. the ( MalT ) n form and lower molecular mass species , the fraction of material in the ( MalT ) n form increasing with the protein concentration .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10559195" target="_blank">10559195</a>]<br></li>
<li>The fact that malEpKp1 ,2,3 , I3 was not fully active in the MalT overproducing strains was not due to the presence of an excess of MalT because intermediate values were obtained when the variant was assayed in strains overproducing MalT to a lesser extent ( in malTp1 malPQ − or malTp7 malPQ − strains ; data not shown ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9000616" target="_blank">9000616</a>]<br></li>
<li>The MalP-LacZ protein fusion was synthesized in the transcriptiontranslation coupled system programmed with pOM34 in the presence of various amounts of purified MalT , MalTC26 , or MalTC22 protein and in the presence ( O , 0 , and A ) or absence ( El , 0 , and A ) of 1 mM maltotriose .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2180908" target="_blank">2180908</a>]<br></li>
<li>The MalP-LacZ protein fusion was synthesized in the transcriptiontranslation system programmed with pOM34 in the presence of a MalT 2 U of limiting amount of the activator protein ( 1.8 U of [ M ] , MalTc22 [ A ] , or 1.5 U of MalTC26 [ 0 ] ) and in the presence of various concentrations of maltotriose .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2180908" target="_blank">2180908</a>]<br></li>
<li>The outer membrane contains the receptor maltodextrins requires the presence of the regulator protein , for phage X ( 5 ) , which functions as a maltodextrin-specific MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=1544897" target="_blank">1544897</a>]<br></li>
<li>The fractions containing MalT protein were identified by analysis on polyacrylamide gels in the presence of SDS and pooled .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=6283313" target="_blank">6283313</a>]<br></li>
<li>The expression of malT is not autoregulated by MalT but is subject to catabolite repression and therefore requires the presence of the cAMP/CAP complex ( 35 , 36 , 65 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9529892" target="_blank">9529892</a>]<br></li>
<li>The absence or presence of MalT ( 0.5 PM for Ep236 , Ep225 , Ep204 , Ep193 and Epl68 ; 0.5 and 1.0 PM for Ep92 ; and 1.0 FM for Ep47 ) are marked with - and + signs , respectively .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2538630" target="_blank">2538630</a>]<br></li>
<li>The cells were grown in minimal medium in the presence of glycerol and maltose , i.e. under conditions in which both MalT and CRP are active .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9000616" target="_blank">9000616</a>]<br></li>
<li>As shown in Table I , MalT binds dATP and AMP-PNP as effectively as ATP , has a relatively high affinity for ADP and GTP , but exhibits only ( © ) IRL Press ~ ~ .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>As shown in Fig. 7A , MalY inhibited MalT activity when AMP-PNP was substituted for ATP .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>Gel filtration experiments were performed in the presence of AMP-PNP , a non-hydrolysable analogue of ATP , or ADP , both of which also function as positive effectors of MalT ( Richet and Raibaud , 1989 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>The weak efficiency of ADP , apparent only at a low concentration of MalT , might therefore simply reflect a 5-times lower affinity of the MalT-ADP form for the mnlPp promoter as compared to the MalT-ATP or MalT-AMP-PNP forms .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>3 Furthermore , the use of AMP-PNP instead of ATP as a positive effector of MalT ensures sample homogeneity by avoiding production of ADP-liganded species .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15491603" target="_blank">15491603</a>]<br></li>
<li>The MalT/ADP Form Is Insensitive to Competition by the Inducer -- Both AMP-PNP and ADP can replace ATP as a positive effector of MalT ( 5 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>50-fold higher affinity for MalY than AMP-PNP ± MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>Nucleotide effect on the affinity of MalT for maltotriose The nucleotide effect on the relative affinities of MalT for maltotriose and MalY could be explained by ( i ) an effect on the activator affinity for maltotriose , i.e. AMP-PNP ± MalT would have a higher affinity for maltotriose than ADP ± MalT ; ( ii ) an effect on MalT affinity for MalY , i.e. AMP-PNP ± MalT would have a lower affinity for MalY than ADP ± MalT ; or ( iii ) a combination of both effects .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>Under the assay conditions , the ADP-bound form of MalT has 20-fold lower affinity for maltotriose compared with the AMP-PNP-bound form , too small an effect to account for the .1000 - fold increase in the ratio of the affinity for MalY to the affinity for maltotriose observed under the same conditions .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>These data reveal that , when present together , maltotriose and AMP-PNP strongly favor the self-association of MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10559195" target="_blank">10559195</a>]<br></li>
<li>Provided that the model proposed is correct , this may mean that the binding of AMP-PNP by the maltotriose-bound form not only results in an increase of the association equilibrium constant of the dimer 3 ( MalT ) n step but that it also increases the association and dissociation rate constants .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10559195" target="_blank">10559195</a>]<br></li>
<li>When assayed at 10 ztM in the presence of 0.28 ltM MalT , AMP , cAMP , dGTP , CTP , dCTP , UTP and TTP were totally inactive ( Table I and data not shown ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>We clearly establish that : ( i ) the unliganded form of the protein is monomeric ; ( ii ) when present alone , each effector , maltotri-ose or AMP-PNP ( or ATP ) , induces a partial multimerization of MalT ; and ( iii ) MalT self-associates in the presence of both effectors .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10559195" target="_blank">10559195</a>]<br></li>
<li>It is unlikely that interactions with the matrix of the Super-dex column ( cross-linked agarose and dextran ) cause the size of the major AMP-PNP/MalT form to be underestimated , because MalT also eluted as a 100-kDa globular protein when filtered at 20 ° C in the presence of AMP-PNP through a Superose 12 column ( cross-linked agarose only ) ( data not shown ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10559195" target="_blank">10559195</a>]<br></li>
<li>That the AMP-PNP bound form of MalT is primarily monomeric is also consistent with the result of a velocity sedimentation experiment performed at 4 ° C with 11 mM MalT in the presence of AMP-PNP , which gave a sedimentation coefficient s20 , w of 5.4 S for the predominant form ( which corresponds to that of an ' 95-kDa globular protein ) ( data not shown ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10559195" target="_blank">10559195</a>]<br></li>
<li>Indeed , although ADP had a small stimulatory effect when assayed at saturating concentrations in the presence of 0.28 , ^ M MalT ( see Figure 4 ) , full activation could be achieved if the MalT concentration was raised to -1 , uM ( Figure 5 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>Owing to the reduced ability of MalT ± ADP to promote open complex formation , a higher concentration of MalT had to be used in the assays performed in the presence of ADP .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>MalT-ADP is also fully competent for transcription activation in the presence of maltotriose , except that a 5-fold higher concentration of MalT is required to achieve half of the maximum response ( 18 ) .2 Maltotriose and the adenine nucleotides were present at saturating concentrations ( 1 and 0.1 mM , respectively ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10559195" target="_blank">10559195</a>]<br></li>
<li>Similarly , comparative malPp activation assays showed that the ADP-MalT form is fully competent for transcription activation in the presence of maltotriose , except that a 5-fold higher concentration of MalT was required to achieve the half-maximum response compared with what was observed with the AMP-PNP bound forms ( 18 ) .2 ( Both gel filtration and activation assays were performed in the presence of saturating concentrations of ligands , thereby excluding the possibility that the reduced abilities of ADP-MalT to multimerize or activate open complex formation were the result of incomplete saturation of the ligand binding sites .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10559195" target="_blank">10559195</a>]<br></li>
<li>Abortive initiation assays were performed , as described in the text , in the presence of wild-type MalT ( 300 nM ) ( open squares ) or MalTN637T ( 300 nM ) ( ﬁlled squares ) , AMP-PNP ( 0.5 mM ) and the indicated concentration of ( a ) MalK , ( b ) Aes or ( c ) MalY .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li>
				<label class="ACT_collapse_similarity" for="act_similarity_367">
Abortive initiation assays were performed in the presence of 0.5 mM AMP-PNP and the indicated concentrations of maltotriose , wild-type ( wt ) MalT , and wild-type MalK .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></label>
<input id="act_similarity_367", type="checkbox">
<div class="ACT_similar">
<li>Abortive initiation assays were performed in the presence of 0.5 mM AMP-PNP and the indicated concentrations of MalT and MalK variants .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li></div>
<li>Abortive initiation assays were performed in the presence of 50 M ATP , increasing concentrations of Aes , and the indicated concentrations of maltotriose and MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
				<label class="ACT_collapse_similarity" for="act_similarity_370">
Abortive initiation assays were performed in the presence of 10 mM ATP , increasing concentrations of MalY and the indicated concentrations of maltotriose and MalT : ( open triangles ) 1 mM maltotriose and 90 nM MalT ; ( closed circles ) 0.1 mM maltotriose and 120 nM MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></label>
<input id="act_similarity_370", type="checkbox">
<div class="ACT_similar">
<li>C Abortive initiation assays were performed in the presence of 10 mM ATP , increasing concentrations of MalY and the indicated concentrations of maltotriose and MalT 26 : ( closed circles ) 0.1 mM C C maltotriose and 100 nM MalT 26 ; ( closed diamonds ) no maltotriose and 245 nM MalT 26 .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li></div>
				<label class="ACT_collapse_similarity" for="act_similarity_372">
B , abortive initiation assays were performed in the presence of 500 M ADP , increasing concentrations of Aes , and the indicated concentrations of maltotriose and wild-type MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></label>
<input id="act_similarity_372", type="checkbox">
<div class="ACT_similar">
<li>A , abortive initiation assays were performed in the presence of 50 M AMP-PNP , increasing concentrations of Aes , and the indicated concentrations of maltotriose and wild-type MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>A , abortive initiation assays were performed in the presence of 500 M AMP-PNP , 10 M maltotriose , increasing concentrations of Aes , and 50 nM wild-type MalT or MalT T38R .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li></div>
				<label class="ACT_collapse_similarity" for="act_similarity_375">
B. Abortive initiation assays were performed in the presence of 50 mM ADP , increasing concentrations of MalY and the indicated concentrations of maltotriose and wild-type MalT : ( closed circles ) 10 mM maltotriose and 290 nM MalT ; ( open diamonds ) 100 mM maltotriose and 290 nM MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></label>
<input id="act_similarity_375", type="checkbox">
<div class="ACT_similar">
<li>Abortive initiation assays were performed in the presence of increasing concentrations of maltotriose and the indicated concentrations of nucleotide and wild-type MalT : ( closed circles ) 10 mM AMP-PNP and 150 nM MalT ; ( open circles ) 50 mM ADP and 500 nM MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li></div>
<li>B , abortive initiation assays were performed in the presence of 500 M AMP-PNP , 10 M maltotriose , increasing concentrations of MalY , and 50 nM wild-type MalT or MalT T38R .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>A. Abortive initiation assays were performed in the presence of 10 mM AMP-PNP , increasing concentrations of MalY and the indicated concentrations of maltotriose and wild-type MalT : ( closed circles ) 0.1 mM maltotriose and 135 nM MalT ; ( closed diamonds ) 0.01 mM maltotriose and 270 nM MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>MalT T38R was purified from pop7164 ( pOM2malTp7 T38R ) as described for wild-type MalT , with some modifications for the chromatography on propyl-agarose ; the adsorption , washing , and elution steps were performed in the presence of 0.9 , 0.8 , and 0.4 M ( NH4 ) 2SO4 , respectively .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>Malto-triose binding assays were performed at 0.5 M maltotriose with wildc type MalT ( 2 M ) , MalT 26 ( 1 M ) , or MalT-T38R ( 1.5 M ) in the presence of 19 M wild-type MalK or MalK-G346S , as indicated .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>Maltotriose binding assays were performed as described in Experimental procedures in the presence of wild-type MalT ( 5 mM ) , MalT 26 C ( 2.5 mM ) and/or MalY ( 9 mM ) as indicated .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>To find out whether maltotriose antagonizes Aes binding to MalT , we performed gel filtration experiments in the presence of both ATP and 1 mM maltotriose , the concentration of inducer relieving inhibition of wild-type MalT by Aes in our transcription system ( Fig. 2C ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>To find out whether , as hypothesized , maltotriose prevents formation of the MalT ± MalY complex , we also performed gel filtration experiments in the presence of both ATP and 1 mM maltotriose , the maltotriose concentration shown to counteract MalY action in our transcription system ( see Fig. 1 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>As shown in Fig. 1B , MalTc26 was scarcely inhibited by Aes in the presence of 0.1 mM maltotriose , i.e. a maltotriose concentration allowing repression of wild-type MalT by Aes ( Fig. 1A ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>As shown in Fig. 2 , transcription activation by MalT 26 was not depressed by C MalY in the presence of 0.1 mM maltotriose , i.e. under conditions in which the wild-type protein was sensitive to MalY ( compare Figs 1 and 2 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>Furthermore , gel filtration experiments performed in the presence of 0.5 m AMP-PNP showed that M Aes forms a complex with wild-type MalT , but not with MalT T38R ( data not shown ; Fig. 6A ) , and that MalY forms a complex FIG. 3 .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>As shown in Fig. 2A , neither of these MalT variants was affected by MalK when assayed in the presence of AMP-PNP alone , i.e. under conditions in which wild-type MalT is inhibited by MalK .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>In particular , as observed in the presence of ADP , gel filtration of a sample containing 10 mM MalY dimer 120 mM MalT gave a unique peak of MalY/MalT complexes at Fig. 3 .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
				<label class="ACT_collapse_similarity" for="act_similarity_389">
A , samples containing MalT T38R ( 9 M ) Aes ( 9.5 M ) , MalT T38R ( 9 M ) alone , or Aes ( 9.5 M ) alone were incubated and filtered through a Superose 12 column in the presence of 0.5 mM AMP-PNP .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></label>
<input id="act_similarity_389", type="checkbox">
<div class="ACT_similar">
<li>B , samples containing MalT T38R ( 9 M ) MalY ( 4.5 M dimer ) , MalT T38R ( 9 M ) alone , or MalY ( 4.5 M dimer ) alone were incubated and filtered through a Superose 12 column in the presence of 0.5 mM AMP-PNP .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li></div>
<li>A , samples containing MalT ( 9 M ) Aes ( 9.5 M ) , MalT ( 9 M ) alone , or Aes ( 9.5 M ) alone were incubated and chromatographed through a Superose 12 column in the presence of 0.1 mM ATP .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
				<label class="ACT_collapse_similarity" for="act_similarity_392">
B. Samples containing MalT ( 4.6 mM ) and MalY ( 2.1 mM ) , MalT ( 4.6 mM ) only or MalY ( 2.1 mM ) only were preincubated and filtered on the Superose 12 column in the presence of 50 mM ATP , as described in Experimental procedures .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></label>
<input id="act_similarity_392", type="checkbox">
<div class="ACT_similar">
<li>A. Samples containing MalT ( 4.6 mM ) and MalY ( 2.1 mM ) , MalT ( 4.6 mM ) only or MalY ( 2.1 mM ) only were preincubated and filtered on the Superose 12 column in the presence of 50 mM ADP .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li></div>
<li>RESULTS Approach -- To determine the association state of MalT at various protein concentrations in the presence of different combinations of effectors , we performed gel filtration on a Superdex 1 The abbreviations used are : DTT , dithiothreitol ; AMP-PNP , adenylyl imidodiphosphate ; BSA , bovine serum albumin .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10559195" target="_blank">10559195</a>]<br></li>
<li>This possibility was further investigated by analysing MalT repression by MalY in the presence of AMP-PNP or ADP and various concentrations of inducer .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
				<label class="ACT_collapse_similarity" for="act_similarity_396">
Effect of Aes on MalT activity in the presence of AMP-PNP or ADP .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></label>
<input id="act_similarity_396", type="checkbox">
<div class="ACT_similar">
<li>Effect of MalY on MalT activity in the presence of AMP-PNP or ADP .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li></div>
<li>In contrast , as shown for MalY and Aes , inhibition of ADP-bound MalT by MalY or Aes is insensitive to the presence of an excess of maltotriose ( 19 , 20 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>Indeed , as observed in vitro , the ADP-bound form of MalT remains sensitive to MalY ( 16 ) or Aes ( this work ) even in the presence of an excess of maltotriose ( up to 100 mM ) , whereas inhibition by Aes or MalY of the AMP-PNP bound form of MalT is relieved by 0.1 mM maltotriose .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>In the presence of ADP , MalT inhibition by MalY was not relieved by maltotriose , even when present in a large excess ( 100 mM ) , whereas in the presence of AMP-PNP , MalY action was counteracted by 0.1 mM inducer ( 16 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>In the presence of AMP-PNP , MalT inhibition by Aes was relieved by 0.1 mM maltotriose ( Fig. 4A ) , whereas in the presence of ADP , Aes action was not counteracted by maltotriose , even when present at 100 mM ( Fig. 4B ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>This possibility was examined by determining the concentration of maltotriose needed to relieve MalT inhibition by a fixed amount of Aes in the presence of AMP-PNP or ADP in our transcription system .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>Indeed , as shown here , both AMP-PNP and ADP induce self-associa-tion of MalT in the presence of maltotriose , the difference being that association of the ADP-bound forms is less favored ; a 7-fold higher concentration of MalT is required to achieve the same degree of association in the presence of maltotriose 1 ADP as in the presence of maltotriose 1 AMP-PNP .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10559195" target="_blank">10559195</a>]<br></li>
<li>These data thus suggest that the concentration of maltotriose required to overcome inhibition by MalY in the presence of ADP would be .1000 times higher than in the presence of AMP-PNP ; in other words , the apparent ratio of MalY affinity to maltotriose affinity is .1000 - fold higher for ADP ± MalT than for AMP-PNP ± MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>In the Presence of AMP-PNP , ATP , or ADP -- Fig. 2B shows the data obtained when samples containing increasing concentrations of MalT ( 8 -- 47 mM ) were subjected to gel filtration in the presence of AMP-PNP .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10559195" target="_blank">10559195</a>]<br></li>
<li>Gel filtration of 23 mM MalT in the presence of ATP or ADP gave profiles identical to that obtained with AMP-PNP except that no multimeric species were observed in the presence of ADP ( data not shown ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10559195" target="_blank">10559195</a>]<br></li>
<li>In the Presence of Maltotriose and ATP or ADP -- Gel filtration of MalT in the presence of maltotriose 1 ATP or ADP gave profiles similar to those obtained in the presence of maltotriose and AMP-PNP except that , in both cases , at any MalT concentration tested , the major peak eluted later than observed in the presence of maltotriose and AMP-PNP ( Figs. 6 and 8 , data not shown ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10559195" target="_blank">10559195</a>]<br></li>
<li>The fact that ATP gave an intermediate response close to that obtained with AMP-PNP ( a 10-fold higher concentration of maltotriose was required to antagonize MalY action in the presence of ATP compared with that observed in the presence of AMP-PNP ) might reflect the presence of both ATP-bound and ADP-bound forms resulting from ATP hydrolysis by MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>The experiments were performed in the presence of AMP-PNP ( as shown below , MalT and MalY also form a complex in the presence of AMP-PNP or ADP , which elutes at 1.19 ml , as observed in the presence of ATP ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>The results obtained in the presence of AMP-PNP instead of ATP were identical to those obtained in the presence of ATP : a MalT ± MalY complex was observed in the presence of AMP-PNP alone , whereas no complexes were observed in the presence of both AMP-PNP and maltotriose ( data not shown ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>The MalT ± MalY complex also assembled in the presence of ADP ( Fig. 6A ) but , surprisingly , its formation was not prevented by the presence of 1 mM maltotriose , in contrast to what was observed with ATP or AMP-PNP ( Fig. 6B ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>( In transcription activation assays performed in the presence of ATP and a limiting concentration of MalT , half of the plateau is achieved with 20 mM maltotriose .2 The Kd for AMP-PNP , ATP , and ADP # 1 , 0.5 , and 3 mM , respectively , as measured at ' 1 mM MalT ( 18 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10559195" target="_blank">10559195</a>]<br></li>
<li>The assays were performed at limiting MalT concentrations close to those used for MalY assays and chosen in order to give the same signal ( two-thirds of the maximum response ) at saturating concentrations of maltotriose : 150 nM MalT for the assays performed in the presence of AMP-PNP and 500 nM for those performed in the presence of ADP .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>In the Presence of Maltotriose and AMP-PNP -- Gel filtration of MalT at 6 ° C in the presence of both maltotriose and AMP-PNP gave two peaks , a minor one , corresponding to the mono-meric species , and a major one that was asymmetric and the position of which shifted to smaller retention volumes as MalT concentration was raised ( Fig. 5 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10559195" target="_blank">10559195</a>]<br></li>
<li>It is somewhat surprising that the dimers and the higher order association species formed in the presence of maltotriose give two distinct peaks , whereas in the presence of both maltotriose and AMP-PNP , one unique peak is obtained , which shifts smoothly toward higher apparent molecular masses as the MalT concentration is raised .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10559195" target="_blank">10559195</a>]<br></li>
<li>To ﬁnd out whether the multimeric structures formed by MalT in solution are involved in promoter binding , we observed nucleoprotein complexes formed when incubating MalT in the presence of AMP-PNP , maltotriose and the malPp500 promoter .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15491603" target="_blank">15491603</a>]<br></li>
<li>Consistent with the reduced ability of the maltotriose/ADP pair of effectors to drive MalT self-association , a larger number of isolated , globular forms were , however , visible in the vitreous ice background compared to what observed in the presence of maltotriose and AMP-PNP ( compare Figure 1A and B ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15491603" target="_blank">15491603</a>]<br></li>
<li>Furthermore , the observation that , in the presence of maltotriose , AMP-PNP favors MalT multim-erization to a greater extent than ADP suggests that in vivo ATP hydrolysis by MalT might be coupled to the disassembly of the multimer formed by the protein or of the nucleoprotein structures assembled at the mal promoters .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10559195" target="_blank">10559195</a>]<br></li>
<li>All rights reserved Results Cryo-EM analysis of MalT self-associated species Adenylyl imidodiphosphate ( AMP-PNP ) , a nonhydrolysable analog of ATP , is slightly more effective than ATP in driving MalT self-association in the presence of maltotriose .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15491603" target="_blank">15491603</a>]<br></li>
<li>ATP and AMP-PNP , a nonhydrolyzable analog of ATP , are equally effective in promoting activation of transcription by MalT in the presence of maltotriose ( 18 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10559195" target="_blank">10559195</a>]<br></li>
<li>Third , there is a correlation between the relative abilities of AMP-PNP and ADP to promote the self-association of MalT and transcription activation in the presence of maltotriose .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10559195" target="_blank">10559195</a>]<br></li>
<li>MalT activity in the presence of ATP , AMP-PNP or ADP .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>Thus , both ATP and ADP promote MalT self-association in the presence of malto-triose , but ADP is clearly less effective than ATP , which is itself less effective than AMP-PNP .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10559195" target="_blank">10559195</a>]<br></li>
<li>In the presence of maltotriose 1 ATP , the degree of association of MalT is intermediate between that observed in the presence of maltotriose 1 AMP-PNP and that observed in the presence of maltotriose 1 ADP ; this is best explained by the presence of both ATP - and ADP-bound forms due to ATP hydrolysis by the protein .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10559195" target="_blank">10559195</a>]<br></li>
<li>2 AMP-PNP , which can replace ATP as an effector of MalT ( 33 ) , is actually more effective than ATP in driving MalT self-association in the presence of maltotriose due to the absence of ATP hydrolysis , which generates ADP-bound forms that are less prone to multimerization ( 16 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>Gel filtration and sedimentation experiments were used to analyze the quaternary structure of MalT in solution in the absence or presence of maltotriose and/or AMP-PNP , ATP , or ADP .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10559195" target="_blank">10559195</a>]<br></li>
<li>In the presence of maltotriose 1 ATP , an ' 2-fold higher concentration of MalT was required to obtain the same apparent molecular mass as in the presence of maltotriose 1 AMP-PNP , whereas an ' 7-fold higher concentration of MalT was required to obtain the same apparent molecular mass in the presence of maltotriose 1 ADP .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10559195" target="_blank">10559195</a>]<br></li>
<li>Samples containing various concentrations of 1 MalT were chromatographed at 20 ° C in the presence of maltotriose and AMP-PNP on the Superdex 200 column .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10559195" target="_blank">10559195</a>, <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10559195" target="_blank">10559195</a>]<br></li>
				<label class="ACT_collapse_similarity" for="act_similarity_429">
Gel filtration of MalT on the Superdex 200 column in the presence of maltotriose 1 AMP-PNP .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10559195" target="_blank">10559195</a>]<br></label>
<input id="act_similarity_429", type="checkbox">
<div class="ACT_similar">
<li>Gel filtration of MalT on the Superdex 200 column in the presence of maltotriose .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10559195" target="_blank">10559195</a>]<br></li>
<li>Gel filtration of MalT on the Superdex 200 column in the presence of maltotriose 1 ADP .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10559195" target="_blank">10559195</a>]<br></li></div>
<li>Consideration of all of the data obtained in the presence of maltotriose alone and in the presence of maltotriose 1 AMP-PNP , however , suggests the following association pathway : monomer 3 dimer 3 ( MalT ) n 3 unlimited aggregates , where ( MalT ) n would be a discrete size multimer , possibly a tetramer or a hexamer .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10559195" target="_blank">10559195</a>]<br></li>
<li>B , The typical ﬁeld of cryo-EM obtained with 5 mM MalT incubated in the presence of AMP-PNP , maltotriose and 1 mM malPp500 promoter .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15491603" target="_blank">15491603</a>]<br></li>
<li>3 In the presence of AMP-PNP , MalT activity is partially independent of maltotriose ( E. Richet , unpublished results ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>Altogether , these results provide strong evidence that the curved structures observed in the presence of maltotriose and AMP-PNP correspond to selfassociated species formed by MalT in solution .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15491603" target="_blank">15491603</a>]<br></li>
<li>MalT responses to increasing concentrations of maltotriose were measured in the presence of AMP-PNP or ADP .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>We show that , in the presence of maltotriose and AMP-PNP , MalT associates into novel , polydisperse , curved homopolymers .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15491603" target="_blank">15491603</a>]<br></li>
<li>They reveal that , in the presence of AMP-PNP and maltotriose , MalT associates into curved homopolymers of varying size .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15491603" target="_blank">15491603</a>]<br></li>
<li>First , in both cases , 3 MalT self-association requires the presence of both AMP-PNP and maltotriose .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15491603" target="_blank">15491603</a>]<br></li>
<li>Hence , we analyzed multimeric species formed by MalT in the presence of AMP-PNP and maltotriose .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15491603" target="_blank">15491603</a>]<br></li>
<li>Image processing of the MalT multimers formed in the presence of maltotriose and AMP-PNP .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15491603" target="_blank">15491603</a>]<br></li>
<li>3 MalT is 50 % as active in the presence of AMP-PNP alone as it is in the presence of AMP-PNP and a saturating concentration of maltotri-ose .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>Hence , these data indicate that MalT is principally monomeric in the presence of AMP-PNP but that it shows a slight tendency to multimerize .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10559195" target="_blank">10559195</a>]<br></li>
<li>Gel filtration of MalT at 20 ° C in the presence of malto-triose AMP-PNP .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10559195" target="_blank">10559195</a>, <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10559195" target="_blank">10559195</a>]<br></li>
<li>The MalT concentration used to assess the Aes effect was that eliciting about half of the maximum response under the chosen conditions ( the inset of Fig. 1A shows the response curve obtained in the presence of 50 M ATP and 0.1 mM maltotriose ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
				<label class="ACT_collapse_similarity" for="act_similarity_446">
The inset shows the responses to increasing concentrations of MalT obtained in the presence of 0.5 mM AMP-PNP 0.1 mM maltotriose .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></label>
<input id="act_similarity_446", type="checkbox">
<div class="ACT_similar">
<li>The inset in ( A ) shows the responses to increasing concentrations of MalT obtained in the presence of 10 mM AMP-PNP and 0.01 or 0.1 mM maltotriose .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li></div>
<li>The inset shows the response to increasing concentrations of wild-type MalT in the presence of 50 M ATP and 0.1 mM maltotriose .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>The inset in ( B ) shows the responses to increasing concentrations of MalT obtained in the presence of 50 mM ADP and 10 or 100 mM maltotriose .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
				<label class="ACT_collapse_similarity" for="act_similarity_450">
The inset shows the response to increasing concentrations of MalT obtained in the presence of 10 mM ATP and 0.1 or 1 mM maltotriose .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></label>
<input id="act_similarity_450", type="checkbox">
<div class="ACT_similar">
<li>The inset shows the response to increasing C concentrations of MalT 26 obtained in the presence of 0.1 mM or no C maltotriose .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li></div>
<li>The affinity of MalT for other nucleotides was determined by performing competition assays in which MalT was incubated in the presence of 1 mM maltotriose , 0.1 AM [ 3H ] ATP and various concentrations of competing nucleotide .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>Figure 3B shows the response to increasing concentrations of MalT in the presence of RNA polymerase ( 0.1 tM ) , ATP and maltotriose .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>in the presence of 1 mM maltotriose , 10 IsM ATP and increasing concentrations of MalT , as described in Materials and methods .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>Abortive initiation assays were carried out on malPp in the presence of 0.28 ztM MalT , 1 mM maltotriose Figure 3A , abortive product synthesis at malPp , a promoter Fig. 6 .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>Induction by maltotriose ( 0.5 mM ) was not inhibited in the presence of any of these noninducing sugars ( 10 mM ) , indicating that the lack of effect of these sugars probably resulted from their low affinity for MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=3298211" target="_blank">3298211</a>]<br></li>
<li>Panel B : the time course of ATP hydrolysis by 0.58 MM MalT ( fraction 44 of the mono-Q column ) was determined at 6 MM ATP in the presence of 1 mM maltotriose ( 0 ) , 1 mM maltose ( O ) or in the absence of sugar ( 0 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>assays were as MalT ( U and OI ) various described ( 30 ) in the presence of or amounts of MalTc26 ( 0 and 0 ) and in the presence ( closed symbols ) or absence ( open symbols ) of 1 mM maltotriose .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2180908" target="_blank">2180908</a>]<br></li>
<li>The assays were performed with 1.3 AM ( A ) or 0.8 itM MalT ( B ) , in the presence of I mM maltotriose ( - ) , I mM maltose ( O ) or in the absence of sugar ( 0 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>, <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>In the Presence of Maltotriose -- Complex chromatograms were obtained when MalT was subjected to gel filtration in the presence of maltotriose alone ( Fig. 4 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10559195" target="_blank">10559195</a>]<br></li>
<li>MalT activity depends on the presence of maltotriose , the inducer of the regulon ( 5 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10559195" target="_blank">10559195</a>]<br></li>
<li>In the presence of maltotriose , the activity of MalTC26 about the was same as that of MalT ( 30 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2180908" target="_blank">2180908</a>]<br></li>
<li>Such a model accounts for the three peaks observed by gel filtration in the presence of maltotriose alone , the two discrete peaks corresponding to the dimer and the monomer and the early peak , which first appears at 600 kDa and the apparent molecular mass of which increases as the concentration of MalT is raised .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10559195" target="_blank">10559195</a>]<br></li>
<li>The first step might lead to the formation of a discrete size multimer , ( MalT ) n , possibly the multimer present in the 600-kDa peak observed in the presence of maltotriose alone .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10559195" target="_blank">10559195</a>]<br></li>
<li>The asymmetry of the MalT peak observed in the presence of maltotriose is likely due to the presence of faster sedimenting multimeric forms .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10559195" target="_blank">10559195</a>]<br></li>
<li>ATPase activity assays The assays were carried out by incubating MalT at 30 ° C in 20 MI of buffer C containing 30 mM KCI , 1 mM dithiothreitol , 100 Mg/mi acetylated BSA , 0.2 MCi [ 3H ] ATP ( or [ a-32P ] dATP ) and the indicated concentrations of unlabelled ATP ( or dATP ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>HCl ( PH f + OL 40 mM-KCI , 10 miw-MgCl , , 1 mM-CaCl , , 0.1 mM-EDTA , 1 mw-dithiothreitol ; 100 pg acetylated bovine serum albumin/ml , 1 miw-maltotriose , 0.2 mM-ATP , w 1 niv-end-labelled DNA fragment and various concentrations of purified MalT protein .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2538630" target="_blank">2538630</a>]<br></li>
<li>Maltotriose Binding Assay -- The 30 - l reaction mixture contained 22 mM HEPES-KOH ( pH 8.0 ) , 10 mM Tris-HCl ( pH 7.7 ) , 22 mM tri-potas-sium citrate , 6 mM magnesium acetate , 0.07 mM EDTA , 0.1 mM ATP , 1 M [ 14C ] maltotriose ( 850 mCi mmol 1 ) , 0.2 mg ml 1 acetylated bovine serum albumin , and MalT and Aes as indicated .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>Results MalT has a high affinity for A TP and dATP Previous studies have shown that MalT can bind ATP and dATP ( Richet and Raibaud , 1987 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>Moreover , MalT ± BCCP immobilization on the streptavidin column from crude extracts was performed in the absence of ATP , a condition known to lead to MalT inactivation ( Richet and Raibaud , 1987 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
				<label class="ACT_collapse_similarity" for="act_similarity_471">
Wild-type MalT and MalTc26 proteins were purified in the presence of ATP as described by Danot and Raibaud ( 24 ) and by Schreiber et al. ( 16 ) , respectively .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></label>
<input id="act_similarity_471", type="checkbox">
<div class="ACT_similar">
<li>Wild-type MalT , MalTc26 , and MalT T38R proteins were purified in the presence of ATP as described by Danot and Raibaud ( 15 ) , Schreiber et al. ( 19 ) and Joly et al. ( 20 ) , respectively .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li></div>
<li>36,37 Materials and Methods Proteins MalT protein was puriﬁed in the presence of ATP as described .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15491603" target="_blank">15491603</a>]<br></li>
<li>Wild-type MalT protein was purified in the presence of ATP as has been described by Danot and Raibaud ( 1994 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>Proteins MalT was purified in the presence of ATP as previously described ( Richet and Raibaud , 1987 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>EXPERIMENTAL PROCEDURES MalT -- MalT was purified in the presence of ATP as described ( 14 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10559195" target="_blank">10559195</a>]<br></li>
<li>Proteins Wild-type MalT was puriﬁed in the presence of ATP from pop3657 ( pOM2 malTp7 ) , as described .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li>
<li>Recently , we have discovered that MalT activity is also strictly dependent on the presence of ATP ( 30 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2180908" target="_blank">2180908</a>]<br></li>
<li>Negative effectors bind MalT in 2 the presence of ATP or ADP .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li>
<li>MalT is known to be predominantly monomeric in the presence of ATP alone ( 4 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>As expected , MalT is not inhibited by the MalK-G346S variant in the presence of 4 E. Richet , unpublished results .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>Puriﬁed MalT was subjected to chromatography in the presence of ATP on Ni-NTA-agarose microcolumns preloaded with His-tagged MalK as described in the text .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li>
<li>Purified MalT was chromatographed on Ni-NTA-agarose microcolumns preloaded with His-tagged MalK in the presence of 2 mM ATP as described under `` Experimental Procedures .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>In contrast , MalT was not retained on the MalK-loaded column when affinity chromatography was performed in the presence of ATP and 10 mM maltotriose ( Fig. 3B ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>MalT was incubated in the presence of ATP , labeled maltotriose , and MalK , and the amount of bound maltotriose was measured by precipitating the proteins with ammonium sulfate .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>Using an abortive initiation assay , we further show that activation of open complex formation by MalT depends on the presence of ATP in addition to that of maltotriose , the inducer of the maltose system .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>A +1 5 ' - A T A A C G T T 3 ' - T A T T G C A A ApA + p p * pC -- ApA * pC z 50B 30 ° 20 ) 10 ATP is required for activation of open complex formation by MalT Using the abortive initiation assay described above , we examined the effect of ATP on open complex formation in the presence of MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>Gel filtration of a mixture containing both proteins in the presence of ATP and maltotriose gave two peaks , at 1.11 and 1.32 ml , i.e. the volumes at which MalT and MalY , respectively , elute when filtered separately .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>MalT was preincubated with malPp in the presence of ATP , maltotriose , and various concentrations of Aes before adding RNA polym-erase and allowing open complex formation .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>MalT was preincubated with malPp DNA , ATP and maltotriose in the presence or absence of MalY , before adding RNA polymerase and allowing open complex formation .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>Therefore , in the presence of ATP , MalT and MalY form a complex , the apparent molecular weight of which is 165 kDa .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>Finally , we showed that the formation of a MalY ± MalT complex is a reversible reaction : when MalT and MalY were first preincubated together in the presence of ATP alone , before incubation and gel filtration in the presence of maltotriose 1 ATP , few complexes , if any , were observed ( data not shown ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>Thus , this result clearly demonstrates that , in the presence of ATP , maltotriose inhibits formation of the MalT ± MalY complex and makes us confident that the MalT ± MalY interaction seen here is functionally relevant .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>Assembly of the complex between MalY and ADP-MalT is thus less sensitive to the presence of maltotriose than that observed for the ATP-bound form .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>Conversely , formation of an inhibitory 3 complex between MalT and MalY or Aes is inhibited by maltotriose in the presence of ATP , but not in the presence of ADP .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15491603" target="_blank">15491603</a>]<br></li>
<li>However , maltotriose does not relieve MalT inhibition by Aes or MalY in vitro in the presence of ADP , whereas it can do so in the presence of ATP .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li>
				<label class="ACT_collapse_similarity" for="act_similarity_497">
Schreiber , V. , and Richet , E. ( 1999 ) Self-association of the Escherichia coli transcription activator MalT in the presence of maltotriose and ATP .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></label>
<input id="act_similarity_497", type="checkbox">
<div class="ACT_similar">
<li>Self-association of the Escherichia coli transcription activator MalT in the presence of maltotriose and ATP .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=12003949" target="_blank">12003949</a>, <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11575919" target="_blank">11575919</a>, <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15491603" target="_blank">15491603</a>, <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li></div>
<li>MalT , the transcriptional-activator of the Escherichia coli maltose regulon , binds the MalT-dependent promoters and activates transcription initiation only in the presence of maltotriose and ATP ( or adenylyl imido-diphosphate ( AMP-PNP ) ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10559195" target="_blank">10559195</a>]<br></li>
<li>Summary MalT , the transcriptional-activator of the Escherichia coli maltose regulon , self-associates , binds promoter DNA and activates initiation of transcription only in the presence of ATP and maltotriose , the inducer .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>Transcription activation by MalT involves cooperative binding of the protein to an array of sites located upstream from the 35 region of the target promoters and requires the presence of two positive effectors , maltotriose ( the inducer ) and ATP ( reviewed in Ref .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>Transcription activation by MalT depends on the presence of ATP and maltotriose , two effectors of the protein ( Raibaud and Richet , 1987 ; Richet and Raibaud , 1989 ) , and involves MalT binding to an array of sites located upstream of the ` 235 ' region of the mal promoters ( Boos and Shuman , 1998 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>In the presence of maltotriose and ATP , MalT , the activator protein specific for the regulon , binds to a short asymmetrical sequence which is present in several copies in alt the MalT-dependent promoters ( Vidal-lngigiiardi etai , 1991 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=7830577" target="_blank">7830577</a>]<br></li>
<li>In the presence of ATP and maltotriose , MalT binds to decanucleotide MalT boxes that are found upstream of mal promoters and activates transcription at these sites .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9822819" target="_blank">9822819</a>]<br></li>
<li>Thus , we infer that , at least up to this step , ATP merely acts as an allosteric-effector , i.e. that neither the potential energy of ATP hydrolysis nor the phosphorylation of MalT or maltotriose are needed .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>Two small effectors , maltotriose and ATP , specifically bind to MalT and are absolutely required for its activity ( 25 , 30 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2180908" target="_blank">2180908</a>]<br></li>
<li>Figure 6 shows that MalT binds to the MalT boxes only if ATP and maltotriose are present together .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>MalT also binds and 2,8 -- 10 hydrolyses ATP into ADP , with ATP and ADP differentially affecting the interplay between maltotriose and the negative effectors .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li>
<li>In vitro , both ATP and ADP promote maltotriose binding and MalT self-associa-tion ( Fig. 8 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>From these data , we conclude that the role of maltotriose and ATP as positive effectors is to induce the multimerization of MalT , and hence its cooperative binding to the mal promoters .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10559195" target="_blank">10559195</a>]<br></li>
<li>Both these properties suggest that maltotriose binding and ATP binding are co-operative , consistent with the fact that these two effectors promote MalT oligomerization when present together .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>We show that the unliganded form of MalT is monomeric and that maltotriose and ATP induce the multimerization of the activator .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10559195" target="_blank">10559195</a>]<br></li>
<li>Note that AMP-PNP can replace ATP as a positive effector of MalT , and that the 2 AMP-PNP-bound form is partially active in the absence of maltotriose Figure 4 .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li>
<li>Cryo-15 electron microscopy showed that , in the active form , i.e. in the presence of both ATP and maltotriose , MalT monomers consist of a globular domain connected by a peduncle to an inner domain , that mediates self-association into polydisperse homopolymers .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li>
<li>Efﬁcient MalT multimerization requires ATP or ADP in addition to maltotriose , with ATP being more effective than ADP in driving MalT self-association in the presence of maltotriose , indicating that the maltotriose/ATP-bound form is the transcriptionally active species .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li>
<li>ATP-bound MalT is more prone to multimerization in the presence of maltotriose than is the ADP-bound form ( 16 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>In the presence of ADP and maltotriose , MalT has an apparent molecular weight ( 174 kDa ) lower than that observed in the presence of ATP and maltotriose , consistent with the fact that ADP ± MalT has a reduced tendency to multimerize compared with ATP ± MalT ( Schreiber and Richet , 1999 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>Both maltotriose and ATP are required for the act , ivit , y of MalT ( Raibaud & Richet , 1987 ; Richet & Raibaud , 1989 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2016744" target="_blank">2016744</a>]<br></li>
<li>Indeed , ATP ± MalT has a higher affinity for maltotriose than ADP ± MalT , whereas MalT has a higher affinity for ATP than ADP in the presence of maltotriose ( Richet and Raibaud , 1989 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>When chromatographed alone , Aes eluted at the same position as described above , whereas MalT eluted as a 300-kDa protein , consistent with the fact that MalT is multimeric in the presence of ATP and maltotriose ( 4 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>Considering that maltotriose and/or ATP might regulate the oli-gomerization of the protein , we studied both the liganded and the unliganded forms of MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10559195" target="_blank">10559195</a>]<br></li>
<li>One trivial explanation is that the purified MalT protein is a mixture of MalT molecules either unable to-bind ATP , able to-bind ATP only in the presence of maltotriose , or able to-bind ATP independently of the presence of maltotriose , which are present in the ratio 2 : 1 : 1 , respectively .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>Recent studies have revealed that the unliganded form of MalT is monomeric in solution and that the protein self-associates in the presence of ATP and maltotriose ( Schreiber and Richet , 1999 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>Role of ATP in activation of transcription initiation by MalT The main conclusion of this work is that activation of transcription initiation by MalT requires , in addition to maltotriose , the presence of ATP ( or dATP ) as an effector of MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>The footprinting assays were performed in the presence of ATP and maltotriose , both of which are required for MalT to-bind to DNA ( E. Richet , unpublished results ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2538630" target="_blank">2538630</a>]<br></li>
<li>The regulation of this system is based on the function of MalT , which becomes an activator in the presence of cyclic AMP-catabolite activator protein , ATP and maltotriose , the speciﬁc inducer of the system ( 38 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9401025" target="_blank">9401025</a>]<br></li>
<li>DISCUSSION Ligand-induced Self-association of MalT -- The results of the gel filtration and sedimentation experiments reported in this paper reveal several features of the association state of MalT in the absence or presence of its effectors , maltotriose and ATP .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10559195" target="_blank">10559195</a>]<br></li>
<li>The MalT protein hydrolyses dATP as effectively as ATP in the absence and in the presence of maltotriose ( data not shown ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>The assay of MalT after filtration of a 20 mM sample in the absence of ligands and after filtration of a 6.4 mM sample in the presence of maltotriose and ATP showed that the protein was ' 100 and ' 80 % active , respectively .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10559195" target="_blank">10559195</a>]<br></li>
<li>MalT binding to the MalT box depends on the presence of both maltotriose and A TP We next examined whether both ATP and maltotriose , or only one of them , were required for the binding of MalT to its recognition sequences in the promoter , one of the first steps of the activation process .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>As shown by DNase I footprinting , MalT binding to its recognition sites present in the malEp - malKp promoters depends on the presence of both ATP and maltotriose , which indicates that both of them are required at an early stage of the transcription initiation process .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>Inducer binding was measured by incubating MalT with ATP and [ C ] -14 maltotriose for 15 min at 308C in the presence or absence of MalY and counting the radioactivity present in the pellet after ammonium sulphate precipitation of the proteins .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>In the presence of ATP , MalT is activated by binding maltotriose , the inducer of the system ( 54 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9023215" target="_blank">9023215</a>]<br></li>
<li>Alternatively , a MalT monomer may possess two distinct ATP-binding sites , one of them binding ATP only in the presence of maltotriose .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>Surprisingly , the stoichiometry of the binding of ATP is 0.25 and 0.5 molecules of ATP per monomer of MalT in the absence and in the presence of maltotriose , respectively .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>Second , both MalT oligomerization and promoter binding depend on the presence of ATP and maltotriose .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10559195" target="_blank">10559195</a>]<br></li>
<li>Both techniques indicate that , in the presence of maltotriose , MalT binds 0.5 molecules of ATP per monomer with a Kd of 0.6 AM ( equilibrium dialysis ) or 0.4 izM ( ammonium sulphate precipitation ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>MalT binds and activates its target promoters ( 29 ) only in the presence of ATP ( 34 ) and the inducer maltotriose ( 28 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=12003949" target="_blank">12003949</a>]<br></li>
<li>Little is known , however , about the multimeric species formed by MalT in solution in the presence of ATP and maltotriose .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15491603" target="_blank">15491603</a>]<br></li>
<li>MalT is active only in the presence of ATP and maltotriose , both of which are required for multimerization ( 16 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>To obtain more quantitative data on these interactions , we measured [ H ] ATP binding to MalT by two different techniques : equilibrium dialysis and ammonium sulphate precipitation of the nucleotide - MalT complex .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>As already observed for ATP binding , no stimulatory effect was observed when maltose and maltotetraose , two maltodextrins which are not effectors of MalT for transcription activation , were substituted for maltotriose ( Figure 2B and data not shown ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>The binding of ATP ( K , 0.4 pM ; Richet & Raibaud , 1989 ) and maltotriose ( K , about 2 0 p M ; Raibaud & Richet , 1987 ) to MalT , stabilizes active MalT ( MalT , ) for transcriptional activation .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9884223" target="_blank">9884223</a>]<br></li>
<li>The expression of these genes is controlled by the MalT protein , a 103 kDa monomer that binds ATP and maltotriose ( Richet and Raibaud , 1987 ; Dardonville and Raibaud , 1990 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9822819" target="_blank">9822819</a>]<br></li>
<li>MalT self-associa-tion , which is expected to be crucial for promoter binding , is hence the target of several of the controls to which the activator is subjected , i.e. the inducer , ATP , and ATP hydrolysis .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10559195" target="_blank">10559195</a>]<br></li>
<li>Indeed , no [ 3H ] ATP-binding to the protein was detected when ammonium sulphate was added immediately after mixing ATP and MalT , and no loss of incorporated [ 3H ] ATP was observed when a large excess of unlabelled ATP was added together with the ammonium sulphate .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>A simple model is that binding of both ATP and maltotriose drive MalT protein into a conformation appropriate for binding of a MalT box .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>ATP binding to the MalT protein .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>, <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>The Self-association of MalT , a Checkpoint -- One major conclusion of this work is that maltotriose and ATP regulate MalT activity by controlling the self-association of the protein , a step thought to precede or accompany cooperative binding of the activator to promoter DNA .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10559195" target="_blank">10559195</a>]<br></li>
<li>As revealed by DNase I footprinting , both ATP and maltotriose are required for the binding of the MalT protein to the mal promoter DNA .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>MalT binds two ligands , maltotriose and ( d ) ATP , both of which are required for binding to promoter DNA ( 5 , 18 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10559195" target="_blank">10559195</a>]<br></li>
<li>This seems rather unlikely since the Kd value of MalT for ATP is 3-4 orders of magnitude lower than the intracellular concentration of ATP ( Chapman and Atkinson , 1973 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>The binding of ATP to MalT depends strictly on the presence of Mg2 , as is usually observed for nucleotide-binding proteins .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>The affinity of MalT for other nucleotides was determined by measuring their competitive effect on [ 3H ] ATP binding to MalT using both techniques .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>The plateau was reached with 1 ATP , and half maximal activity of MalT was obtained , tM-with 0.2 / LM ATP , a value consistent with the Kd measured above ( Table I ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>The intermediate results obtained with ATP are best explained by the presence of both ATP - and ADP-bound forms of MalT due to ATP hydrolysis during the assay .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>The equilibrium between the various MalT species also depends on whether MalT is liganded to ATP or ADP .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>The amount of ATP bound to MalT was calculated by using the mean value of the 4.5 and 5.5 h samplings .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>The turn-over number of ATP hydrolysis was low , about 0.08 mol of ATP hydrolysed/min/mol of MalT ( Figure 2A ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>The event that would cause ATP hydrolysis and the MalT form that undergoes ATP hydrolysis are both unknown .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>In its absence , only 0.25 molecules of ATP were bound per monomer of MalT , with a Kd of 0.7 , uM ( Figure 1B ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>ATP-free MalT was prepared , and MalT monomer concentrations were determined as described by Schreiber and Richet ( 1999 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>50-fold higher affinity for ADP ± MalT than for ATP ± MalT ( this work ) is unclear .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>No ApApC synthesis was detected in the absence of ATP at 0.28 / tM MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>So far , the role of ATP as an effector of MalT is unknown .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>MalT preparations devoid of ATP were obtained as follows .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>Finally , the ability of MalY to repress MalT , irrespective of whether the activator is liganded to ATP or a non-hydrolysable analogue , is evidence that MalY action is not coupled to ATP hydrolysis by MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>3 ADP can replace ATP as a positive effector of MalT in vitro , but it is less effective than ATP in shifting the equilibrium toward the transcriptionally competent form .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15491603" target="_blank">15491603</a>]<br></li>
<li>However , the fact that a very high concentration of maltotriose is required in vitro to overcome repression by MalY when MalT is bound to ADP makes it unlikely that MalY sequesters MalT in the ADP-bound form , unless one assumes a rapid exchange between ADP and ATP .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>We do not know whether , in vivo , the inactive form of MalT stabilized by MalY is in an ATP - or ADP-bound state .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>Both the ATP-bound and the ADP-bound forms of MalT are in equilibrium between inactive and active monomeric forms designated a and i , respectively , in the case of ATP/MalT and a and i , respectively , in the case of ADP/MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>Theoretically , both the inactive and the active forms may exist as ATP - or ADP-bound forms , as both ATP ± MalT and ADP ± MalT can bind MalY or bind maltotriose and oligomerize .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>The malTc26 mutation , which generates the R242P substitution in the DT1-DT2 linker , confers constitutive expression of the maltose regulon by favoring the transition from the inactive state to the active state of MalT ( 18 , 21 ) , and it is known to abolish MalT sensitivity to Aes in vivo ( 33 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>The transition between the inactive and the active form of MalT involves DT1 , DT2 , and DT3 , three domains that are specific to the MalT family of transcriptional-activators and are thought to constitute a signal integration module ( 21 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>Mutation malTc26 , which corresponds to the R242P substitution in the DT1-DT2 linker , is indeed known to shift the equilibrium toward the active form of MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>MalT appears monomeric in solution and , in the absence of inducer , is in an inactive form ( MalT , ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9884223" target="_blank">9884223</a>]<br></li>
<li>MalY most likely stabilizes MalT in its inactive ( monomeric ) form ( 37 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=12003949" target="_blank">12003949</a>]<br></li>
<li>Thus , they might all interact with MalT and keep it in the monomeric ( inactive ) form .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=12003949" target="_blank">12003949</a>]<br></li>
<li>The monomeric , inactive MalT form ( Ti ) is in equilibrium with the monomeric , active form ( Ta ) , which is prone to multimerization .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>According to the current 13 model , MalT exists in equilibrium between an inactive monomeric form and an active monomeric form that is prone to multimerization .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li>
<li>According to available data , the unliganded form of MalT is in equilibrium between a monomeric , inactive form and a monomeric active form that is prone to multimerise .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15491603" target="_blank">15491603</a>]<br></li>
<li>Available data suggest that unliganded MalT is in equilibrium between an inactive monomeric form and an active monomeric form prone to self-association .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>The available data are consistent with a model in which MalT is in equilibrium between two forms : an inactive , monomeric form stabilized by MalY and an active , monomeric form stabilized by maltotriose and prone to multimerize .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>Our data are consistent with the simple model proposed by Boos and Shuman ( 1998 ) , according to which MalT would exist in an equilibrium between two forms , an inactive form stabilized by MalY and an active form stabilized by maltotriose .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>All of the available data suggest a model in which MalT exists in an equilibrium between an inactive form stabilized by repressor binding and an active form stabilized by maltotriose binding and prone to multimerization ( 37 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=12003949" target="_blank">12003949</a>]<br></li>
<li>According to our working model , the unliganded form of MalT is in equilibrium between an inactive , monomeric form and an active monomeric form that is stabilized by maltotriose and prone to multimerise , provided that ATP is present .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15491603" target="_blank">15491603</a>]<br></li>
<li>MalT is in equilibrium between an inactive and an active form with the negative effector stabilizing the inactive form and maltotriose stabilizing the active form .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>As revealed by limited proteolysis , maltotriose binding triggers a conformational change in MalT that involves domains 1 -- 3 and most likely reflects part of the postulated transition from the inactive form to the active form of MalT ( 21 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>Therefore , these results indicate that the T38R substitution does not alter the balance between the inactive and the active foms of MalT , nor does it increase MalT affinity for maltotriose .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>c The malT 26 mutation , which generates the R242P substitution in the DT1-DT2 linker , increases the affinity of MalT for maltotriose by favoring the transition from the inactive state to the active state ( 9 , 21 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>As indicated by the absence of an effect on the intrinsic ability of MalT to activate transcription initiation , the amino acid changes caused by the up mutations do not grossly disturb DT3 structure nor alter a DT3 surface element that would play a key role in the stabilization of the active form of MalT or any subsequent step .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li>
<li>levels ( Debarbouille and Schwartz , 1980 ) , and the third expresses normal levels of the constitutively activated form of MalT , MalT1 ( Con ) ( Dardonville and Raibaud , 1990 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9822819" target="_blank">9822819</a>]<br></li>
<li>Based on the known ability of the MalT protein to form multimers and to-bind to T boxes , we believe that either the hybrid protein forms inactive mixed oligo-mers with wild-type MalT protein or that it simply occupies MalT boxes but is unable to activate transcription .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9822819" target="_blank">9822819</a>]<br></li>
<li>We had previously shown that , although excess MalK protein inhibits transcription of mal genes by wild-type MalT , a mutant form of MalT that is constitutively in the active form , MalT1 ( Con ) ( Dardonville and Raibaud , 1990 ) , is resistant to MalK-mediated repression ( Reyes and Shuman , 1988 ; and see below ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9822819" target="_blank">9822819</a>]<br></li>
<li>We show that Aes alone interferes with transcription activation by MalT in a purified transcription system and that Aes acts via the same mechanism as MalY , although their cognate recognition sites on MalT are likely to be distinct .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>We show that MalY inhibits transcription activation by MalT in a purified transcription system .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>Q 2000 Blackwell Science Lt Results MalY inhibits transcription activation by MalT in a purified transcription system We examined first whether MalY alone is able to repress transcription activation by MalT in a purified in vitro system .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>RESULTS MalK Inhibits Transcription Activation by MalT in Vitro -- We first examined whether purified MalK inhibits MalT in an in vitro transcription system .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>By using a biochemical approach and the soluble form of MalK as a model substrate , we demonstrate that MalK alone inhibits transcription activation by MalT in a purified transcription system .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>We show that MalK alone impedes transcription activation by MalT in a purified transcription system .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>ATP ± MalT is more effective than ADP ± MalT in oligomerizing and promoting transcription activation , which indicates that ATP/maltotriose/MalT is the species responsible for the transcriptional activity and that ATP hydrolysis might be coupled to the disassembly of oligomeric structures ( Schreiber and Richet , 1999 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>Altogether these results establish that ATP is required as a positive effector of MalT in the process of transcription activation .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>Does ATP hydrolysis occur at one step of the activation process , as suggested by the ability of MalT to hydrolyse ATP ?	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>MalT has a weak intrinsic ATPase activity If ATP is used by MalT as an energy donor to drive some conformational change or as a Pi donor to phosphorylate Abortive initiation at malPp , a new assay for MalT The ability of MalT to-bind ATP suggested that ATP might be involved in the transcription activation process .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>The finding that ATP is involved in transcription activation by MalT raises several questions about its role .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>The activation of these in transcription at promoters requires , addition to CAP , the activating proteins AraC and MalT , respectively ( 5 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=1569008" target="_blank">1569008</a>]<br></li>
<li>Mlc is known to repress the MalT activator , so perhaps it might activate transcription of an ldhA-speciﬁc activator that is yet to be identiﬁed .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11535784" target="_blank">11535784</a>]<br></li>
<li>LuxR alone activates transcription of the luxI-E operon , and MalT alone activates the pulC and pulA promoters ( 27 , 39 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=1569008" target="_blank">1569008</a>]<br></li>
<li>First , the fact that the presence of a MalT box at this position is the unique feature common to all the MalT-dependent promoters suggests that this binding site plays a key role in transcription activation ( Chapon & Raibaud , 1985 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2538630" target="_blank">2538630</a>]<br></li>
<li>Altogether , these results and the data presented here are strong evidence that the 5 ' - GGAT/GGA -3 ' sequence forms the core of the MalT recognition sequenceand that it mediates transcription activation by MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2538630" target="_blank">2538630</a>]<br></li>
<li>Plasmid DNAs were incubated with MalT and CRP , both present at concentrations that were optimal for activation of transcription , and then treated with dimethylsulphate .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2016744" target="_blank">2016744</a>]<br></li>
<li>Effect of Aes on transcription activation by MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>They suggest that the role of the MalT moiecules bound to site 2 and 3 in the activation of transcription is , at least in part , independent of the occupancy of site 1 .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=7830577" target="_blank">7830577</a>]<br></li>
<li>domain of MalT play a crucial role in transcription activation .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9000616" target="_blank">9000616</a>]<br></li>
<li>Synergistic activation of a transcriptional-regulator together with CRP has been shown at several loci including the ara locus by AraC and CRP , malE by MalT and CRP , rha by RhaS / RhaR and CRP and asc by two CRP dimers , among others ( 37,44 -- 47 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=24335284" target="_blank">24335284</a>]<br></li>
<li>Sequence conservation in the carboxyl-terminal activation module is found among numerous transcription activators , some of which ( NarL , DegU , FixJ , ComA , etc. ) are parts of two-component regulatory systems , whereas others ( LuxR , MalT , etc. ) are apparently regulated by direct ligand binding and not by protein phosphorylation ( Henikoff et aI .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=8144492" target="_blank">8144492</a>]<br></li>
<li>This supports the notion that DT1 and DT2 are involved in inter - or intramolecular interactions taking place in the process of MalT activation and that these domain interactions are interfered by Aes .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=12003949" target="_blank">12003949</a>]<br></li>
<li>Some of the data suggest that protein-protein interactions between the MalT molecules bound to the different sites are involved in the formation of nucieoprotein complexes leading to activation of transcription .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=7830577" target="_blank">7830577</a>]<br></li>
				<label class="ACT_collapse_similarity" for="act_similarity_619">
Danot , O. , and Raibaud , O. ( 1994 ) Multiple protein-DNA and protein-protein interactions are involved in transcriptional activation by MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=8596446" target="_blank">8596446</a>]<br></label>
<input id="act_similarity_619", type="checkbox">
<div class="ACT_similar">
<li>Danot , O. , and Raibaud , O. ( 1994 ) Multiple protein-DNA and protein ± protein interactions are involved in transcriptional activation by MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>Multiple protein-DNA and proteinprotein interactions are involved in transcriptional activation by MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9529892" target="_blank">9529892</a>]<br></li>
<li>Multiple protein-DNA and protein-protein interactions are involved in transcriptional activation by MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9000616" target="_blank">9000616</a>]<br></li>
<li>Multiple protein -- DNA and protein -- protein interactions are involved in transcriptional activation by MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15491603" target="_blank">15491603</a>, <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li></div>
<li>The AraC and MalT proteins are encoded by genes t h a t are closely linked to one of the operons they regulate ( araBAD , Wilcox et al. , 1974 ; and malPQ , D6barbouill6 & Schwartz , t Abbreviations used : DAP , diaminopimelate : bp , base-pair ; kb , l0a bases ; XGal , 5-bromo-4-chloro-3-indolyl - ~ - D-galactoside ; CAP , catabotite gene activator protein : AA , amino acid ( s ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=6350602" target="_blank">6350602</a>]<br></li>
<li>The search for proteins with homology to the putative BglJ protein yielded other members of this family including FimZ , UvrC , MalT , RcsA , NarP , and NarL ( ALTSCHUL et al. 1990 ; STOUTet al. 1991 ; SWENSOaNnd CLEGG1992 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=8725214" target="_blank">8725214</a>]<br></li>
<li>Purification of the f \ AalT protein MalT was purified essentially as described by Richet and Rai-baud ( 1987 ) with some improvements that result in a 10-fold increase in yield , malTp7 , a mutation that causes a 15-fotd increase in efficiency of malT translation ( Chapon , 1982 ) , was introduced into pOM2 , a derivative of pBR322 carrying ma/r ( Raibaud et ai , 1985 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=7830577" target="_blank">7830577</a>]<br></li>
<li>Since we recently purified the MalT protein ( Richet and Raibaud , submitted for publication ) , we reconsidered this problem of induction by studying the activation of a maltose regulon promoter in vitro .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=3298211" target="_blank">3298211</a>]<br></li>
<li>The specific activity of the purified protein was • -4500 Umg '' ^ ( 1 unit of MalT is defined as the amount of protein that gives the half-maximal response in the tran-scription-translation system of Zubay ( Richet and Raibaud , 1987 ) ) ; it is identical to the specific activity of the MalT protein purified using the previous protocol .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=7830577" target="_blank">7830577</a>]<br></li>
<li>The purification of MalT in an active form and the development of a purified in vitro transcription system recently made the process of transcription activation by MalT amenable to biochemical analysis ( Richet and Raibaud , 1987 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>The MalT protein , which has been recently purified in an active form , appears to be a monomer in solution ( M , = 102,000 ) ( Richet & Raibaud , 1987 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2538630" target="_blank">2538630</a>]<br></li>
<li>Assuming that the extinction coefficient of the tryptophane and tyrosine residues in the denatured protein are the same as those of N-acetyl-L-tryptophanamide and glycyl-L-tyrosyl-glycine , 5690 and 1280 M21 cm21 , respectively ( 20 ) , we calculated the extinction coefficient of MalT in 6 M guanidine hydrochloride as e 4 21 21 280 , M , denatured 5 14.95 3 10 M cm .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10559195" target="_blank">10559195</a>]<br></li>
<li>10.32 maa ( mac , F183a ) 20 , 26 Glucose/maltose transacetylase , not MalT dependent , responsible for exit of maltose and glucose in their acetylated forms .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9529892" target="_blank">9529892</a>]<br></li>
<li>In this respect , it will be interesting to understand how all of these signals are integrated at the level of the protein and , in particular , to identify the conformational changes that are involved in the transition between the inactive and the active forms and to determine the role that the ATPase activity of MalT plays in the control of this interconversion .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>After 60 min of incubation at 30 ° C , the , - galactosidase activity ( proportional to the quantity of MalP-LacZ synthesized ) was measured ; 1 Unit of MalT was defined as the amount of protein which gave the half-maximal response in this assay .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2180908" target="_blank">2180908</a>]<br></li>
<li>To ﬁnd out whether the MalK916 protein was unable to anatgonize MalT activity because of an inability to interact with the MalT protein , we performed an experiment similar to that shown in Fig. 1C , this time using the GST -- MalT protein bound to glutathione-agarose .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9822819" target="_blank">9822819</a>]<br></li>
<li>As in the case of MalT1 ( Con ) , it seems unlikely that the inability of the MalK916 protein to antagonize MalT activity can be explained by a lack of ability to-bind MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9822819" target="_blank">9822819</a>]<br></li>
<li>This interpretation was confirmed by showing that filtration of samples containing MalT and Aes in a 2:1 or 1:2 ratio ( 18 M MalT 9.5 M Aes or 9 M MalT 19 M Aes ) gave an additional peak at the position at which the protein present in excess is expected to elute ( data not shown ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>In the Absence of Ligands -- Gel filtration of 23 mM MalT in the absence of any ligand gave a symmetrical peak at the position of a 100-kDa globular protein ( Fig. 2A ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10559195" target="_blank">10559195</a>]<br></li>
<li>This conclusion is consistent with the 1sedimentation coefficient s20 , w of MalT ( 5.8 S ) meas-ured by sedimentation through a sucrose gradient in the absence of ligands , which corresponds to that of an ' 105-kDa globular protein ( Fig. 3A ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10559195" target="_blank">10559195</a>]<br></li>
<li>In the absence of Aes , MalT eluted as a 96-kDa globular protein ( elution volume , 1.30 ml ) , consistent with the fact that MalT is mainly monomeric under these conditions ( 4 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>When only MalT is present ( and provided it is overproduced ) , the protein specifically binds to the MalT boxes through their major groove , and initiates the formation of an aggregate of MalT monomers around which the intervening sequence is wrapped .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2538630" target="_blank">2538630</a>]<br></li>
<li>28 -- 33 How , for transcription factors such as MalT , NtrC or TyrR , differential spatial relative organizations of protein protomers and cognate sites are reconciled remains to be determined .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15491603" target="_blank">15491603</a>]<br></li>
<li>A better understanding of how MalT binds the array of MalT sites present in the mal promoters should be provided by the knowledge of the association state of the protein in solution .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10559195" target="_blank">10559195</a>]<br></li>
<li>The MalT protein , which is the activator at all mal promoters ( 112 , 206 , 214 ) , and the sites at which it binds ( MalT boxes ) have provided an important alternative view to the lac operon about how transcription is activated .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9529892" target="_blank">9529892</a>]<br></li>
<li>Higher concentrations of the protein were reproducibly inhibitory , a phenomenon which might , be related to the slight inhibition seen in ~ dz * o when MalT is overproduced ( Schwartz , 1987 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2016744" target="_blank">2016744</a>]<br></li>
<li>Samples containing the indicated concentrations of MalT protein were filtered at 6 ° C as described under `` Experimental Procedures .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10559195" target="_blank">10559195</a>]<br></li>
<li>This requirement for ATP is a property which , together with other features of the MalT protein ( its size and the asymmetry of its recognition sequence ) distinguishes it from the classical bacterial regulators such as the CI or the CRP proteins .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>When the MalT protein was compared with the HtpR , RpoD , OmpR , CAP or Fnr proteins of E. cold , together with the N , CI and CII proteins of bacteriophage i , no significant homologies were detected .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=3015733" target="_blank">3015733</a>]<br></li>
<li>We therefore searched for assay conditions under which the MalT protein would still be active at the end of the assay , even when ATP was omitted .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>Controls showed that , even in the absence of ATP , MalT protein was still active at the end of the assay , thus ruling out a mere stabilizing effect of ATP ( data not shown ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>Neither the requirement for maltotriose nor the requirement for ATP reflect a stabilizing effect on MalT activity ; the protein was still active at the end of the assay even if one effector had been omitted ( data not shown ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>It is tempting to propose that , in all of these cases , ATP hydrolysis is coupled to dissociation of the oligo-meric structure formed by the protein , as inferred for XylR ( 28 ) and as suggested for MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10559195" target="_blank">10559195</a>]<br></li>
<li>ATP-free MalT was prepared by precipitating 5 the puriﬁed protein with ammonium sulfate in the absence of ATP , washing the pellet and ﬁltering the resuspended material through a G-75-Sephadex column according to Schreiber et al. .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15491603" target="_blank">15491603</a>]<br></li>
<li>However , in their experiments the immobilized MalT protein might be unfolded because of the absence of ATP during the extraction process ( 30 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>When ATP is bound to MalK ( but not hydrolyzed due to the absence of triggering substrate-loaded MBP ) , the protein is a repressor and interacts with MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9529892" target="_blank">9529892</a>]<br></li>
<li>We conclude that the low levels of MalT detected in these strains were due to the absence of H-NS , which appeared to play a positive role in malT gene expression at the level of translation .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9829919" target="_blank">9829919</a>]<br></li>
<li>Since the malT promoter is controlled by the cAMP-CRP complex , we considered the possibility that the decreased expression of MalT observed in hns and hns-stpA strains was in part also due to a reduced level of cAMP-CRP .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9829919" target="_blank">9829919</a>]<br></li>
<li>To test this hypothesis , we added pHA7 * to the malT-lacZ fusion strains to see if excess active CRP levels would restore the levels of MalT expression .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9829919" target="_blank">9829919</a>]<br></li>
<li>If the form of the wild-type transporter containing K ATP anta-gonizes the ability of MalT to activate transcription , it would enable the cell to adjust the level of mal gene expression Plasmids malK genes b-Galactosidase unitsa present present 6 SEM a. Overnight cultures of CP475 transformed with the indicated plasmids grown in half-strength LB broth were assayed for b-galactosidase activity as described in Experimental procedures .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9822819" target="_blank">9822819</a>]<br></li>
<li>3752 6 230 290 6 5 29 6 1 185 6 7 36 6 2 NONE þ pBR322 þ pACYC184 pMR10 þ pACYC184 pCP50 þ pACYC184 pMR10 þ pMR11 pCP50 þ pMR11 malK malK941 malK þ malK þ þ malK malK941 Increased levels of MalK ATPase reverse MalK antagonism of MalT activity If this model is correct , then the active form of the transpor-ter should not antagonize the ability of MalT to activate transcription .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9822819" target="_blank">9822819</a>]<br></li>
<li>Second , mutations in malF and malG that result in high constitutive levels of MalK ATPase activity ( 41 , 57 ) show a high level of mal gene expression in the absence of inducer , presumably because the ATP-hydrolyzing form of MalK is mimicking transport activity and is unable to repress MalT activity ( 183 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9529892" target="_blank">9529892</a>]<br></li>
<li>We reasoned that mutations that cause high levels of MalK ATPase activity should have the opposite effect of MalK941 ; that is , a reduced ability to antagonize MalT activity and therefore result in constitutive mal gene expression .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9822819" target="_blank">9822819</a>]<br></li>
<li>Fitting this strain with chromosomal levels of wild-type malT or with the different malT mutations , we used mal gene expression in the absence or presence of each individual plas-mid-encoded repressor as a means to test the interaction of the three repressors with these mutant MalT proteins .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=12003949" target="_blank">12003949</a>]<br></li>
<li>It has been established previously that , in a wild-type strain , MalT is limiting , as mutations that increase the amount of MalT increase mal gene expression as well ( Chapon , 1982b ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9484893" target="_blank">9484893</a>]<br></li>
<li>Under the chosen conditions , mal gene expression controlled by wild-type MalT was inhibited 7.5-fold by MalK , whereas the elevated mal gene expression caused by the MalT mutant proteins was inhibited by MalK from 3.3 - ( T38R ) to 52-fold ( R242C ) ( pmalK column in Table 4 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=12003949" target="_blank">12003949</a>]<br></li>
<li>Among the 26 MalT mutations , there were none that exhibited wild-type mal gene expression in the absence of MalK .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=12003949" target="_blank">12003949</a>]<br></li>
<li>With plasmid-encoded Aes , mal gene expression controlled by wild-type MalT was inhibited more than 7.5-fold , whereas several MalT variants were hardly affected ( only one - to twofold inhibition ; paes column in Table 4 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=12003949" target="_blank">12003949</a>]<br></li>
<li>Thus , these mutant MalT proteins were as sensitive to Aes as wild-type MalT or even more sensitive ( 7.5 - versus 20-fold inhibition ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=12003949" target="_blank">12003949</a>]<br></li>
<li>Thus , increased mal gene expression in these MalT mutants must have been caused solely by a change in the equilibrium towards the active form of MalT without altering appreciably the binding sites for any of the repressors .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=12003949" target="_blank">12003949</a>]<br></li>
<li>OxyR , AraC , and MalT present three unique examples of how shifts in DNA contacts can lead to changes in gene expression .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=8087856" target="_blank">8087856</a>]<br></li>
<li>It is necessary to have both MalT and the mutated form of CRP ( CRP * ) to induce mal gene expression in sfsl-dependent systems .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2013578" target="_blank">2013578</a>]<br></li>
<li>Mutants in MalT causing elevated mal gene expression in the absence of exogenous maltodextrins were tested in their response to the three repressors .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=12003949" target="_blank">12003949</a>]<br></li>
<li>demonstrating that Mlc controls mal gene expression by regulating the amount of MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9484893" target="_blank">9484893</a>]<br></li>
				<label class="ACT_collapse_similarity" for="act_similarity_674">
Overproduction reduces mal gene expression by interaction with MalT and its inactivation .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9529892" target="_blank">9529892</a>]<br></label>
<input id="act_similarity_674", type="checkbox">
<div class="ACT_similar">
<li>Overproduction reduces mal gene expression , presumably by interaction with MalT and its inactivation .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9529892" target="_blank">9529892</a>]<br></li></div>
<li>However , as shown by Schlegel et al. , ( 33 ) the T38R substitution , isolated2 by Notley-McRobb and Ferenci ( 32 ) and located in MalT domain 1 ( DT1 ) , renders the protein insensitive to Aes in vivo , whereas it slightly increases its sensitivity to MalY , thereby suggesting that the substitution specifically alters the Aes binding site .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>Several lines of evidence suggest that MalT is the target of the three repressor proteins : ( i ) overexpression of MalT relieves repression by MalK and Aes ( Peist et al. , 1997 ; Panagiotidis et al. , 1998 ) ; ( ii ) MalK titrates MalT in vivo ( Panagiotidis et al. , 1998 ) ; and ( iii ) a malT c strain , which constitutively expresses the maltose system in vivo , is largely insensitive to repression by MalK , MalY and Aes ( Reyes and Shuman , 1988 ; Reidl et al. , 1989 ; Peist et al. , 1997 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>A MalT variant is largely insensitive to repression by c MalY in vitro In vivo , the malT 1 mutation , which confers constitutive c expression of the maltose regulon , suppresses repression by MalY ( Reidl et al. , 1989 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>Given that the ATPase activity of MalT does not play any role in the activation of open complex formation ( 5 ) , it is tempting to propose that it actually plays a role in the negative control of MalT activity and that the MalT/ADP form is the actual target of MalY and Aes in vivo .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>These data suggest that 8,9 the ATPase activity of MalT might play a role in the competition between the positive and negative effectors .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li>
<li>The differential effects of ATP and ADP on the competition between the inducer and Aes ( or MalY ) suggest that the ATPase activity displayed by MalT plays a role in the negative control of its activity .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>The differential effects of ATP 9,10 and ADP on the competition between maltotriose and negative effectors suggest that the ATPase activity displayed by MalT might play a role in the control of the activator activity .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15491603" target="_blank">15491603</a>]<br></li>
<li>The requirement for ATP as a positive effector of MalT might reflect a role for the ATPase activity of MalT in the competition between positive and negative effectors .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>One likely explanation is that the retention effects ( Silhavy et al. , 1975 ) and the slow kinetics of the interaction between MalT and ATP ( see below ) together result in the freezing of the equilibrium upon addition of ammonium sulphate at 0 ° C .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>One such example is the TyrR regulator , which does not belong to the MalT family of transcriptional-activators and whose activity is modulated differentially by three ligands : ATP , tyrosine and phenylalanine ( Wilson et al. , 1995 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>It has also been demonstrated that MalK , a component of the ABC-type transporter for maltose , physically interacts with MalT to downregulate its transcriptional activity in response to the levels of ATP hydrolysis associated with maltose transport ( Panagiotidis et al. , 1998 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11157755" target="_blank">11157755</a>]<br></li>
<li>Panagiotidis et al. ( 11 ) observed that a MalK variant that binds but does not hydrolyze ATP has a super-repressor phenotype , whereas MBP-independent transporter variants with high ATPase activity , even in the absence of transportable substrate , show a reduced ability to repress MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>We verified that the concentrations of wild-type MalT , MalTc26 , and MalTT38R in the assays were limiting , i.e. that the absence of an inhibitory effect was meaningful ( data not shown ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>Likewise , the T38R MalT variant , which is insensitive to repression by MalK , did not bind MalK , nor does wild-type MalT bind MalK-G346S , the MalK variant defective in MalT regulation ( Fig. 3 , C and D ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>B , closed squares , 240 nM wild-type MalT wild-type MalK ; open diamonds , 240 nM wild-type MalT MalK-G346S .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>As shown in Figure 4 , a fraction of the wild-type MalT protein was retained on the column and co-eluted with MalK .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li>
<li>Although the amount of wild-type MalK that bound to the glutathione-agarose in the presence of GST was much less than that found in the presence of GST-MalT , the results with the MalK916 protein were less clear .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9822819" target="_blank">9822819</a>]<br></li>
<li>To our knowledge , MalT is the fourth type of prokaryotic regulator with the association state shown to be modulated by the binding of ligands .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10559195" target="_blank">10559195</a>]<br></li>
<li>As shown in Fig. 4 , wild-type MalK markedly reduced maltotriose binding by wild-type MalT , whereas it had no significant effect on maltotriose binding by MalTc26 or MalT-T38R .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>Furthermore , as predicted , G346S MalK does not prevent maltotriose binding by wild-type MalT ( Fig. 4 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>As shown in Fig. 3 , Aes reduced the amount of maltotriose bound by wild-type MalT by about two-thirds , whereas it did not affect maltotriose binding by the FIG. 2 .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>As shown in Fig. 5 , MalY markedly decreased the amount of maltotriose bound by wild-type MalT , whereas , as expected , it had no effect on maltotriose binding by the MalT 26 variant .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>It should be pointed out that , although both promoters function only in the presenceof CRP in a wild-type strain , they are partially active in a crpbackground provided that MalT is overproduced .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2538630" target="_blank">2538630</a>]<br></li>
<li>Controls showed that malEp + is slightly more active in the malPQ − overproducing strain while it is marginally less active in the malPQ + overproducing strain ( Table 1 ) , which indicates that MalT overproduction does not lead to promoter inhibition , at least in the case of the wild-type promoter .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9000616" target="_blank">9000616</a>]<br></li>
<li>In contrast , if the MalK941 mutant regulatory properties are dominant to wild type , we would conclude that the increased ability to antagonize MalT activity is due to a gain of function .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9822819" target="_blank">9822819</a>]<br></li>
<li>To make sure that the in vitro activity of the wild-type promoter was not inhibited by 300 nM MalT , we also performed a set of such maiPp allele ' Gly Gty + Mal Gly-h Mai a. All ot the strains were derived from pop1951 .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=7830577" target="_blank">7830577</a>]<br></li>
<li>the in vitro activity of the malPp15 variant was measured by this test ( Fig. 7 ) ; it was also found to be very iow , although in the case of this variant , the binding of MalT to sites 1-3 was strictly identical to that observed on the wild-type promoter .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=7830577" target="_blank">7830577</a>]<br></li>
<li>malT and malK Mutations Relieving MalT Inhibition by MalK in Vivo Also Suppress the Inhibitory Effect of MalK in Vitro -- To confirm that the inhibition caused by MalK in vitro is functionally significant , we examined whether two different malT mutations that are known to confer resistance to MalK in c vivo ( malT 26 and malT-T38R ) have the same effect in vitro .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>Repression of MalT Activity by MalK Involves a Direct Interaction between MalK and MalT -- Having established an in vitro repression system mimicking in vivo events , we characterized the repression process and tested the simple hypothesis that MalT inhibition by MalK involves formation of a MalKMalT complex .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>In vivo characterization of the malT T38R mutant revealed that besides rendering MalT fully resistant to repression by Aes , the mutation also significantly decreases MalT sensitivity to repression by MalK ( 33 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>In vivo and in vitro analyses revealed that the substitutions altering the so-called H10/H11 motif do not affect the ability of MalT to activate transcription or its sensitivity to MalY and Aes , but dramatically decrease its sensitivity to MalK .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li>
<li>In vivo and in vitro characterization of the mutated MalT proteins provides compelling evidence that the substitutions do not signiﬁcantly impair the intrinsic ability of MalT to activate transcription initiation , but speciﬁcally render MalT resistant to the inhibition by MalK .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li>
<li>This last property may explain why the substitution has been selected in a glucose-limited chemostat ( 32 ) ( by reducing MalT sensitivity to repression by MalK in the absence of exogenous maltodextrins , the T38R substitution would lead to an increased basal expression of the LamB porin ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>In contrast , the existence of two distant half-sites on MalK whose spatial relationship depends on whether MalK is in the open or the closed conformation , i.e. on whether the transporter is resting or actively transporting maltodextrins , 24 explains how the ability of MalK to interact with MalT might be coupled to the absence of transport .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li>
<li>It has not escaped our attention that the different abilities of MalK to regulate MalT , depending on the occupancy of MalK by different nucleotides bears at least superﬁcial resemblance to the manner in which GTP-bind-ing proteins transmit information about receptor occupancy to various output functions in eukaryotic cells .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9822819" target="_blank">9822819</a>]<br></li>
<li>MalT control by MalK was first recognized with the finding that malK null mutants express constitutively the maltose regulon , whereas MalK overproduction blocks mal gene induction ( 5 , 6 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>The observation that the repression by MalK is relieved both by MalT overexpression and by a class of malT mutations ( malTc ) that confer constitutive expression of the maltose regulon suggested further that MalT is the target of the negative control exerted by MalK ( 6 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>Control of MalT 9 -- 11 activity by MalK , the ATP-binding component of the maltodextrin transporter , is thought to couple the induction of the maltose regulon to the entry of maltodextrins into the cell .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15491603" target="_blank">15491603</a>]<br></li>
<li>Control of MalT 8 -- 10 activity by MalK is thought to couple induction of the maltose regulon to the entry of maltodextrins into the cell .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li>
<li>The observation that transport of maltodextrins alone in the apparent absence of internal maltotriose can elicit induction poses an inherent problem : the activity of MalT can be controlled ( inhibited ) by the interaction with MalK , representing transport-controlled induction .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=16321936" target="_blank">16321936</a>]<br></li>
<li>Genetic data suggest that MalK acts as a repressor of MalT when the maltodextrin transport system is resting , thereby preventing induction of the maltose regulon by endogenous maltotriose in the absence of maltodextrins in the growth medium ( 10 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>MalT repression by MalK ensures that the maltose regulon is not induced by endogenous maltotriose , the inducer of the system , in the absence of external maltodextrins ( 8 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>In the accompanying paper ( 17 ) , where we discuss the osmoregulation of endogenous induction , we come to the conclusion that , aside from the glycogen-de-rived inducer maltotriose that is sensitive to MalZ , there exists glycogen-independent endogenous induction that is insensitive to MalZ and therefore must be caused by an inducer distinct from maltotriose that is able to activate MalT when MalK is not inhibiting MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=16321936" target="_blank">16321936</a>]<br></li>
<li>Also , when maltose enters the cell via a constitutive transport system for trehalose ( see below ) , an inducer that renders MalT insensitive to overproduction of MalK as well as MalY can be formed .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9529892" target="_blank">9529892</a>]<br></li>
<li>In the absence of maltose , the afﬁnity of MalK for MalFG is lowered and it becomes available to interact with MalT , keeping MalT in its inactive state as a mal gene transcriptional-activator .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9529892" target="_blank">9529892</a>]<br></li>
<li>In the Maltose/Maltodextrin transport system , MalT , when stabilized by the inducer malto-triose , acts as a transcriptional-activator , whereas stabilization by MalK renders MalT inactive ( reviewed in Boos & Bohm , 2000 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=16451192" target="_blank">16451192</a>]<br></li>
<li>Thus , when stabilized by inducer , MalT would be able to act as a transcriptional-activator ( 66 ) , whereas when stabilized by MalK , it would be inactive .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9529892" target="_blank">9529892</a>]<br></li>
<li>In addition to its role in transport , MalK influences maltose gene expression , probably by competing with the endogenous inducer for MalT , .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9884223" target="_blank">9884223</a>]<br></li>
<li>In the presence of substrate to be transported , MalK would shift to the transport conformation allowing MalT to function as mal gene activator .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9529892" target="_blank">9529892</a>]<br></li>
<li>Based on the isolation of MalK-insensitive mutants , we had concluded previously that MalK-mediated mal gene repression is dependent on an additional protein , thus excluding a direct interaction between MalK and MalT ( Boos et al. , 1996 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9484893" target="_blank">9484893</a>]<br></li>
<li>Panagiotidis et al. ( 11 ) observed a MalT-MalK interaction in vitro , but this MalTMalK complex did not respond to signals known to relieve MalT repression by MalK in vivo .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>However , aside from the demonstration that MalK interacts with MalT in vitro ( Panagiotidis et al. , 1998 ) , direct evidence for this model is either scarce or lacking .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>As demonstrated by Joly et al. , MalT 10 inhibition by MalK can be reproduced in a puriﬁed transcription system by using the soluble form of MalK as a model substrate .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li>
<li>Decker et al. ( 1993 ) postulated that in the absence of MalK , MalT would not require an inducer to be active .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9884223" target="_blank">9884223</a>]<br></li>
<li>A putative function of MalK would be to compete with the endogenous inducer for binding to MalT , ( Decker et al. , 1993 ) , leading to lower amounts of MalT , available for conversion into MalT , .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9884223" target="_blank">9884223</a>]<br></li>
<li>On the basis of genetic data , Panagiotidis et al. ( 11 ) proposed that only the ATP-bound form of MalK , which is expected to predominate when the transporter is resting , is able to repress MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>Based on the properties of mutant forms of MalK , it appears that the inactive ATP-bound form of MalK is able to antagonize the ability of MalT to activate transcription .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9822819" target="_blank">9822819</a>]<br></li>
<li>The working model for its function predicts that , in the absence of transport , under conditions when ATP is bound to but not hydrolyzed by transport complex-engaged MalK , MalT is likely to be seques-tered by MalK in monomeric ( inactive ) form .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=12003949" target="_blank">12003949</a>]<br></li>
<li>Instead , the inducer and the malTc26 mutation probably antagonize MalK binding indirectly by stabilizing the active form of MalT , i.e. the form in which the MalK binding site is either masked or has a reduced affinity for MalK .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>This suggests that , even if mutations in the MalK binding site are among these mutations , they will simultaneously shift MalT to its active , multimeric form .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=12003949" target="_blank">12003949</a>]<br></li>
<li>( iii ) MalK could act as an enzyme that either polymerizes or degrades the internal inducer into a form which can no longer be recognized by MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2423504" target="_blank">2423504</a>]<br></li>
<li>Hence , MalK and the inducer would compete for MalT , shifting the equilibrium either with maltotriose to the inducing conformation or with MalK to the inactive form , causing repression .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9529892" target="_blank">9529892</a>]<br></li>
<li>Thus , which form of MalK down-regulates MalT in vivo , the MalFGK2 transporter or a soluble MalK form that would cycle between the membrane and the cytoplasm ?	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>These results are consistent with a model in which the inactive form of MalK down-modulates MalT and decreases transcription , whereas the active form of MalK does not .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9822819" target="_blank">9822819</a>]<br></li>
<li>These results support the hypothesis that in vivo , the activated form of MalK is less able to antagonize MalT activity than the inactive form .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9822819" target="_blank">9822819</a>]<br></li>
<li>The MalK-binding site might result from the juxtaposition of the DT1 and DT3 determinants that would occur when MalT is in the inactive form .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li>
<li>Alternatively , the DT1 and DT3 determinants recognized by MalK might not be close to each other in the inactive form of MalT , and might correspond to two distinct patches recognized by MalK .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li>
<li>10 Finally , it remains possible that the H10/H11 motif is not recognized by MalK but , instead , is involved in the stabilization of the MalT inactive form recognized by MalK .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li>
<li>However , such a hypothesis implies that the active form of MalT would be in equilibrium with at least two different inactive forms of MalT , and that only the form recognized by MalK would be stabilized by an intra-molecular domain/domain interaction mediated by the DT3 H10/H11 motif .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li>
<li>Given that the T38R substitution does not change MalT affinity for maltotriose in vitro as shown here , the reduced sensitivity to MalK conferred by the substitution is not caused by an increased affinity for maltotriose but might result from an impaired interaction between MalT and MalK .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>It might seem surprising that the MalT/MalK interaction revealed here by the affinity chromatography experiments performed with immobilized MalK responds to maltotriose or to c the malT 26 mutation , whereas this was not the case in similar experiments that were performed with immobilized MalT by Panagiotidis et al. ( 11 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>Indeed , by performing affinity chromatography , Panagiotidis et al. ( 1998 ) provided evidence for a direct interaction between MalK and MalT , as observed with MalY but , surprisingly , the MalK ± MalT interaction was not affected in vitro by the presence of maltotriose or by a malT c mutation .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>The substitution indeed alleviates the requirement for maltotriose , i.e. renders the protein constitutively active in the presence of ADP .5 Nevertheless , the T38R MalT substitution also modifies , directly or indirectly , the DT1 determinant recognized by MalK , because it makes the DT1 / MalK interaction insensitive to the mutation malK-G346S in the DT1 context .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>We examined the effects of adding ATP , ADP , maltotriose or depleting ATP with glucose þ hexokinase or apyrase on the levels of MalK that associated with the MalT -- BCCP protein but found no signiﬁcant differences from the results shown in Fig. 1C ( data not shown ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9822819" target="_blank">9822819</a>]<br></li>
<li>Either the interaction of MalK prevents the ability of MalT to-bind to MalT boxes at mal promoters or MalK may have no direct effect on DNA binding but interfere with transcriptional activation of RNA polymerase .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9822819" target="_blank">9822819</a>]<br></li>
<li>Böhm et al. ( 10 ) identified a surface determinant on the C-terminal domain of MalK that is specifically involved in MalT repression and might represent the MalT binding site .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>On the basis of the observation that the N637T substitution prevents MalK from interacting with MalT in vitro , we infer that the H10/H11 surface element is involved in MalK binding .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li>
<li>Since MalK is known to-bind DT1 , another domain of MalT , it was possible that the H10 / 10 H11 motif is important for MalK function ( i.e. repression of MalT activity ) but not for its binding to MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li>
<li>Hence , its substitution with glycine might affect MalT repression by MalK , because it disrupts the salt-bridge between helices 10 and 11 and/or because it alters the H10/H11 motif surface .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li>
<li>Based on in vivo observations , it was proposed that MalK and Aes also inhibit MalT by antagonizing maltotriose binding ( 3 ) : overexpression of MalT relieves repression by MalK and Aes ( 10 , 14 ) , and MalTc constitutive mutants that have a higher affinity for maltotriose than wild-type MalT are less sensitive to MalK and Aes in vivo ( 18 , 33 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>Some MalTc variants are known to display a higher affinity for maltotriose and to be less sensitive to repression by MalK , which suggests that MalK inhibits MalT by competing with maltotriose ( 6 , 9 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>Indeed , it is easy to imagine how interaction of MalK or another domain of MalT with the exterior cleft separating the ﬁfth and sixth helix bundles could change the curvature of the inner surface of the tunnel and preclude the binding of maltotriose , if it does bind in the tunnel , and , reciprocally , how maltotriose could prevent the H10/H11 motif from binding its target .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li>
<li>However , the lack of in vitro response to the presence of maltotriose or a malT mutation might be c caused by an alteration in the structure of the immobilized MalT protein , resulting in an unregulated presentation of the MalK-binding motif .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>Furthermore , since the interior of the tunnel is thought to-bind maltotriose ( O. D. , unpublished results ) , our ﬁnding might provide a simple explanation for the competition between MalK and maltotriose for MalT binding .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li>
<li>MalK Antagonizes Inducer Binding by MalT -- We then tested whether , reciprocally , MalK would inhibit maltotriose binding by MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>Altogether , these data strongly suggest that MalK and maltotriose compete for MalT binding .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>Effect of MalK on maltotriose binding by MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>Conversely , MalK inhibits maltotriose binding by MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>Based on these results , we conclude that MalK inhibits maltotriose binding by MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>Characterization of the repression process revealed that MalK inhibits MalT by forming a complex with the activator and by blocking inducer binding .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>It also demonstrates that MalK inhibits MalT by interacting with the activator and by antagonizing inducer binding .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>Intriguingly , the amino acid change impairs MalK binding in the full-length MalT context but not in the DT1 context .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>MalT -- BCCP hybrid for binding to MalK and to reduce the amount of MalK recovered on the streptavidin beads .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9822819" target="_blank">9822819</a>]<br></li>
<li>Nor did the pre-sence of the normal MalT protein result in binding of MalK to the streptavidin beads in the absence of the MalT -- BCCP hybrid .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9822819" target="_blank">9822819</a>]<br></li>
<li>The malT-N637T mutation interferes with MalT inhibition by MalK in vitro To conﬁrm this interpretation , we determined whether N637T , one of the surface-exposed substitutions altering the H10/H11 surface determinant ( see Discussion ) , also relieves MalT repression by MalK in vitro .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li>
<li>The substituted amino acids are either part of a surface determinant , the H10/H11 motif , playing a crucial role in MalT repression by MalK or contribute to the correct exposition of this determinant .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li>
<li>The retention observed is signiﬁcant because it completely disappears when afﬁnity chromatography is performed with a MalK variant ( G346S ) defective in MalT repression .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li>
<li>The inhibitory effect observed in vitro is relieved by maltotriose and by two malT mutations and one malK mutation known to interfere with MalT repression by MalK in vivo .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>The fact that maltotriose antagonizes MalT inhibition by MalK , as was expected based on in vivo data , provides evidence that the inhibitory effect observed in vitro is physiologically relevant .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>The MalK941 mutant protein has an increased ability to down-modulate MalT activity If MalK is somehow involved in antagonizing the ability of MalT to activate transcription at mal promoters based on the level of maltose transport into the cell , there must be a mechanism for transmitting information about transport rates to MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9822819" target="_blank">9822819</a>]<br></li>
<li>The G346S substitution , which is thought to alter the MalT-binding site , specifically decreases the ability of MalK to down-regulate MalT in vivo without damaging its ability to catalyze maltose transport both when overproduced or when constitutively ex-4 pressed from a chromosomal locus ( 10 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>The structural consequences of ATP hydrolysis might be different , however , in the context of the assembled transporter , and conformational changes of the MalK regulatory region might accompany the ATP hydrolysis cycle when coupled to transport and thus control the ability of MalK to interact with MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>The search , which was performed under conditions in which MalT activity was repressed by MalK , led to the identiﬁcation of a surface region on DT3 that is involved speciﬁcally in the control of MalT activity by MalK .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li>
<li>Discussion The search for gain of function mutations in DT3 under conditions of MalT inhibition by MalK revealed a surface-exposed determinant that is involved speciﬁcally in MalT control by MalK .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li>
<li>The data presented in this paper dealing with one of these MalK-insensitive mutations no longer give evidence for a mediator of MalK in its function of inhibiting MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9484893" target="_blank">9484893</a>]<br></li>
<li>The regulatory domain of MalK also interacts with MalT , inhibiting its activity as a transcriptional-activator ( 31 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=16321936" target="_blank">16321936</a>]<br></li>
<li>The results presented here do not provide any information about how the MalK subunit antagonizes the activity of MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9822819" target="_blank">9822819</a>]<br></li>
<li>The observation of sequences that are homologous in the three proteins MalK , MalT , and MalI would speak for a common sugar recognition site in these proteins .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2670898" target="_blank">2670898</a>]<br></li>
<li>The lack of any effect of nucleotides on the ability of MalK to interact with MalT may be due to differences in the MalK protein when it is separated from the MalF and MalG integral membrane proteins or an inability to completely deplete or exchange nucleotides in crude extracts .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9822819" target="_blank">9822819</a>]<br></li>
<li>The in vivo and in vitro assays described here should permit the identiﬁcation and characterization of mutant forms of the MalT and MalK proteins that are defective in their ability to interact .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9822819" target="_blank">9822819</a>]<br></li>
<li>Results MalT and MalK interact in vivo We constructed a hybrid form of MalT , MalT -- BCCP , that contains the biotination signals from the BCCP protein ( Cronan , 1990 ) attached to the C-terminus of MalT ( see Fig. 1A ) to test the hypothesis that MalK antagonizes the transcriptional activity of MalT via a direct physical interaction .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9822819" target="_blank">9822819</a>]<br></li>
<li>The greatest amount of MalK bound to streptavidin beads containing the MalT -- BCCP protein .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9822819" target="_blank">9822819</a>]<br></li>
<li>No detectable MalK was bound to the streptavidin beads in the presence of the normal MalT protein .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9822819" target="_blank">9822819</a>]<br></li>
<li>Although these data do not permit quantiﬁcation of the relative amounts of MalK and MalT -- BCCP bound to the streptavidin beads , they are consistent with a speciﬁc interaction between MalK and the MalT -- BCCP protein .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9822819" target="_blank">9822819</a>]<br></li>
<li>As can be seen in Fig. 4A , the amounts of MalK protein bound to the streptavidin beads are indistinguishable whether the MalT -- BCCP or the Mal-T1 ( Con ) -- BCCP are present on the beads .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9822819" target="_blank">9822819</a>]<br></li>
<li>To examine the ability of the GST -- MalT protein to-bind to the MalK protein , glu-tathione-agarose beads were loaded with GST -- MalT protein and the beads were incubated with extracts containing the MalK protein .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9822819" target="_blank">9822819</a>]<br></li>
<li>To examine the ability of the His-6 -- MalK protein to interact with the MalT -- BCCP protein , extracts containing each protein were incubated together and then streptavidin-agarose beads were added to capture MalT -- BCCP and any interacting proteins .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9822819" target="_blank">9822819</a>]<br></li>
<li>These data are consistent with the hypothesis that both the MalT -- BCCP and the normal MalT proteins bind to the MalK protein .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9822819" target="_blank">9822819</a>]<br></li>
<li>We conclude that MalK can speciﬁcally interact with both the MalT protein and the two hybrid MalT proteins .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9822819" target="_blank">9822819</a>]<br></li>
<li>We conclude that the MalK protein can directly interact with the MalT and MalT -- BCCP proteins .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9822819" target="_blank">9822819</a>]<br></li>
<li>If the interaction between MalK and the MalT -- BCCP hybrid is speciﬁc , extracts containing normal MalT protein would be expected to compete with the Fig. 1 .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9822819" target="_blank">9822819</a>]<br></li>
<li>Although the BCCP protein is present in the sample , results presented above ruled out the role of the BCCP portion of the MalT -- BCCP hybrid in mediating its interaction with the MalK protein .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9822819" target="_blank">9822819</a>]<br></li>
<li>In this report we describe the use of tagged versions of MalT to provide evidence that it physically interacts with the MalK protein both in vitro and in vivo .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9822819" target="_blank">9822819</a>]<br></li>
<li>Before using this protein as a tool to study the ability of MalK and MalT to interact in vitro , we ﬁrst examined its ability to function in vivo .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9822819" target="_blank">9822819</a>]<br></li>
<li>Even though we do not yet know the basis of the dominant phenotype , we reasoned that if MalK and MalT interact in vivo , excess MalK might titrate the MalT -- BCCP protein and reverse its dominant negative effect independently of the mechanism of the dominance .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9822819" target="_blank">9822819</a>]<br></li>
<li>Thus , in order to measure the ability of MalK to reverse the dominant negative effect of the MalT -- BCCP protein , we used a strain that contains the malT1 ( Con ) mutation and a malP -- lacZ þ transcriptional fusion .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9822819" target="_blank">9822819</a>]<br></li>
<li>These data provide compelling evidence that MalT physically interacts with MalK , that the interaction is functionally relevant , and that maltotri-ose prevents formation of the MalT-MalK complex .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>To ﬁnd out whether MalK and MalT form a binary complex or whether additional proteins participate in this interaction , we constructed the same His-6 -- MalK hybrid described by Davidson ( Davidson and Sharma , 1997 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9822819" target="_blank">9822819</a>]<br></li>
<li>As a result , the ability of MalT to interact with MalK was possibly unregulated , and the secondary structural motifs involved in MalK recognition were permanently exposed .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>Mutant forms of MalT and MalK are defective in signalling but retain the ability to interact As previously reported and shown here , the MalT1 ( Con ) mutant form of MalT is not antagonized by MalK ( Reyes and Shuman , 1988 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9822819" target="_blank">9822819</a>]<br></li>
<li>In addition , a search for transposon-induced mutants of E. coli in which MalK can not repress mal transcription did not yield candidate genes for a third putative factor required for the MalK -- MalT interaction ( K. Decker and W. Boos , unpublished results ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9822819" target="_blank">9822819</a>]<br></li>
<li>In addition , we show that a novel malK mutation , malK941 , results in an increased ability of MalK to down-modulate MalT activity in vivo .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9822819" target="_blank">9822819</a>]<br></li>
<li>In contrast , cells with high levels of MalK ATPase show a reduced ability to down-mod-ulate MalT and express several mal genes constitutively .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9822819" target="_blank">9822819</a>]<br></li>
<li>In this report we show that the MalK and MalT proteins physically interact and that the levels of FGK2 ATPase control the ability of MalK to inﬂuence MalT-dependent transcription .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9822819" target="_blank">9822819</a>]<br></li>
<li>We do not know if the afﬁnity of the interaction between MalT and MalK is the same as that between MalT1 ( Con ) -- BCCP and MalK , but given the results in Fig. 4A , it seems unlikely that the nearly complete resistance of malT1 ( Con ) strains to antagonism by MalK can be explained by an inability of the two proteins to interact .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9822819" target="_blank">9822819</a>]<br></li>
<li>These results are consistent with the hypothesis that MalK and MalT functionally interact in vivo .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9822819" target="_blank">9822819</a>]<br></li>
<li>MalT and MalK physically interact in vitro Even though the results obtained in vivo are consistent with a functional interaction between MalK and MalT , they do not demonstrate a direct physical interaction between the two proteins .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9822819" target="_blank">9822819</a>]<br></li>
<li>Our test system should easily have detected even a slight interference by these MalT fragments as a relief from MalKmediated repression , since repression due to only basal levels of chromosomally encoded MalK was not saturating ( Tables 2 and 3 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=12003949" target="_blank">12003949</a>]<br></li>
<li>However , full-length MalT-T38R does not bind MalK ( Fig. 3C ) ; the effect of the T38R substitution on the interaction between MalK and full-length MalT must therefore be indirect and probably involves a conformational effect .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>Puriﬁed MalT protein was chromatographed on a Ni-NTA column preloaded with His-tagged MalK , and after extensive washing , MalK was eluted with imidazole .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li>
<li>Purified MalT was run over a MalK-loaded column , and , after extensive washing , MalK was eluted with 500 mM imidazole .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>When MalT is provided in trans by pOM180 , malEpD92 activity is low in the absence of external malto-dextrins as a result of MalT repression by MalK † .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li>
<li>To ﬁnd out whether immobilized MalT -- BCCP binds MalK in vitro , crude extracts were prepared from the MalT -- BCCP-producing strain that does not produce MalK .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9822819" target="_blank">9822819</a>]<br></li>
<li>To gain insight into the mechanism whereby MalK modulates MalT activity , we developed an in vitro system that reproduces MalT inhibition by MalK .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>Effect of MalK on MalT activity in an in vitro system .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>Since no relief of repression was observed even with the longest fragment , the site of MalK interaction in MalT must differ from the MalY-MalT interaction site .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=12003949" target="_blank">12003949</a>]<br></li>
<li>This is consistent with the conclusion that MalK and MalY interaction sites with MalT are not identical .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=12003949" target="_blank">12003949</a>]<br></li>
<li>This shows not only that MalK acts as a repressor but also that MalT is activated by internal sources .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9529892" target="_blank">9529892</a>]<br></li>
<li>Effect of malT and malK mutations on MalT repression by MalK .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>Because ATP is a ligand for both MalK and MalT , it would be surprising if purine nucleotides did not inﬂuence the MalK -- MalT interaction .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9822819" target="_blank">9822819</a>]<br></li>
<li>There are several indications that it is the state of transport activity which controls the interaction of MalK with MalT and thus the activity of the latter ( 2 , 6 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=16321936" target="_blank">16321936</a>]<br></li>
<li>Interference of the N-termi-nal fragments of MalT with the MalK-MalT interaction should easily be detected by an increase in MalK-LacZ activity .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=12003949" target="_blank">12003949</a>]<br></li>
<li>Thus , interaction with MalK might occur at a position in MalT that is engaged in the activation ( multimerization ) mechanism .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=12003949" target="_blank">12003949</a>]<br></li>
<li>Mutant forms of MalK and MalT defective in signalling are able to interact .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9822819" target="_blank">9822819</a>]<br></li>
<li>At the present time there is no information about the sites on MalK and MalT that contribute to their physical interaction .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9822819" target="_blank">9822819</a>]<br></li>
<li>Furthermore , it is not known how the properties of the MalK -- MalT interaction depend on ligands such as purine nucleotides or oligosaccharides .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9822819" target="_blank">9822819</a>]<br></li>
<li>These beads were able to-bind MalK , demonstrating an interaction between MalK and MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9529892" target="_blank">9529892</a>]<br></li>
<li>Physical interaction of MalK and MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9822819" target="_blank">9822819</a>]<br></li>
<li>D. Binary interaction of MalK and MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9822819" target="_blank">9822819</a>]<br></li>
<li>A second possibility is that MalK , as long as it is not engaged in transport , interacts with MalT and inactivates it .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9529892" target="_blank">9529892</a>]<br></li>
<li>Approximately equivalent amounts of His-6 -- MalK and MalT -- BCCP are seen in the ﬁrst lane .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9822819" target="_blank">9822819</a>]<br></li>
<li>Under these conditions , MalK is tightly associated with the MalFG complex and has no afﬁnity for MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9529892" target="_blank">9529892</a>]<br></li>
<li>It is formally possible , however , that a third mole-cule , undetactable by Coomassie blue stain , bridges the MalK and MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9822819" target="_blank">9822819</a>]<br></li>
<li>What is the function of the H10/H11 surface motif in MalT inhibition by MalK ?	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li>
<li>It should be stressed that there is no compelling evidence that MalK actually dissociates from MalFG during MalT inhibition .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9529892" target="_blank">9529892</a>]<br></li>
<li>In this latter region , 4 amino acids of MalK were identical to those of MalT , and the homology , taking conservative exchanges into account , was 54 % .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2670898" target="_blank">2670898</a>]<br></li>
<li>Identical amino acids in the region 161 to 190 of MalK and the region 751 to 780 of MalT are indicated by boldface letters in the MalT sequence .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2670898" target="_blank">2670898</a>]<br></li>
<li>In the absence of substrate to be transported , MalK would be free to interact with MalT and cause repression .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9529892" target="_blank">9529892</a>]<br></li>
<li>In contrast to a malK strain , the MalK-LacZ activity of BRE1219 ( malK ) is low due to the inhibition of MalT by chromosomal levels of MalK .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=12003949" target="_blank">12003949</a>]<br></li>
<li>In contrast , our attempts to observe interference of the Nterminal fragments of MalT with MalK-mediated repression failed .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=12003949" target="_blank">12003949</a>]<br></li>
<li>In this scenario , MalK engaged in transport would relieve MalT from inhibition .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=16321936" target="_blank">16321936</a>]<br></li>
<li>In contrast , all of the substitutions alleviate MalT inhibition by MalK partially or entirely .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li>
<li>In contrast , the mechanism of MalT inhibition by MalK remains unclear .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>Comparison of the responses to increasing concentrations of MalY indicates that the T38R substitution actually slightly increases MalT susceptibility to inhibition by MalY , as observed in vivo ( 33 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>This therefore demonstrates that the inhibitory effect observed in vitro reflects the phenomenon of MalT repression by Aes observed in vivo .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>The reduced sensitivity to MalY action displayed by the MalT 26 C variant provides evidence that the repressive effect analysed in vitro faithfully mimics the repression phenom-enon observed in vivo .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>On the other hand , the inhibiting effect of MalY can still be observed in mlc mutants that have elevated levels of MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9529892" target="_blank">9529892</a>]<br></li>
<li>To ensure that the inhibitory effect observed in vitro was functionally relevant , we verified that a MalT variant was not inhibited by MalY in C our in vitro system .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>To test this hypothesis , we purified the T38R MalT variant and analyzed its sensitivity to both inhibitory proteins in vitro .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
				<label class="ACT_collapse_similarity" for="act_similarity_855">
Effect of MalY on wild-type MalT in a purified in vitro system .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></label>
<input id="act_similarity_855", type="checkbox">
<div class="ACT_similar">
<li>Effect of MalY on MalT 26 in a purified in vitro system .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li></div>
<li>Aes-mediated repression of malK-lacZ is counteracted by increasing MalT b-Galactose activity ( U/mg of protein ) b Relevant genotypea Plasmid ( s ) Uninduced IPTG induced TABLE 5 .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9401025" target="_blank">9401025</a>]<br></li>
<li>To obtain a better understanding of how the activity of MalT is negatively modulated , we have analyzed in vitro the mechanism whereby the Aes protein inhibits MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>None of the hybrid proteins displayed MalT activity as expected from the finding that deletions affecting the C-terminus of MalT lead to inactivation .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=3015733" target="_blank">3015733</a>]<br></li>
<li>This conclusion is consistent with the observation that MalY does not stimulate the intrinsic ATPase activity of MalT ( data not shown ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>As shown in Table 1 , MalT overproduction strongly enhances-the-activity of malEpD92 .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9000616" target="_blank">9000616</a>]<br></li>
<li>DISCUSSION The in vitro analysis reported here establishes that negative control of MalT activity by Aes is direct .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>Indeed , in vivo , the substitutions scarcely affect MalT activity in a no-repression context as well as MalT response to MalY or , in the four cases tested , to Aes .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li>
<li>Thus , the activity of the malK-lacZ fusion is low in ME429 due to MalY-MalT interaction .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=12003949" target="_blank">12003949</a>]<br></li>
<li>The mechanism by which MalT activity is negatively controlled is best understood in the case of MalY .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>Interestingly , Aes seems to down-regulate MalT activity via the same mechanism as MalY .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>Using a biochemical approach , we analyse here the mechan-ism whereby MalY represses MalT activity .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>We then asked whether the up mutations also relieve MalT inhibition by MalY and by Aes , two other negative effectors of MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li>
<li>In addition , similar in vitro repression assays performed with Aes and MalY conﬁrmed that the MalT-N637T substitution does not alter MalT response to the other two negative effectors ( Figure 3 ( b ) and ( c ) ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li>
<li>In contrast , little is known regarding the raison d' être of the negative controls exerted by MalY and Aes on MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>The interaction of MalT with two other enzymes , MalY and Aes , can lead to its inactivation ( Boos & Bohm , 2000 ; Schlegel et al. , 2002 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=16451192" target="_blank">16451192</a>]<br></li>
<li>The T38R Substitution in MalT Specifically Prevents Aes Binding -- The above-mentioned results point toward identical mechanisms for MalT inhibition by MalY and Aes .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>Since MalY also recognizes determinants in DT1 and -2 , the interaction sites in MalT for MalY and Aes may overlap but can not be identical .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=12003949" target="_blank">12003949</a>]<br></li>
<li>Effect of MalT substitution T38R on MalT sensitivity to Aes and MalY .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>Gel filtration : effect of MalT substitution T38R on MalT interaction with Aes and MalY .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>In order to ﬁnd out more about the interaction of MalT with its three repressors MalK , MalY , and Aes , we analyzed whether mutations in MalT leading to elevated mal gene expression have different sensitivities towards the three repressors .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=12003949" target="_blank">12003949</a>]<br></li>
<li>Biochemical analyses of the mechanisms whereby MalK and Aes prevent MalT from activating the mal promoters should clarify the question of whether both repressors act like MalY .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>An interesting finding of this work is that MalK inhibits MalT via the same mechanism as MalY and Aes ( 19 , 20 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>It is our working hypothesis that both MalY and Aes act in the same way as MalK by interacting with MalT to shift the equilibrium to its inactive state .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9529892" target="_blank">9529892</a>]<br></li>
<li>MalK Interacts with DT1 -- The similarity between the action modes of the three negative effectors of MalT suggests that , like MalY and Aes , MalK might interact with DT1 .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>Since MalT is known to interact not only with MalK but also with MalY and Aes , we tested in vivo the sensitivity of these mutant MalT proteins towards the three repressor proteins .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=12003949" target="_blank">12003949</a>]<br></li>
<li>Finally , MalT activity is negatively regulated by three different proteins , MalK ( the ATP-binding component of the maltose transporter ) , MalY , and Aes via an unknown mechanism ( 1 , 6 -- 8 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10559195" target="_blank">10559195</a>]<br></li>
<li>MalK , the ATP-hydrolyzing subunit of the cognate ABC transporter , MalY , an enzyme with the activity of a cystathionase , and Aes , an acetyl esterase , phenotypically act as repressors of MalT activity .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=12003949" target="_blank">12003949</a>]<br></li>
<li>In addition , as revealed by the MalT activity assays , a high concentration of maltotriose fully relieves MalT inhibition by MalK ( Fig. 1A ) , MalY , or Aes , thereby suggesting a phenomenon of competitive inhibition .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>Furthermore , the N637T substitution , which alters a surface-exposed residue , does not affect MalT activity in vitro , or its sensitivity to the inhibition by MalY or Aes , but fully prevents MalT inhibition by MalK .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li>
<li>Effect of the MalTN637T substitution on the inhibition of MalT activity by MalK , Aes and MalY , in vitro .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li>
<li>In addition , MalK , the ABC component of the maltodextrin transport system , and the two enzymes MalY and Aes down-regulate MalT activity in vivo .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>In addition to MalK , two other proteins , namely MalY , a C-S lyase , and Aes , an acyl esterase , down-regulate MalT activity ( 17 , 18 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>Hence , although we can not exclude the possibility that the DT1-DT2 linker might be part of the MalK , MalY , and Aes binding sites , we favor the idea that the malTc26 mutation makes MalT insensitive to the repressor proteins simply by stabilizing the active form of MalT , i.e. via a long range effect .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>Hence , the model according to which MalY would stabilize the inactive form of MalT applies equally to Aes , but it is presently unclear whether the molecular details of the inhibitory reactions are the same .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>Given that the three inhibitory proteins are unrelated at the sequence level and that MalK and MalY do not share any obvious structural similarity ( 29 , 32 ) , the molecular details of the interaction between the inactive form of MalT and each of the negative effectors is likely to be different .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>SDS ± PAGE analysis and Coomassie blue staining of the gel revealed that a significant amount of MalT bound to the MalY ± agarose column and was recovered in the 2 M KCl eluate ( Fig. 3A ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>The fact that the competition between the inhibitory protein and the inducer is similarly influenced by the nucleotide bound to MalT strongly suggests that MalY and Aes interact with the same conformational MalT species .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>Previous work had revealed that competition between the inducer and MalY is affected by the nucleotide bound to MalT ( 16 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>Thus , we investigated whether the nucleotide bound to MalT also affects the competition between Aes and the inducer .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>Thus , the nucle-otide bound to MalT similarly affects competition between the inducer and MalY or Aes .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>MalT and Aes Form a Complex -- To test the hypothesis that MalT inhibition by Aes involves a direct protein-protein interaction , we tried to isolate a MalT-Aes complex by gel filtration .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>MalT interacts directly with MalY To test the hypothesis that repression by MalY involves formation of a MalT ± MalY complex , we examined whether immobilized MalY protein would bind the activator .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>Complex formation was hitherto observed with samples containing 2.1 mM MalY dimer and 4.6 mM MalT , i.e. 0.9 MalY polypeptide/one MalT polypeptide , and no additional peak was observed except for some trailing of the MalT protein , which suggested that MalY and MalT might be present in the complex in a 1:1 ( protomer : protomer ) ratio .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>Finally , analyses of samples containing various concentrations of MalY and MalT , the two proteins present in a 1:1 ( protomer : protomer ) ratio , revealed that the apparent molecular weight of the complex varied with the concentrations of MalY and MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>In vivo studies have revealed that MalT action is negatively controlled by the MalY protein .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>To seek insight into how MalT action is negatively regulated , we used a biochemical approach and chose , as a model , the MalY protein whose structure is known .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>Altogether , these data strongly suggest that MalT binding to the MalY column is the result of a specific interaction between MalT and MalY .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>Controls showed that BSA did not bind to the MalY ± agarose column , nor did MalT bind to the column matrix ( data not shown ; Fig. 3B ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>Finally , we showed that MalY also binds the unliganded form of MalT ( data not shown ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>Our data also demonstrate that MalY action upon MalT does not require any additional factor .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>This DT1H-MalY interaction is speciﬁc since no complex could be observed when DT1H was replaced by DT3 , another domain of MalT , at the same molar concentration ( data not shown ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=12003949" target="_blank">12003949</a>]<br></li>
<li>Furthermore , the spatial location of the putative MalTbinding patches in the MalY dimer are consistent with a heterotetrameric complex ( MalT ± MalY ± MalY ± MalT ) ( T. Clausen et al. , unpublished ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>This argues against the possibility that the MalY ± MalT complex contains one protomer of each protein .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>In order to characterize the MalT ± MalY complex , we isolated it by filtration through a molecular sieve .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>Isolation of the MalT ± MalY complex Fig. 4 .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>What is the stoichiometry of the MalY ± MalT complex ?	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>It should be noted that , because protection shows a steep dependence upon MalT concentration ( Raibaud et al. , 1989 ) , a 4-fold effect of maltotriose or ATP on the affinity of MalT for the promoter DNA could account for the absence of protection observed when one effector was omitted .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>Whereas MalT is mostly monomeric in the absence of maltotriose ( Schreiber and Richet , 1999 ) , MalY is a dimer whose subunits are held together by numerous salt bridges and hydrogen bonds , as well as extensive hydrophobic interactions ( T. Clausen et al. , unpublished ) , and it is therefore extremely unlikely that the protein monomerizes upon binding MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>Point mutations in malT ( malTc ) have been isolated that confer a constitutive expression of the maltose regulon when maltodextrin is not present in the growth medium ( 12 , 13 ) The in vitro analysis of two corresponding MalTc proteins revealed that , in contrast to the wild-type MalT , they could activate transcription from a MalT-depen-dent promoter in the absence of maltotriose but could still be * Corresponding author .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=12003949" target="_blank">12003949</a>]<br></li>
<li>Even though in vivo , the maltose system is induced by all maltodextrins in the medium serving as a carbon source , in vitro , MalT is activated only to stimulate malP transcription by maltotriose ( 49 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=16321936" target="_blank">16321936</a>]<br></li>
<li>Although all of the maltodextrins , including maltose , induce the expression of the regulon in vivo , in vitro studies have revealed that the only maltodextrin able to activate purified MalT protein is maltotriose ( 25 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2180908" target="_blank">2180908</a>]<br></li>
<li>It binds maltotriose , the only maltodextrin able to act as a positive effector of MalT for activation of transcription in vitro ( Raibaud and Richet , 1987 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>Complex mechanisms regulate the expression of this operon ; expression is activated by MalT , which binds to the malEFG promoter in its maltotriose-bound form and by the cAMP receptor protein , which binds in its cAMP bound form .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11350954" target="_blank">11350954</a>]<br></li>
<li>In glucose minimal medium , there is neither activation of the promoter by MalT because of a lack of maltotriose nor activation by cAMP receptor protein because of a lack of cAMP ( 33 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11350954" target="_blank">11350954</a>]<br></li>
<li>In nutrient broth maltotriose is present , so MalT activates malE expression even though the cAMP receptor protein is not active ( 33 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11350954" target="_blank">11350954</a>]<br></li>
<li>This mutant produced a MalT protein that did not need exogenous maltose for activation .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2423504" target="_blank">2423504</a>]<br></li>
<li>Effect of maltose , maltotriose , and maltotetraose on activation of transcription from malPp by the MalT protein .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=3298211" target="_blank">3298211</a>]<br></li>
<li>MalT protein requires intracellular maltotriose for activation of transcription ( Rarbaud arid Richet , 1987 ) and growth-on-maltose or other maltosaccharides is the classical means of eliciting mal gene induction .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=7651130" target="_blank">7651130</a>]<br></li>
<li>Thus , when cells are grown on maltose , this sugar has to be converted to maltotriose or another as yet unknown internal inducer for the activation of MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2670898" target="_blank">2670898</a>]<br></li>
<li>This constitutivity is attributed to an altered MalT protein , which either no longer requires internal inducer for activation or has an increased affinity for the internal inducer , be it maltotriose or an as yet unidentified polysaccharide .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2670898" target="_blank">2670898</a>]<br></li>
<li>Alternatively , they may have a MalT protein with increased affinity for internal maltotriose or with decreased specificity , so that it can recognize the longer maltodextrins expected to derive from the degradation of endogenous glycogen .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=3298211" target="_blank">3298211</a>]<br></li>
<li>In vitro , a constitutive MalT variant ( which is partially active in the absence of maltotriose ) is less sensitive than wild-type MalT to repression by MalY , as observed in vivo .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>Compared with what is observed with wild-type MalT , the MalT 26 mutation simply decreases the C maltotriose concentration required to relieve repression by MalY , which , together with the fact that MalT 26 has a C higher affinity for the inducer , further supports the hypothesized competition between maltotriose and MalY .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>This article must therefore be hereby capable of acting as exogenous inducers , only maltotriose is marked `` aduertisement '' in accordance with 18 U.S.C. Section 1734 able to activate MalT i n uitro ( 28 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=1544897" target="_blank">1544897</a>]<br></li>
<li>Since they are not degraded inside the cells and since MalT in vitro is activated only by maltotriose ( 48 ) , the induction seen under these conditions must be due to the transport of these sugars per se .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=16321936" target="_blank">16321936</a>]<br></li>
<li>The explanation for this phenomenon is that maltotetraose and maltotriose which are released from phosphorylase-limited glycogen by GlgX , the debranching enzyme , are no longer repolymerized by the missing MalQ activity and result in the activation of MalT by the endogenously accumulating inducer maltotriose .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=21421758" target="_blank">21421758</a>]<br></li>
<li>The mutations of the mutants isolated and characterized in this work eliminate the dependence of MalT upon one of its ligands , maltotriose .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2180908" target="_blank">2180908</a>]<br></li>
<li>The only maltodextrin known to activate MalT is maltotriose ( 44 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2670898" target="_blank">2670898</a>]<br></li>
<li>The only inducer established so far to be able to activate MalT in vitro is maltotriose ( 202 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9529892" target="_blank">9529892</a>]<br></li>
<li>The effect of MalY on MalT activity was investigated in the presence of various concentrations of maltotriose , as the inducer might interfere with repression by MalY .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>The effect of nucleotides on the dependence of MalT activity on maltotriose concentration .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>MalT activity is controlled by two regulatory circuits : a positive one with maltotriose as effector and a negative one involving several proteins .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=12003949" target="_blank">12003949</a>]<br></li>
<li>To investigate the possibility that the ATPase activity observed in the absence of maltotriose was due to a contaminating enzyme , we further purified MalT by anion-exchange chromatography .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>MalT has an ATPase activity stimulated by maltotriose .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>This ATPase activity was stimulated 2 - to 3-fold by maltotriose , strongly suggesting that this activity was indeed intrinsic to MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>In contrast , similar curved homopolymers were observed when MalT was incubated with maltotriose and ADP ( Figure 1B ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15491603" target="_blank">15491603</a>]<br></li>
<li>In vitro transcription experiments with purified MalT have shown that , of all dextrins tested , only maltotriose is effective in stimulating the action of MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=1856179" target="_blank">1856179</a>]<br></li>
<li>To distinguish between these possibilities , we tested whether the apparent affinity of MalT for maltotriose varied according to the nucleotide ligand .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>A , f , 0.1 mM maltotriose and 100 nM wild-type MalT ; , 1 mM maltotriose and 80 nM wild-type MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>B , 2 mM MalT incubated with maltotriose and ADP .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15491603" target="_blank">15491603</a>]<br></li>
<li>Closed squares , no maltotriose and 240 nM MalT ; open diamonds , 0.1 mM maltotriose and 120 nM MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>, 10 M maltotriose and 100 nM MalT ; f , 100 M maltotriose and 80 nM MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>, 10 mM maltotriose and 450 nM MalT ; f , 100 mM maltotriose and 400 nM MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>These conclusions are supported by the following observations : ( i ) Aes inhibits MalT in a purified transcription system , ( ii ) Aes and MalT form a complex stable enough to be isolated by gel filtration , ( iii ) Aes inhibits malto-triose binding by MalT , and ( iv ) reciprocally , maltotriose inhib-its Aes binding to MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>These conclusions are based on the following observations : ( i ) MalY inhibits transcription activation by MalT in a purified transcription system ; ( ii ) MalY forms a complex with MalT that is stable enough to be isolated by gel filtration ; and ( iii ) maltotriose and MalY compete for MalT binding .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>Both nucleotides allow MalT inhibition by MalY and Aes in vitro , but they clearly differentially affect the equilibrium between inactive complexes ( MalT-Aes or MalT-MalY ) and active MalT-maltotriose complexes , with ADP favoring the interaction with the inhibitory protein ( Fig. 8 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>MalT inhibition by MalY and Aes is observed for similar concentrations of inhibitory proteins and is counteracted by the same concentrations of maltotriose ( 16 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>Furthermore , the inhibition by MalY observed when maltotriose was omitted from the reaction mixture ( Fig. 2 ) demonstrates that a MalT variant , such C as MalT 26 , has not completely lost the ability to respond C to MalY .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>These gel filtration data suggested that the nucleotide bound to MalT influences the relative affinities of MalT for MalY and maltotriose .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>The competition between MalY and maltotriose is influenced by the nucleotide bound to MalT We next investigated whether the ability of MalY to form a complex with MalT depends on the nucleotide bound to MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>The ADP ± MalT form was also inhibited by MalY but , interestingly , the action of the repressor was not antagonized by up to 100 mM maltotriose ( Fig. 7B ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>All these data therefore indicate that MalTc26 is still intrinsically sensitive to Aes and that one effect of malTc26 is to decrease the concentration of maltotriose required to relieve MalT repression by Aes .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>These data clearly demonstrate that maltotriose inhibits interaction between MalT and Aes .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>In addition , this work demonstrates that Aes is a negative effector of MalT that competes with maltotriose , as previously hypothesized on the basis of in vivo data ( 3 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>One intriguing feature of MalT is the complex interplay between ATP or ADP binding and the binding of the inducer and the negative effectors , MalY and Aes .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>Together , these results establish that MalY acts directly upon MalT without the help of any factor , and that MalY is a negative effector of MalT competing with the inducer for MalT binding .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>Like MalY , Aes is a negative effector of MalT that interferes with malto-triose binding ( N. Joly and E. Richet , personal communication ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=12003949" target="_blank">12003949</a>]<br></li>
<li>Furthermore , we show that MalY interacts physically with MalT and inhibits the activator by preventing the binding of maltotriose , one of its positive effectors .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>MalY is a negative effector of MalT that competes with maltotriose binding , thereby inhibiting its transcriptional activity .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=12003949" target="_blank">12003949</a>]<br></li>
<li>Aes Inhibits Maltotriose Binding by MalT -- Having observed that maltotriose antagonizes Aes binding by MalT , we tested whether , inversely , Aes inhibits maltotriose binding .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>Effect of Aes on maltotriose binding by MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>Moreover , the observation that a high concentration of maltotriose relieves repression by MalY supports the model in which MalY and maltotriose compete for MalT binding .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>Together with the observation that maltotriose impedes MalY binding by MalT , these data provide compelling evidence that MalY and maltotriose compete for MalT binding .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>MalY and maltotriose compete for binding to MalT ( 16 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>Effect of MalY on maltotriose binding by MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>Together with the ability of maltotriose to prevent Aes binding by MalT , these data conclusively demonstrate that , like MalY , Aes competes with the inducer for MalT binding .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>Recent studies have revealed that both MalY and Aes interact directly with MalT and compete with maltotriose for MalT binding ( 19 , 20 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>We demonstrate that MalY forms a complex with MalT only in the absence of maltotriose and that , conversely , MalY inhibits maltotriose binding by MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>MalY inhibits maltotriose binding by MalT Having demonstrated that the inducer prevents MalT from interacting with MalY , we asked whether , reciprocally , MalY inhibited maltotriose binding .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>As MalT variants display a c higher affinity for maltotriose ( Dardonville and Raibaud , 1990 ) , it has been proposed that MalK , MalY and Aes inhibit MalT by competing with maltotriose for the binding of the activator ( Boos and Shuman , 1998 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>The inactive form is stabilized by MalK , MalY or Aes , whereas the active form is stabilized by maltotriose , which thus competes with the negative effectors for binding to MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li>
<li>MalK , another negative effector of MalT ( 10 ) , is also thought to prevent maltotriose binding like MalY and Aes ( 3 ) , but thus far , we do not know where its binding site is located on MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>All of these features indicate that MalK inhibits MalT by the same mechanism as two other proteins , MalY and Aes , that also act as negative effectors of MalT by antagonizing maltotriose binding by MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>Maltotriose , the inducer , promotes MalT self-association , a critical step in promoter binding , whereas three proteins acting as negative allosteric-effectors ( MalK , the ABC-component of the maltodextrin transporter , MalY , and Aes ) antagon-ize maltotriose binding .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li>
<li>One 6 distinctive feature of MalT is the multiplicity of regulatory signals that modulate MalT selfassociation : MalT multimerization is stimulated by maltotriose , the inducer , and inhibited by three 7 proteins , Aes , MalK and MalY , which act as negative allosteric-effectors .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li>
<li>The stronger effect of mutations in sites 1 , 2 , and 3 under noninducing conditions may be due either to the lower concentration of active MalT molecules or to an increase in the intracellular concentration of cAMP resulting from the absence of maltose in the growth medium .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=1824723" target="_blank">1824723</a>]<br></li>
<li>The time-course and dilution-rate dependence of induction of / amS and ma/fransporfer genes during glucose limitation was not simply ascribable to a cAMP effect , nor was if RpoS-dependent , MalT was absolutely requir-ed for higher / amS expression in chemostats buf MalT concentration perse was not the regulating lacfor .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=7651130" target="_blank">7651130</a>]<br></li>
<li>The observed severe decrease in malEFG and malKlamB malM transcription as well as LamB levels in hns and hns-stpA mutant strains was most likely caused by the combined and additive effects of the lower levels of both MalT and CRP which characterized these strains ( this work and unpublished data ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9829919" target="_blank">9829919</a>]<br></li>
<li>The indicator strain has a very low level of malE-lacZ expression in the absence of MalT ( 0.005 U/mg of protein ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=12003949" target="_blank">12003949</a>]<br></li>
<li>The mean specific activity of several purified MalT preparations was 4,000 U/mg of protein .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2180908" target="_blank">2180908</a>]<br></li>
<li>The MalT protein synthesized under these conditions was totally insoluble , and sedimented with the cell debris .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=6283313" target="_blank">6283313</a>]<br></li>
<li>The GST -- MalT protein bound to glutathione-agarose and could be eluted by glutathione .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9822819" target="_blank">9822819</a>]<br></li>
<li>When RcsA is limiting [ Ion * cells ) and RcsB is not activated by phosphorylation , the cps region is not transcribed The predicted protein sequences of both RcsA and RcsB contain a carboxy-terminal domain similar to that found in a class of DNA-binding proteins exemplified by UhpA , MalT , and FixJ ( Fig. 1 ; Stout etal .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=1943696" target="_blank">1943696</a>]<br></li>
<li>The fusion proteins may bind to the MalT recognition site and thereby prevent the wt protein from binding .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=3015733" target="_blank">3015733</a>]<br></li>
<li>The induced expression of malK , classes , one made under low osmolarity and the other controlled by MalT ' , was identical to uninduced ex - under high osmolarity .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9884223" target="_blank">9884223</a>]<br></li>
<li>832 The metabolism of maltodextrins once inside the cell is achieved by three enzymes whose encoding genes are controlled by MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=16321936" target="_blank">16321936</a>]<br></li>
<li>The activity of MalT is also negatively controlled by three * This work was supported in part by grants from the Deutsche Forschungsgemeinschaft and the Fonds der Chemischen Industrie .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>The carboxyl-terminal region is also conserved in transcriptional-activators that are not subject to phosphorylation control , such as LuxR and MalT ( 12 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=1569008" target="_blank">1569008</a>]<br></li>
<li>The absence of the H-NS and StpA proteins resulted in a reduction in the levels of MalT to about 20 % the normal level .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9829919" target="_blank">9829919</a>]<br></li>
<li>The latter proteins are MalT , SdiA , and FimZ of E. coli , GerE of B. subtiIis , LuxR of Vibrio fischeri , ' and AlkS of Pseudomonas oleovorans ( Fig. 7 , Table 1 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=7699720" target="_blank">7699720</a>]<br></li>
<li>The expression of genes under the control of MalT was , however , signiﬁcantly increased ( approximately 5 - to 20-fold ) ( Table 2 and Fig. 1 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15716448" target="_blank">15716448</a>]<br></li>
<li>The observation that MalT inhibition by Aes was relieved in the presence of a high concentration of inducer suggests that the inhibitory effect observed in vitro is functionally relevant .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>The unlimited aggregation that is observed at high concentrations of MalT and that is strongly favored at 20 ° C is unlikely to be functionally relevant .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10559195" target="_blank">10559195</a>]<br></li>
<li>The unlimited aggregation of MalT observed here probably also accounts for the inhibition of transcription observed in vivo and in vitro at high concentrations of MalT ( 25 , 26 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10559195" target="_blank">10559195</a>]<br></li>
<li>The uninduced level of expression of the maltose regulon observed in a wild-type strain in the absence of maltose in the growth me-dium corresponds to the residual MalT activity that escapes repression by MalK .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>The increase in MalKLacZ activity caused by the 325 - and the 250-aa MalT fragments was not observed in a strain that does not express MalY and contains wild-type MalK ( Table 3 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=12003949" target="_blank">12003949</a>]<br></li>
<li>The same data were obtained for 10 - and 30-min incubation times , which excludes the possibility that the differences between the responses of wild-type MalT and the mutated proteins were due to kinetic effects .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>The partially purified fraction of wild-type MalT used for affinity chromatography on the MalY column was obtained as follows .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>The results are expressed relative to the level obtained with wild-type MalT in the absence of Aes ( 2515 units ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li>
<li>The level of b-galactosidase observed with wild-type MalT when repressed by Aes corresponded to 4 % of the unrepressed level ( Figure 2 ( b ) ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li>
<li>The b-galactosidase levels ranged from 0.7 to 1.4 times that obtained with wild-type MalT , which contrasts with the 5 -- 14 times stimulatory effect observed in the presence of MalK .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li>
<li>The presence of MalT-BCCP is negatively dominant over wild-type MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9529892" target="_blank">9529892</a>]<br></li>
<li>The dotted line represents the sum of the profiles obtained when MalT and MalY were filtered separately .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>, <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>The level of activity observed with wildC type MalT in the presence of MalY was 17 % of the unrepressed level under these conditions Figure 1 .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li>
<li>The T38R substitution does not alter the specific activity of MalT ( in the presence of a saturating concentration of nucleoside triphosphate ) , nor does it suppress its ability to interact with MalY .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>The effect of the DT3 up mutations on MalT repression by MalY was assessed by measuring the levels of b-galactosidase made by an isogenic DmalT DmalK malITTn10 strain ( pop7192 ) carrying pOM181 or derivatives thereof .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li>
<li>The model proposed is consistent with the observations that mutation malTc26 renders MalT insensitive to repression by FIG. 5 .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>The clustering of these mutations favors a mechanism of proteinprotein interaction with MalT as causing repression .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9529892" target="_blank">9529892</a>]<br></li>
<li>malT ( Con ) mutants , which also express the system constitutively ( 3 ) , were class-ically considered to produce a MalT protein able to activate transcription in the absence of inducer .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=3298211" target="_blank">3298211</a>]<br></li>
<li>For instance , all of them show very little effect in malT ( Con ) strains where the induction of the mal system becomes independent of inducer or under conditions where the level of MalT is increased .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9401025" target="_blank">9401025</a>]<br></li>
<li>For a fixed concentration of RNA polymerase , this rate depends on the concentration of MalT , thereby providing an assay for MalT activity .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>For this purpose , we determined the concentration of MalT in the peak fraction by quantification on a SDS-polyacrylamide gel and tested MalT activity by using the malPp abortive initiation assay ( 18 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10559195" target="_blank">10559195</a>]<br></li>
<li>Since some of the mutations reduced the affinity of MalT for the non-mutated sites ( see above ) , it was interesting to measure the activity of the maIPp variants under conditions in which MalT was 15 times more abundant ( pre-sence of malTp7 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=7830577" target="_blank">7830577</a>]<br></li>
<li>Because the activity of malEpD92 is limited by the concentration of active MalT forms under these conditions , one can identify gain of function mutations in malT by looking for red colonies on MacConkey lactose plates .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li>
<li>To characterize further MalT self-associated species formed in solution , we used cryo-electron microscopy of frozen-hydrated samples and image processing .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15491603" target="_blank">15491603</a>]<br></li>
<li>It will be interesting , therefore , to ﬁnd out whether these proteins self-associate in the same way as MalT and how such multimerization serves the function of the PknK kinase .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15491603" target="_blank">15491603</a>]<br></li>
<li>malEp 92 is a truncated variant of the malEp promoter whose full activation requires a higher concentration of MalT than does malEp ( 33 ) and which is expected to respond to any increase in the concentration of active MalT in an unrepressed context ( i.e. , free of MalK ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=12003949" target="_blank">12003949</a>]<br></li>
<li>With regard to the speciﬁc role played by CRP bound to site 1 , it is unlikely that the protein acts by preventing an aggregation phenomenon since its stimulatory effect does not increase with the concentration of MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9000616" target="_blank">9000616</a>]<br></li>
<li>It could be that producing 15 times more MalT polypeptides does not necessarily result in a 15-fold increase in the concentration of active MalT molecules in the cell , and that , even under these conditions , MalT site 1 could still be incompletely occupied .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=7830577" target="_blank">7830577</a>]<br></li>
<li>Note also that , for a given concentration of MalT , the fraction of the protein that is in the active form , as judged by the promoter response , depends on the concentrations of the positive effectors and on the MalT variant assayed .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>This is true under all of the conditions that we have tested : low concentration of active MalT protein ( growth in the absence of maltose ) , moderate MalT concentration ( growth in the presence of maltose ) and high MaiT concentration ( growth in the presence of maltose of a strain overproducing MalT ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=7830577" target="_blank">7830577</a>]<br></li>
<li>Statistically this would result in significant variations of the concentration of MalT protein in individual cells .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=6325162" target="_blank">6325162</a>]<br></li>
<li>( Note that such an increase does not necessarily result in an equivalent increase in the concentration of active MalT ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9000616" target="_blank">9000616</a>]<br></li>
<li>A further increase in the intracellular concentration of active MalT protein appeared to be slightly inhibitory ( Table 1 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9000616" target="_blank">9000616</a>]<br></li>
<li>A high inducer concentration ( or the malT ( Con ) mutation ) is more effective than an increase in the concentration of MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9529892" target="_blank">9529892</a>]<br></li>
<li>Raising the concentration of MalT caused the appearance of a discrete 220-kDa peak with increasing magnitude .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10559195" target="_blank">10559195</a>]<br></li>
<li>For a purified MalT preparation , a concentration of 1 mg/ml corresponded to 8 , uM MalT monomers ( 30 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2180908" target="_blank">2180908</a>]<br></li>
<li>Clearly , the repression of malE expression by CreBC is dominant to activation by MalT , because constitutive activation of CreBC ( i.e. the creC3 allele ) leads to a reduction of malE expression during growth in nutrient broth .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11350954" target="_blank">11350954</a>]<br></li>
<li>This does not rule out the possibility that Mlc may also control individual mal genes directly , which is difﬁcult to test as malE or malK can not be expressed in the absence of MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9484893" target="_blank">9484893</a>]<br></li>
<li>However , malZ is also induced at high osmolarity independent of MalT 251 ( 15 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=21421758" target="_blank">21421758</a>]<br></li>
<li>Recently , we found that malZ expression can also occur in the absence of MalT , in particular under conditions of high medium osmolarity .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9529892" target="_blank">9529892</a>]<br></li>
<li>MalT formed intracelullar aggregates under most growth conditions ( M63B1 , rich medium at 37 C ) but remained soluble when the cells were grown in rich medium at 25 ` C .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=7830577" target="_blank">7830577</a>]<br></li>
<li>This discrepancy between data obtained with conditions known to shift MalTJMalT , equilibrium towards MalT , indicates that the increase in MalT , conversion would not be the only effect of some of these mutations or induced conditions .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9884223" target="_blank">9884223</a>]<br></li>
<li>Induced conditions and malT ' , malQ or malK mutations have all been shown to shift the MalT , / MalT , equilibrium towards MalT , .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9884223" target="_blank">9884223</a>]<br></li>
<li>However , molecular mechanisms to shift MalT , / MalT , equilibrium towards MalT , .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9884223" target="_blank">9884223</a>]<br></li>
<li>Filtration of a sample containing both MalT and Aes gave two peaks at the positions at which MalT and Aes , respectively , elute when chromatographed alone .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>Also , overproduction of MalT counteracted the Aes-dependent repression , indicating a direct interaction between MalT and Aes .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9401025" target="_blank">9401025</a>]<br></li>
<li>This demonstrates that the degree of repression is dependent on the concentration of Aes and that it can be counteracted by increasing the level of MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9401025" target="_blank">9401025</a>]<br></li>
<li>Therefore , Aes and MalT do form a complex .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>This ensures that MalT inhibition by Aes , if any , would be detected .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>Repression by Aes is counteracted by elevated levels of MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9401025" target="_blank">9401025</a>]<br></li>
<li>However , an increase in the level of MalT counteracts the effect of Aes .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9401025" target="_blank">9401025</a>]<br></li>
<li>Of the three positive regulators , Crp , MalT , and Lrp , the effect of Lrp is by far the weakest and may not be direct .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=7751276" target="_blank">7751276</a>]<br></li>
<li>Yet , for its activation , MalT needs to-bind inducer ( 49 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=16321936" target="_blank">16321936</a>]<br></li>
<li>This , in turn , will release MalT , allowing its activation by inducer , and will lead to transcriptional activity ( 3 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=12003949" target="_blank">12003949</a>]<br></li>
<li>A model for the interplay between the inducer and the negative effectors of MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>35 , 135 , 143 , 206 75.1 malI Repressor for malXY , not dependent on MalT , inducer unknown .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9529892" target="_blank">9529892</a>]<br></li>
<li>Response curves of malt + and malKp to increasing concentrations of MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2016744" target="_blank">2016744</a>]<br></li>
<li>This includes DnaA , FarR , GlpR , MalT , Lrp , MetR , NarL , TyrR , TorR and TreR .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9813115" target="_blank">9813115</a>]<br></li>
<li>MalT therefore specifically binds the adenine nucleoside triphosphates , with no distinction being made between the ribo - and the deoxyribo-forms .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>, 1984 ; Weber & Steitz , 1984 ) and , as discussed above , MalT probably also contacts the MalT box through the major groove .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2538630" target="_blank">2538630</a>]<br></li>
<li>Under the conditions used , ADP ± MalT would then have .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>For example , GerE Bsu is only 74 residues in length while MalT Eco is 901 residues long .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=7699720" target="_blank">7699720</a>]<br></li>
<li>Other nucleotides were examined for their ability to activate MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>Hence , eigenvector 2 is most likely related to a variation in the size of the MalT homopolymers .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15491603" target="_blank">15491603</a>]<br></li>
<li>MalT remains fully active for years .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=7830577" target="_blank">7830577</a>]<br></li>
<li>We verified that MalT was not inactivated during the chromatography .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10559195" target="_blank">10559195</a>]<br></li>
<li>MalT does not control its own expression .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9484893" target="_blank">9484893</a>]<br></li>
<li>j j MalT malPO j MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=1943993" target="_blank">1943993</a>]<br></li>
<li>Where in MalT do the repressors bind ?	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=12003949" target="_blank">12003949</a>]<br></li>
<li>In conclusion , we propose that the eight amino acid substitutions result in the same discrete and well-defined change in MalT conformation .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2180908" target="_blank">2180908</a>]<br></li>
<li>MalT monomers most likely exist under different conformations that induce a change in the geometry of the interaction between two adjacent monomers .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15491603" target="_blank">15491603</a>]<br></li>
<li>In this work we attempted to learn more about the interaction between MalT and its different protein repressors .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=12003949" target="_blank">12003949</a>]<br></li>
<li>23.5 20.0 3.8 16.3 9.1 12.7 Maltose transport MalT , Crp malK lamB malM ibpB ibpA htpG Maltose transport MalT , Crp 18.6 5.3 3.3 39.0 24.4 11.7 32.7 13.3 9.1 24.2 20.2 8.2 2.6 2.1 1.7 4.6 4.1 2.0 48.6 19.2 20.0 52.6 35.9 16.6 s32 Heat shock Heat shock s32 Heat shock chaperone s32 Protease ; chaperone Regulator Regulator ; chaperone Protease Periplasmic clpB 11.5 12.9 17.3 21.0 20.4 14.3 3.3 3.2 1.3 1.8 2.5 2.9 8.0 2.7 2.9 24.5 6.8 5.7 1.7 1.3 yceP/bssS cpxP ( b3913 ) degP ( htrA ) spy CpxR CpxR , H-NS CpxR , BaeSR CpxR CpxR Unknown Unknown ydeH yebE 49.2 44.8 63.1 21.0 30.7 32.2 56.9 33.1 9.5 1.1 1.6 6.1 7.3 7.3 2.6 1.5 1.6 2.0 1.4 1.2 1.3 2.9 Unknown ; signal peptide Putative transporter Regulator ; phage shock protein Regulator ; phage shock protein Regulator ; phage shock protein Inner membrane Sulphurtransferase yncJ ( b1436 ) yhjX pspA pspB pspC pspD pspE 1.6 44.1 1.1 1.6 1.7 1.2 1.2 3.1 165.6 1.8 1.5 2.1 1.2 1.5 PspF , IHF 1.3 1.9 5.0 2.4 4.7 2.7 2.6 1.4 PspF , IHF PhoB RbsR , Crp 37.9 22.0 2.6 1.2 1.8 2.3 0.8 1.1 Inner membrane Unknown Ribose transport Ribose transport Ribose transport Ribose transport Ribose transport Ribose transport pspG ( yjbO ) ytfK rbsD rbsA rbsC rbsB rbsK rbsR 0.7 3.8 1.8 1.0 1.6 1.4 1.2 0.8 0.9 3.0 8.2 5.4 21.3 6.6 9.0 2.8 manX Mannose permease 4.2 2.1 1.1 5.0 manY Mannose permease 3.4 2.6 1.1 5.2 manZ Mannose permease 6.5 5.7 1.0 16.7 NagC , DgsA , Crp a. Genes and operons which are induced 10-fold in three independent experiments are listed with the average fold induction for the three experiments .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=18710431" target="_blank">18710431</a>]<br></li>
<li>aerobic to anaerobic anaerobic to aerobic ArgR CysB BirA DgsA MalT GadW MetJ NikR OxyR SoxR SoxS DcuR CueR FadR HcaR NtrC PhoB PurR SgrR TdcA TrpR ZraR ArcA CpxR CRP CusR FhlA Fis FNR Fur H-NS IHF IscR Lrp ModE NarL NrdR PdhR FlhDC GlcC EvgA GadX LeuO PspF RbsR steady states Figure 3 .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=22870390" target="_blank">22870390</a>]<br></li>
<li>sitesa % CGb Count % Non-codinge Ada 3 38.7 AraC 6 40.3 2 3 100 100 47 76 100 28 33 32 73 38 100 52 100 86 79 89 100 67 26 100 28 100 70 37 67 28 100 82 100 47 50 51 100 100 38 33 64 3 6 100 100 38 54 100 23 40 18 43 29 100 38 100 39 27 53 58 71 19 100 23 33 47 100 40 65 21 23 60 25 100 41 100 26 43 36 100 35 35 30 64 36 23 22 26 14 100 83 28 ArcA 12 20.0 ArgR 17 22.9 CarP 2 46.0 Crp 49 37.0 CspA 4 41.3 CynR 2 33.3 CysB 3 34.2 CytR 5 37.8 DeoR 3 22.9 DnaA 8 36.7 FadR 7 47.0 FarR 4 20.0 FhlA 3 42.0 Fis 19 38.2 FlhCD 3 53.8 Fnr 9 25.8 FruR 12 42.7 Fur 9 23.4 GalR 7 43.8 GcvA 4 22.5 GlpR 13 39.6 HipB 4 40.9 Hns 15 31.5 IclR 2 26.7 Ihf 26 32.6 IlvY 2 32.4 LacI 3 44.4 LexA 18 33.9 Lrp 18 28.9 MalT 10 61.0 MarR 2 37.5 MelR 2 33.3 MetJ 15 40.1 MetR 8 33.3 NagC 6 22.5 NarL 9 34.6 NtrC 6 51.9 OmpR 9 26.7 OxyR 4 42.3 PdhR 3 33.3 PhoB 15 29.7 PurR 23 45.3 RhaS 2 50.0 RpoD15 27 37.4 RpoD16 48 34.9 RpoD17 116 37.3 RpoD18 34 38.0 RpoD19 25 38.2 RpoE 3 38.9 RpoH13 8 42.1 RpoH14 7 44.3 RpoN 7 40.6 RpoS17 15 43.0 RpoS18 7 45.2 SoxS 14 40.8 TorR 4 37.5 TrpR 4 38.5 Tus 6 26.8 TyrR 17 33.2 a The number of input sites used to construct the matrix .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9813115" target="_blank">9813115</a>]<br></li>
<li>of additional probable sites in predictionsd 3 3 7e 7 -- 4 22e 0 1 0 2 -- -- 5 0 1 -- 13 7 18 1 0 6e 1 1 1 3 Ada AraC ArcA ArgR CarP CpxR Crp CspA CynR CysB CytR DeoR DnaA FadR FhlA Fis FlhCD Fnr FruR Fur GalR GcvA GlpR IciA ( ArgP ) IclR Ihf IlvY LacI LexA Lrp MalT MarR MelR MetJ MetR Mlc ( DgsA ) ModE NagC NarL NarP NtrC OmpR OxyR PdhR PhoB PurR RhaR RhaS SoxR SoxS TorR TrpR TyrR Stem -- loopsf 6 2 0 5 2 9 1 3 4 5e 5 -- 5 5 4 6 3 4 2 -- 1 3 5 1 3 -- aThe number of genes in our study set with documented binding sites for each TF .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11160901" target="_blank">11160901</a>]<br></li>
				</div></ul><br>
			<label class="collapse_DOM" for="_2"><font size="5px">MalT protein domains</font></label>
				<input id="_2" type="checkbox">
				<div class="DOM"><br><ul><li>In this paper , we further characterize the interaction of NMalT with ATP and show that ATP-binding is essential for the activity of the protein .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
				<label class="DOM_collapse_similarity" for="dom_similarity_2">
Crystal structure of transcription factor MalT domain III : a novel helix repeat fold implicated in regulated oligomerization .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=12003949" target="_blank">12003949</a>]<br></label>
<input id="dom_similarity_2", type="checkbox">
<div class="DOM_similar">
<li>Crystal structure of transcription factor MalT domain III : A domain helix repeat fold implicated in regulated oligomerization .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15491603" target="_blank">15491603</a>]<br></li>
<li>Crystal structure of transcription factor MalT domain III : a domain helix repeat fold implicated in regulated oligomerization .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li></div>
<li>Consideration of all of the data obtained in the presence of maltotriose alone and in the presence of maltotriose 1 AMP-PNP , however , suggests the following association pathway : monomer 3 dimer 3 ( MalT ) n 3 unlimited aggregates , where ( MalT ) n would be a discrete size multimer , possibly a tetramer or a hexamer .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10559195" target="_blank">10559195</a>]<br></li>
<li>The fact that ATP gave an intermediate response close to that obtained with AMP-PNP ( a 10-fold higher concentration of maltotriose was required to antagonize MalY action in the presence of ATP compared with that observed in the presence of AMP-PNP ) might reflect the presence of both ATP-bound and ADP-bound forms resulting from ATP hydrolysis by MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>In the presence of maltotriose 1 ATP , the degree of association of MalT is intermediate between that observed in the presence of maltotriose 1 AMP-PNP and that observed in the presence of maltotriose 1 ADP ; this is best explained by the presence of both ATP - and ADP-bound forms due to ATP hydrolysis by the protein .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10559195" target="_blank">10559195</a>]<br></li>
<li>The intermediate results obtained with ATP are best explained by the presence of both ATP - and ADP-bound forms of MalT due to ATP hydrolysis during the assay .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>2 AMP-PNP , which can replace ATP as an effector of MalT ( 33 ) , is actually more effective than ATP in driving MalT self-association in the presence of maltotriose due to the absence of ATP hydrolysis , which generates ADP-bound forms that are less prone to multimerization ( 16 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>MalT activity in the presence of ATP , AMP-PNP or ADP .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>Gel filtration and sedimentation experiments were used to analyze the quaternary structure of MalT in solution in the absence or presence of maltotriose and/or AMP-PNP , ATP , or ADP .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10559195" target="_blank">10559195</a>]<br></li>
<li>Thus , we infer that , at least up to this step , ATP merely acts as an allosteric effector , i.e. that neither the potential energy of ATP hydrolysis nor the phosphorylation of MalT or maltotriose are needed .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>The event that would cause ATP hydrolysis and the MalT form that undergoes ATP hydrolysis are both unknown .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>Does ATP hydrolysis occur at one step of the activation process , as suggested by the ability of MalT to hydrolyse ATP ?	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>ATP ± MalT is more effective than ADP ± MalT in oligomerizing and promoting transcription-activation , which indicates that ATP/maltotriose/MalT is the species responsible for the transcriptional-activity and that ATP hydrolysis might be coupled to the disassembly of oligomeric structures ( Schreiber and Richet , 1999 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>Role of ATP in activation of transcription initiation by MalT The main conclusion of this work is that activation of transcription initiation by MalT requires , in addition to maltotriose , the presence of ATP ( or dATP ) as an effector of MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>ATP and AMP-PNP , a nonhydrolyzable analog of ATP , are equally effective in promoting activation of transcription by MalT in the presence of maltotriose ( 18 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10559195" target="_blank">10559195</a>]<br></li>
<li>Altogether these results establish that ATP is required as a positive effector of MalT in the process of transcription-activation .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>The finding that ATP is involved in transcription-activation by MalT raises several questions about its role .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>Transcription activation by MalT 1 involves MalT self-association , cooperative bind-2 ing to copies of the MalT recognition motif that are present in target promoters , and stimulation of 3 -- 5 open complex formation by RNA polymerase .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li>
<li>Transcription activation by 1,2 MalT involves MalT self-association , cooperative 3 binding to several copies of a 10 bp asymmetric recognition motif ( 5 0-ggGGa ( T/G ) GAgg-30 ) that are located in the target promoters , and stimulation 4 -- 6 of open complex formation by RNA polymerase .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15491603" target="_blank">15491603</a>]<br></li>
<li>Transcription activation by MalT involves MalT self-association , cooperative binding to an array of MalT sites located in the target promoters , and stimulation of open complex formation by the RNA polymerase ( 14 -- 16 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>Given that the ATPase activity of MalT does not play any role in the activation of open complex formation ( 5 ) , it is tempting to propose that it actually plays a role in the negative control of MalT activity and that the MalT/ADP form is the actual target of MalY and Aes in vivo .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>MalT binding to DNA shows the same specificity for maltodextrins and nucleotides as MalT activation of open complex formation .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>MalT displays weak ATPase activity whose function remains elusive : protein self-association , promo-ter binding and open complex formation do not require ATP hydrolysis ( Richet and Raibaud , 1989 ; Schreiber and Richet , 1999 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>A +1 5 ' - A T A A C G T T 3 ' - T A T T G C A A ApA + p p * pC -- ApA * pC z 50B 30 ° 20 ) 10 ATP is required for activation of open complex formation by MalT Using the abortive initiation assay described above , we examined the effect of ATP on open complex formation in the presence of MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>The conclusion that ATP hydrolysis is not needed at least up to formation of the open complex is further strengthened by the observation that the MalT-ADP form was fully competent for activation provided that MalT concentration was high enough .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>0 0.1 0.2 03 0.6 MalT ( PM ) ATP hydrolysis is not required for activation of open complex formation As shown in Figures 4 and 5 , AMP-PNP , a non-hydrolysable analogue of ATP , was as effective as ATP for activation of open complex formation by MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>As clearly shown here , activation of open complex formation by MalT does not require ATP hydrolysis .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>Although MalT displays a weak ATPase activity , ATP hydrolysis is not required for promoter binding and activation of open complex formation ( 18 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10559195" target="_blank">10559195</a>]<br></li>
<li>MalT is endowed with a weak ATPase activity whose role is thus far elusive ; activation of open complex formation does not require ATP hydrolysis ( 5 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>Thus , this result clearly demonstrates that , in the presence of ATP , maltotriose inhibits formation of the MalT ± MalY complex and makes us confident that the MalT ± MalY interaction seen here is functionally relevant .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>MalT activity was assayed by monitoring its ability to activate open complex formation at malPp , a MalT-dependent promoter , in the presence of RNA polymerase .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>MalT was incubated with malPp DNA and AMP-PNP2 in the presence or absence of MalK before adding RNA polymerase and allowing open complex formation .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>MalT was preincubated with malPp in the presence of ATP , maltotriose , and various concentrations of Aes before adding RNA polym-erase and allowing open complex formation .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>MalT was preincubated with malPp DNA , ATP and maltotriose in the presence or absence of MalY , before adding RNA polymerase and allowing open complex formation .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>We suggest that , in the nucieoprotein structure responsible for the initiation of transcription , MalT , RNA polymerase and malPp are held together by several weak interactions .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=7830577" target="_blank">7830577</a>]<br></li>
<li>This clearly indicates a positive interaction between MalT and RNA polymerase on maiPp .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=7830577" target="_blank">7830577</a>]<br></li>
<li>Alternatively , CRP could act through specific protein-protein contacts with either MalT or the RNA polymerase holoenzyme .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2538630" target="_blank">2538630</a>]<br></li>
<li>Finally , MalT might also interact with RNA polymerase and , in some of the MalT-dependent promoters , with the cyclic AMP receptor protein ( 27 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2180908" target="_blank">2180908</a>]<br></li>
<li>Filtration of a sample containing both MalT and Aes gave two peaks at the positions at which MalT and Aes , respectively , elute when chromatographed alone .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>Gel filtration of a mixture containing both proteins in the presence of ATP and maltotriose gave two peaks , at 1.11 and 1.32 ml , i.e. the volumes at which MalT and MalY , respectively , elute when filtered separately .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>In the above-mentioned experiments , complex formation was observed with a sample containing 9 M MalT and 9.5 M Aes , and no additional peak was observed , thereby suggesting that the MalT : Aes ratio in the inhibition complex is 1:1 ( protomer : protomer ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>The stability of the MalY dimer and the available stoichiometry data instead point to a complex containing one MalY dimer and two MalT protomers , with a predicted size of 293 kDa .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>What is the stoichiometry of the MalY ± MalT complex ?	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>This argues against the possibility that the MalY ± MalT complex contains one protomer of each protein .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>The fact that MalT needs to interact with two different ligands to achieve activation strongly suggests that the mechanism by which the protein acts is a complex one .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>As a result , the Aes-MalT complex might contain one protomer of each protein ( predicted molecular mass , 141 kDa ) or one Aes dimer and two MalT monomers ( predicted molecular mass , 281 kDa ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>NarL , FimZ , UhpA and RcsB of subgroup ( c ) also certainly fall into the category of response regulator from the existence of phosphoryl-ation domain , although SdiA and MalT show the similarity to the above four regulatory proteins only in the C-terminal region containing the helix-turn-helix motif .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=8729576" target="_blank">8729576</a>]<br></li>
<li>We speculate that a structural motif present in all three proteins , but not recognizable by sequence , interacts with MalT , thus inactivating the function of MalT as a transcriptional activator .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9401025" target="_blank">9401025</a>]<br></li>
<li>Even though they do not exhibit sequence similarity , all three proteins must contain a similar structural motif by which they recognize MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9529892" target="_blank">9529892</a>]<br></li>
<li>If so , it will be interesting to find out whether the three proteins recognize the same structural motif on MalT , even though they do not display any obvious homology at the sequence level .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>Moreover , the 4 center-to-center distance between outer domains ( 49 Å ) is close to the center-to-center distance between two tandem MalT sites ( 45 Å ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15491603" target="_blank">15491603</a>]<br></li>
<li>MalT forms curvilinear homopolymers of varying length , with separate white globular domains in the outer layer and a continuous white line in the inner layer .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15491603" target="_blank">15491603</a>]<br></li>
<li>In the average map ( Figure 2A ) , MalT multimers contain an average number of seven or eight globular domains , forming the outer layer .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15491603" target="_blank">15491603</a>]<br></li>
<li>Assuming a globular sphere with a diameter of 49 Å for the outer domain and a partial speciﬁc volume of 0.735 cm g as deter-3 K1 mined for MalT , one can calculate a molecular 3 mass of 50 kDa for the outer domain .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15491603" target="_blank">15491603</a>]<br></li>
<li>The building block , corresponding to a MalT monomer , comprises an outer globular domain connected by a peduncle to an inner domain that mediates self-association .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15491603" target="_blank">15491603</a>]<br></li>
<li>Cryo-15 electron microscopy showed that , in the active form , i.e. in the presence of both ATP and maltotriose , MalT monomers consist of a globular domain connected by a peduncle to an inner domain , that mediates self-association into polydisperse homopolymers .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li>
<li>This inference is further supported by the observation that the Vibrio cholerae MalT ortholog has an arginine residue at the corresponding position .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>This last peak is presumed to contain the ( MalT ) n multimer in rapid equilibrium with aggregates of this multimer .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10559195" target="_blank">10559195</a>]<br></li>
<li>The first phase ( up to '10 mM MalT ) would reflect the formation of the ( MalT ) n multimer , and the major peak would contain the ( MalT ) n form in rapid equilibrium with dimer and/or monomer .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10559195" target="_blank">10559195</a>]<br></li>
<li>As revealed by limited proteolysis , maltotriose binding triggers a conformational change in MalT that involves domains 1 -- 3 and most likely reflects part of the postulated transition from the inactive form to the active form of MalT ( 21 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>MalT is in equilibrium between an inactive and an active form with the negative effector stabilizing the inactive form and maltotriose stabilizing the active form .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>Presently , it is difﬁcult to assign the outer domain , the peduncle and the inner domain to any of the MalT structural domains that have been deﬁned biochemically and crystallographically ( DT1 , 27 kDa ; DT2 , 22 kDa ; DT3 , 43 kDa ; and DT4 , 11 kDa ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15491603" target="_blank">15491603</a>]<br></li>
<li>Structural studies revealed that MalT is made of four domains : domain 1 ( DT1 ; residues 1 -- 241 ) , domain 2 ( DT2 ; residues 250 -- 436 ) , domain 3 ( DT3 ; residues 437 -- 806 ) and domain 4 ( DT4 ; residues 807 -- 901 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15491603" target="_blank">15491603</a>]<br></li>
<li>MalT consists of four structural domains ( 11 ) : domain 1 ( DT1 , aa 1 to 241 ) binds ATP , domains 2 ( DT2 , aa 250 to 436 ) and 3 ( DT3 , aa 437 to 806 ) bind the inducer , and domain 4 ( DT4 , aa 807 to 901 ) harbors the DNA-binding site ( 11 , 43 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=12003949" target="_blank">12003949</a>]<br></li>
<li>As proposed by Danot , MalT domains 24 14 1 , 2 and 3 form a novel signal transduction module , linked to an output domain , the activity of which the module controls via a change of its own quaternary structure .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15491603" target="_blank">15491603</a>]<br></li>
<li>The transition between the inactive and the active form of MalT involves DT1 , DT2 , and DT3 , three domains that are specific to the MalT family of transcriptional activators and are thought to constitute a signal integration module ( 21 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>All of these regulatory signals are integrated by a novel signal transduction module that comprises three out of the four MalT structural domains : DT1 , the ATP-binding domain that contains determinants recognized by the negative effectors , DT2 , and DT3 , the maltotriosebinding domain .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li>
<li>Integration of 14,15 the regulatory signals is ensured by the three N-terminal domains , DT1 , DT2 and DT3 , which constitute a novel signal transduction module that is the signature of the MalT subfamily of STAND ATPases .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li>
<li>Besides the MalT family of transcriptional activators , the largest regulators that are structurally well-deﬁned are the NtrC-type or the TyrR-type activators ( about 55 kDa ) , which are members of another family of transcriptional regulators and which are composed of three domains .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15491603" target="_blank">15491603</a>]<br></li>
<li>The only feature that MalT shares with members of another family of transcriptional activators , the LuxR family , is a conserved C-terminal domain ( '10 kDa ) that contains * The costs of publication of this article were defrayed in part by the payment of page charges .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10559195" target="_blank">10559195</a>]<br></li>
<li>Members of this subfamily have an amino-terminal phosphorylation domain characteristic of so-called two-component regulators , such as OmpR , CheY , PhoB , and NtrC , and a carboxyl-terminal domain conserved among many transcriptional activators , including LuxR and MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=1569008" target="_blank">1569008</a>]<br></li>
<li>Insertions corresponding to two or three turns of.DNA helix ( 121 and 131 ) did not alter MalT binding to malEp-malKp , as compared to the wild-type .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2538630" target="_blank">2538630</a>]<br></li>
<li>In contrast , insertions of 1.5 or 2.5 turns of DNA helix ( 116 and 126 ) dramatically affect the way in which MalT interacts with malEp-malKp ( Fig. 7 and data not shown ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2538630" target="_blank">2538630</a>]<br></li>
<li>Therefore , it is difﬁcult to conclude whether the DNA and the MalT oligomers speciﬁcally interact via MalT recognition sites .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15491603" target="_blank">15491603</a>]<br></li>
<li>Only some of the enhancements and diminutions are indicated 6 11 important determinant for MalT interaction with the DNA .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2538630" target="_blank">2538630</a>]<br></li>
<li>Some structural ﬂexibility in the DT3-DT4 linker region might also uncouple the DNA-binding domains from constraints imposed by a heterologous pol-ymerization and allow them to bind cooperatively MalT sites in different orientations and with different spacer region lengths .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15491603" target="_blank">15491603</a>]<br></li>
<li>This supports the notion that DT1 and DT2 are involved in inter - or intramolecular interactions taking place in the process of MalT activation and that these domain interactions are interfered by Aes .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=12003949" target="_blank">12003949</a>]<br></li>
<li>This , in turn , will release MalT , allowing its activation by inducer , and will lead to transcriptional-activity ( 3 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=12003949" target="_blank">12003949</a>]<br></li>
				<label class="DOM_collapse_similarity" for="dom_similarity_81">
Multiple protein-DNA and proteinprotein interactions are involved in transcriptional activation by MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9529892" target="_blank">9529892</a>]<br></label>
<input id="dom_similarity_81", type="checkbox">
<div class="DOM_similar">
<li>Multiple protein -- DNA and protein -- protein interactions are involved in transcriptional activation by MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15491603" target="_blank">15491603</a>, <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li>
<li>Multiple protein-DNA and protein-protein interactions are involved in transcriptional activation by MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9000616" target="_blank">9000616</a>]<br></li></div>
<li>On supercoiled DNA , each MalT binding site contained several G residues whose methylation was either enhanced or diminished ( Fig. 9 ) , thereby indicating that the five MalT binding sites were occupied .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2016744" target="_blank">2016744</a>]<br></li>
<li>Either the interaction of MalK prevents the ability of MalT to bind to MalT boxes at mal promoters or MalK may have no direct effect on DNA-binding but interfere with transcriptional activation of RNA polymerase .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9822819" target="_blank">9822819</a>]<br></li>
<li>Transcription activation by MalT depends on the binding of the protein to an array of binding sites located upstream of the 235 region of the mal promoters ( 13 -- 15 ) and probably involves a contact between the RNA polymerase and a surface element located on the C-terminal domain of MalT ( 16 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10559195" target="_blank">10559195</a>]<br></li>
<li>Transcription activation probably involves a contact between the RNA polymerase ( Es ) and a surface 70 determinant of the DNA-binding domain of the MalT protomer bound to the most proximal MalT site ( Danot et al. , 1996 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>domain of MalT play a crucial role in transcription-activation .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9000616" target="_blank">9000616</a>]<br></li>
				<label class="DOM_collapse_similarity" for="dom_similarity_89">
Danot , O. , Vidal-Ingigliardi , D. , and Raibaud , O. ( 1996 ) Two amino acid residues from the DNA-binding domain of MalT play a crucial role in transcriptional activation .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></label>
<input id="dom_similarity_89", type="checkbox">
<div class="DOM_similar">
<li>Two amino acid residues from the DNA-binding domain of MalT play a crucial role in transcriptional activation .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9529892" target="_blank">9529892</a>, <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15491603" target="_blank">15491603</a>, <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li></div>
<li>First , the fact that the presence of a MalT box at this position is the unique feature common to all the MalT-dependent promoters suggests that this binding site plays a key role in transcription-activation ( Chapon & Raibaud , 1985 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2538630" target="_blank">2538630</a>]<br></li>
<li>Having two MalT binding sites in a direct repeat is a recurrent feature of mal promoters and plays a crucial role in their activation ( 281 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9529892" target="_blank">9529892</a>]<br></li>
<li>If the latter hypothesis is correct , the MalK protein must have another patch involved in MalT recognition , in addition to that already identiﬁed in its regulatory domain .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li>
<li>It is worth noting that the structural complexity of the MalT monomer , as revealed by cryo-EM , parallels the complexity in domain composition of the protein .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15491603" target="_blank">15491603</a>]<br></li>
<li>In the MalT -- BCCP fusion protein the striped box indicates the position of the BCCP biotinylation domain .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9822819" target="_blank">9822819</a>]<br></li>
<li>Indeed , the presence of the biotinylation domain ( BCCP ) attached to the C-terminus of MalT for protein immobilization renders MalT inactive in vivo ( Panagiotidis et al. , 1998 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>Furthermore , the existence of two distinct patches on MalK , in the regulatory domain and in the nucleotide-binding domain , respectively , would help explain how the ability of MalK to interact with MalT might be controlled by the activity of the transporter , as proposed by Panagiotidis et al. .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li>
<li>However , as shown by Schlegel et al. , ( 33 ) the T38R substitution , isolated2 by Notley-McRobb and Ferenci ( 32 ) and located in MalT domain 1 ( DT1 ) , renders the protein insensitive to Aes in vivo , whereas it slightly increases its sensitivity to MalY , thereby suggesting that the substitution specifically alters the Aes binding site .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>Instead , the crystal structures of free and ATP-bound MalK dimers suggest that ATP hydrolysis is not accompanied by conformational changes of the C-termi-nal regulatory domain , where the MalT binding-site is located ( 10 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>By using a biochemical approach , we demonstrate here that ( i ) Aes controls MalT activity through direct pro-tein-protein interaction , ( ii ) Aes competes with maltotri-ose for MalT binding , ( iii ) ATP and ADP differentially affect the competition between Aes and the inducer , and ( iv ) part , if not all , of the Aes binding site is located in DT1 , the N-terminal domain of the activator , which also contains the ATP-binding site .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>In both cases , the inhibitory protein is a negative effector of MalT that competes with the inducer for MalT binding and whose binding site is located on the N-terminal domain of the activator .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>We found that the binding site for Aes is also likely to be contained in the N-terminal portion of MalT encompassing DT1 and DT2 .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=12003949" target="_blank">12003949</a>]<br></li>
<li>Böhm et al. ( 10 ) identified a surface determinant on the C-terminal domain of MalK that is specifically involved in MalT repression and might represent the MalT binding site .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>Whereas the absence of MalK titration by DT1 in vivo excludes the possibility that the N-terminal domain of MalT harbors a major determinant of the MalK binding site ( 33 ) , it remains possible that DT1 contributes to MalK binding and that substitution T38R alters the DT1 element of the MalK binding site .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>These sites would be located in DT1 and DT3 of MalT , and in the nucleotide-binding domain and the regulatory domain of MalK .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li>
<li>Furthermore , we have shown that part , if not all , of the Aes binding site is located on DT1 , the N-terminal domain of MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>Part , if not all , of the MalK-binding site is located on DT1 , the N-terminal domain of MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>Finally , we have demonstrated that , when isolated , DT1 spe-cifically interacts with MalK , which indicates that part if not all of the MalK binding site is located on DT1 , the N-terminal domain of MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>Yet , the MalT/DT1 interaction is weak , which suggests that other MalT domains might contribute , directly or indirectly , to MalK binding .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>This finding obviously indicates that the substitution does not alter the DT1 surface element recognized by MalK but indirectly interferes with MalK binding via a conformational change involving other MalT domains .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>Interestingly , whereas most TPR proteins interact with their binding partner through the interior surface of the superhelix , in this case the interaction patch ( either with MalK or with a domain of MalT ) is located on the exterior surface of DT3 .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li>
<li>Indeed , it is easy to imagine how interaction of MalK or another domain of MalT with the exterior cleft separating the ﬁfth and sixth helix bundles could change the curvature of the inner surface of the tunnel and preclude the binding of maltotriose , if it does bind in the tunnel , and , reciprocally , how maltotriose could prevent the H10/H11 motif from binding its target .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li>
<li>Since MalK is known to bind DT1 , another domain of MalT , it was possible that the H10 / 10 H11 motif is important for MalK function ( i.e. repression of MalT activity ) but not for its binding to MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li>
<li>This residue might therefore contribute 22 to the structure of a determinant located in the MalK nucleotide-binding domain and recognized by the H10/H11 motif of MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li>
<li>Finally , MalT is an ATP-binding protein , as suggested by the following lines of evidence : ( i ) ATP protects MalT against thermal denaturation , ( ii ) ATP can be photo-crosslinked to the protein , and ( iii ) the MalT polypeptide contains at its Nterminus an amino-acid sequence homologous to a conserved sequence ( Gly-X-X-Gly-X-Gly-Lys-Thr-Thr ) found in a large number of ATP - and GTP-binding proteins and considered to be part of the nucleotide-binding domain ( Richet and Raibaud , 1987 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>In particular , the carboxyl termini of the NarP and NarL proteins contain predicted helix-turn-helix motifs of the type that is found in other DNA-binding proteins such as MalT , FixJ , and RcsA ( Fig. 3 ) ( 18 , 42 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=8501030" target="_blank">8501030</a>]<br></li>
<li>Members of the UhpA-LuxR family contain a predicted helix-turn-helix domain , and the specific binding of MalT to target sequences in promoter DNA has been demonstrated ( 22 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=1569008" target="_blank">1569008</a>]<br></li>
<li>The C-termi-nal domains of the UhpA-family of response regulators contain a highly conserved segment predicted to form a helix-turn-helix motif that is similar to the DNA-binding regions of some transcription factors that are not regulated by protein phosphoryl-ation , such as MalT from E. coli and LuxR from Vibrio fischeri ( 14 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=8999880" target="_blank">8999880</a>]<br></li>
<li>However , as 13,14 discussed below , images of the nucleoprotein complexes formed by MalT at the malPp500 promoter suggest that the DNA-binding domain is located on the outer domain .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15491603" target="_blank">15491603</a>]<br></li>
<li>The two-domain structure of NarL ( Baikalov et al. , 1996 ) contains an N-terminal phosphorylation module tethered through a ¯ exible linker to a C-terminal DNA-binding and activation domain that is highly conserved in otherwise unrelated transcription regulators , including MalT , LuxR and s70 ( Henikoff et al. , 1990 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10512697" target="_blank">10512697</a>]<br></li>
<li>When RcsA is limiting [ Ion * cells ) and RcsB is not activated by phosphorylation , the cps region is not transcribed The predicted protein sequences of both RcsA and RcsB contain a carboxy-terminal domain similar to that found in a class of DNA-binding proteins exemplified by UhpA , MalT , and FixJ ( Fig. 1 ; Stout etal .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=1943696" target="_blank">1943696</a>]<br></li>
<li>The output domain is a C-terminal LuxR-type DNA-binding domain in the case of transcriptional activators homologous to MalT or a putative serine/threonine-speci ﬁc kinase domain , N-terminal to DT1 , in the case of the PknK protein from Micrococcus tuberculosis .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15491603" target="_blank">15491603</a>]<br></li>
<li>The last C-terminal 95 amino acids of MalT constitute the DNA-binding domain .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9529892" target="_blank">9529892</a>]<br></li>
<li>Truncated forms of MalT lacking its C-terminal DNA-binding domain are negatively dominant over the function of the wild-type protein , indicating that the protein interacts with itself when binding to DNA ( 40 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9529892" target="_blank">9529892</a>]<br></li>
				<label class="DOM_collapse_similarity" for="dom_similarity_125">
Vidal-Ingigliardi , D. , Richet , E. , Danot , O. , and Raibaud , O. ( 1993 ) A small C-terminal region of the Escherichia coli MalT protein contains the DNA-binding domain .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></label>
<input id="dom_similarity_125", type="checkbox">
<div class="DOM_similar">
<li>A small C-terminal region of the Escherichia coli MalT protein contains the DNA-binding domain .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=12003949" target="_blank">12003949</a>, <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9529892" target="_blank">9529892</a>, <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15491603" target="_blank">15491603</a>, <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li></div>
<li>However , it should be pointed out that MalT binding to the malEp - malKp region , which contains five MalT boxes , appears to be highly cooperative ( Raibaud et al. , 1989 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>This sequenceis often embedded in a purine-rich region ( Bedouelle , 1983 ) , suggesting that additional , less well-conserved residues on both sides of the hexamer might contribute to the specificity of MalT binding .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2538630" target="_blank">2538630</a>]<br></li>
<li>This region in MalT is not identical with the ATP-binding site ( 48 ) but has been discussed as a possible helix-turn-helix motif ( 14 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2670898" target="_blank">2670898</a>]<br></li>
<li>This feature might reflect cooperative binding of MalT to the regulatory region or a MalT -- oligomerization event that would occur prior to D?u ' A binding .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2016744" target="_blank">2016744</a>]<br></li>
<li>Recent studies revealed that the unliganded form of the protein is monomeric and that the function of both of these effectors is to induce MalT selfassociation , thought to play a critical role in promoter binding ( 4 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>In addition , the malE promoter contains a site for MalT activation right at -40 .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=1943993" target="_blank">1943993</a>]<br></li>
<li>In particular , which oligomeric structure ( s ) of MalT is ( are ) at the basis of promoter binding ?	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15491603" target="_blank">15491603</a>]<br></li>
<li>It establishes that MalY is a negative effector of MalT , the transcriptional activator of the regulon , and that it downregulates the activity of MalT through direct protein ± protein interaction and by preventing inducer-binding .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>MalY is a negative effector of MalT that competes with maltotriose binding , thereby inhibiting its transcriptional-activity .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=12003949" target="_blank">12003949</a>]<br></li>
<li>Recently , we have discovered that MalT activity is also strictly dependent on the presence of ATP ( 30 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2180908" target="_blank">2180908</a>]<br></li>
<li>Both these properties suggest that maltotriose binding and ATP-binding are co-operative , consistent with the fact that these two effectors promote MalT oligomerization when present together .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>Alternatively , a MalT monomer may possess two distinct ATP-binding sites , one of them binding ATP only in the presence of maltotriose .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>Second , both MalT oligomerization and promoter binding depend on the presence of ATP and maltotriose .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10559195" target="_blank">10559195</a>]<br></li>
<li>The binding of ATP to MalT depends strictly on the presence of Mg2 , as is usually observed for nucleotide-binding proteins .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>The MalT activator is a large protein of 102,988 molecular weight , containing a binding site for ATP between amino acids 34 and 47 .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2670898" target="_blank">2670898</a>]<br></li>
<li>ATP-binding to the MalT protein .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>, <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>The MalT protein contains a large pro-dary structure predictions , obtained by the method of Garnier et al. ( 1978 ) , suggest that the protein is composed of 60 y0 z-helix , 25 y0 Psheet and 6 y0 turn .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=3015733" target="_blank">3015733</a>]<br></li>
<li>The fractions containing MalT protein were identified by analysis on polyacrylamide gels in the presence of SDS and pooled .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=6283313" target="_blank">6283313</a>]<br></li>
<li>The second lane contains the MalT -- BCCP hybrid and an unidentiﬁed 70 kDa protein that was present in the His-6 -- FabI preparation ( see last lane ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9822819" target="_blank">9822819</a>]<br></li>
<li>The corresponding amino acid changes were clustered in two short regions of the 901-amino-acid MalT polypeptide ( Fig. 3 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2180908" target="_blank">2180908</a>]<br></li>
<li>The following conclusions can be drawn from Table 4 and Fig. 3 and 4 : all malT mutations were clustered in three regions ( A to C ) of the N-terminal third of MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=12003949" target="_blank">12003949</a>]<br></li>
<li>It is noteworthy that only one of the amino acids that are identical in MalI and MalT is common to the other repressor proteins .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2670898" target="_blank">2670898</a>]<br></li>
<li>The region of homology included the helix-turn-helix motif of MalI and the stretch of 30 amino acids exhibiting homology to MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2670898" target="_blank">2670898</a>]<br></li>
<li>The first 26 amino acids of the mature protein were determined by protein sequencing.MalT binding sitesare underlined , with the arrows indicating their orientation .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=1544897" target="_blank">1544897</a>]<br></li>
<li>The protein contained a short stretch of 30 amino acids that was surprisingly homologous to a sequence in MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2670898" target="_blank">2670898</a>]<br></li>
<li>EMBO J 19 : 1777 -- 1783 Schlegel A , Danot O , Richet E , Ferenci T , Boos W ( 2002 ) The N terminus of the Escherichia coli transcription activator MalT is the domain of interaction with MalY .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15616579" target="_blank">15616579</a>]<br></li>
<li>The N-terminus of the Escherichia coli transcription activator MalT is the domain of interaction with MalY .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15491603" target="_blank">15491603</a>, <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li>
<li>The three-dimensional structure of the MalY dimer has been determined , revealing its interaction site with MalT ( 10 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=12003949" target="_blank">12003949</a>]<br></li>
<li>The positions of the amino acid residues in the regulatory domain of MalK , known to affect the interaction with MalT , did not resemble the patch in the crystal structure of MalY ( a hydrophobic cone surrounded by a ring of charged residues ) that represents the interaction site with MalT ( 10 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=12003949" target="_blank">12003949</a>]<br></li>
<li>The plasmid-encoded N-terminal MalT fragments were tested for their ability to interfere with the MalY-MalT interaction , thus lifting malK-lacZ activity .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=12003949" target="_blank">12003949</a>]<br></li>
<li>By in vivo titration assays , we have shown that the N-terminal 250 amino acids of MalT contain the interaction site for MalY but not for MalK .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=12003949" target="_blank">12003949</a>]<br></li>
<li>RESULTS The N-terminal 250 aa of MalT are sufﬁcient for the interaction with MalY in vivo .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=12003949" target="_blank">12003949</a>]<br></li>
<li>The observation that a peptide containing the N-terminal 250 aa of MalT was able to interfere with the MalT-MalY interaction in vivo and that DT1 , the N-terminal domain of MalT ( aa 1 to 241 ) , coelutes together with MalY during mo-lecular sieve chromatography demonstrates that DT1 contains at least part of the interaction site with MalY .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=12003949" target="_blank">12003949</a>]<br></li>
<li>However , the conformation of the isolated DT3 domain might differ from that of DT3 in the full-length MalT context .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li>
<li>This DT1H-MalY interaction is speciﬁc since no complex could be observed when DT1H was replaced by DT3 , another domain of MalT , at the same molar concentration ( data not shown ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=12003949" target="_blank">12003949</a>]<br></li>
<li>The only structural domain of MalT contained in all fragments causing derepression is DT1 .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=12003949" target="_blank">12003949</a>]<br></li>
<li>This was conﬁrmed by gel ﬁltration analysis , where MalY was shown to coelute with the N-terminal MalT structural domain .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=12003949" target="_blank">12003949</a>]<br></li>
<li>Here we show that one region in MalT that interacts with MalY is contained in the N-terminal domain , DT1 , as deﬁned by Danot ( 11 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=12003949" target="_blank">12003949</a>]<br></li>
<li>Here , we report cryo-electron microscopy analyses of MalT multimeric forms .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15491603" target="_blank">15491603</a>]<br></li>
<li>Structural studies have revealed that MalT is composed of four domains ( 21 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>Biochemical and structural studies have provided insight into the structure of MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li>
<li>Where in MalT do the repressors bind ?	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=12003949" target="_blank">12003949</a>]<br></li>
<li>For example , GerE Bsu is only 74 residues in length while MalT Eco is 901 residues long .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=7699720" target="_blank">7699720</a>]<br></li>
<li>The MalT polypeptide contains 22 tryptophan residues and 19 tyrosine residues .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10559195" target="_blank">10559195</a>]<br></li>
<li>Numbers refer to aa residues ( at the C-terminus of the MalT ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=3015733" target="_blank">3015733</a>]<br></li>
<li>Finally , we have shown that the amino acid substitution T38R specifically impairs the interaction between Aes and DT1 or full-length MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>Because the T38R substitution is located in DT1 , we considered the possibility that this amino acid substitution renders MalT insensitive to MalK by altering the DT1 determinant recognized by MalK .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>As revealed by the x-ray structure of MalY , amino acid substitutions in MalY that impair MalT inhibition delineate a patch on the surface of the protein that most likely represents the MalT contact site ( 17 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>These mutations are located at positions 38 , 220 , 243 , and 359 , most likely deﬁning the interaction patch with Aes on the three-dimensional structure of MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=12003949" target="_blank">12003949</a>]<br></li>
<li>The T38R substitution does not alter the specific activity of MalT ( in the presence of a saturating concentration of nucleoside triphosphate ) , nor does it suppress its ability to interact with MalY .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11867639" target="_blank">11867639</a>]<br></li>
<li>In conclusion , all of the substitutions altering residues R634 , E636 , N637 , L638 , L639 , G640 and R656 enhance MalT activity under conditions of repression by MalK but have no signiﬁcant effect o MalT activity in the absence of repressor or in the presence of MalY or , in the cases of residues 634 , 636 , 637 and 639 , in the presence of Aes .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li>
<li>Furthermore , the N637T substitution , which alters a surface-exposed residue , does not affect MalT activity in vitro , or its sensitivity to the inhibition by MalY or Aes , but fully prevents MalT inhibition by MalK .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li>
<li>Computer-aided ﬁtting of the surface structure of MalK known to interact with MalT ( 1 ) onto the surface structure of DT3 ( 40 ) offered a possibility for a surprisingly tight ﬁt between the two proteins , a starting point for future mutant analysis in search of the MalK-MalT interface .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=12003949" target="_blank">12003949</a>]<br></li>
<li>However , such a hypothesis implies that the active form of MalT would be in equilibrium with at least two different inactive forms of MalT , and that only the form recognized by MalK would be stabilized by an intra-molecular domain/domain interaction mediated by the DT3 H10/H11 motif .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li>
<li>The substituted amino acids are either part of a surface determinant , the H10/H11 motif , playing a crucial role in MalT repression by MalK or contribute to the correct exposition of this determinant .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li>
<li>Hence , its substitution with glycine might affect MalT repression by MalK , because it disrupts the salt-bridge between helices 10 and 11 and/or because it alters the H10/H11 motif surface .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li>
<li>What is the function of the H10/H11 surface motif in MalT inhibition by MalK ?	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li>
<li>In this report we describe the use of tagged versions of MalT to provide evidence that it physically interacts with the MalK protein both in vitro and in vivo .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9822819" target="_blank">9822819</a>]<br></li>
<li>Before using this protein as a tool to study the ability of MalK and MalT to interact in vitro , we ﬁrst examined its ability to function in vivo .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9822819" target="_blank">9822819</a>]<br></li>
<li>Results MalT and MalK interact in vivo We constructed a hybrid form of MalT , MalT -- BCCP , that contains the biotination signals from the BCCP protein ( Cronan , 1990 ) attached to the C-terminus of MalT ( see Fig. 1A ) to test the hypothesis that MalK antagonizes the transcriptional-activity of MalT via a direct physical interaction .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9822819" target="_blank">9822819</a>]<br></li>
<li>If the interaction between MalK and the MalT -- BCCP hybrid is speciﬁc , extracts containing normal MalT protein would be expected to compete with the Fig. 1 .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9822819" target="_blank">9822819</a>]<br></li>
<li>We conclude that MalK can speciﬁcally interact with both the MalT protein and the two hybrid MalT proteins .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9822819" target="_blank">9822819</a>]<br></li>
<li>To examine the ability of the His-6 -- MalK protein to interact with the MalT -- BCCP protein , extracts containing each protein were incubated together and then streptavidin-agarose beads were added to capture MalT -- BCCP and any interacting proteins .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9822819" target="_blank">9822819</a>]<br></li>
<li>These data provide compelling evidence that MalT physically interacts with MalK , that the interaction is functionally relevant , and that maltotri-ose prevents formation of the MalT-MalK complex .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>MalT and MalK physically interact in vitro Even though the results obtained in vivo are consistent with a functional interaction between MalK and MalT , they do not demonstrate a direct physical interaction between the two proteins .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9822819" target="_blank">9822819</a>]<br></li>
<li>To ﬁnd out whether MalK and MalT form a binary complex or whether additional proteins participate in this interaction , we constructed the same His-6 -- MalK hybrid described by Davidson ( Davidson and Sharma , 1997 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9822819" target="_blank">9822819</a>]<br></li>
<li>It is not known where in MalT the interaction with these proteins takes place .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=12003949" target="_blank">12003949</a>]<br></li>
<li>Since no relief of repression was observed even with the longest fragment , the site of MalK interaction in MalT must differ from the MalY-MalT interaction site .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=12003949" target="_blank">12003949</a>]<br></li>
<li>Thus , interaction with MalK might occur at a position in MalT that is engaged in the activation ( multimerization ) mechanism .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=12003949" target="_blank">12003949</a>]<br></li>
<li>Physical interaction of MalK and MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9822819" target="_blank">9822819</a>]<br></li>
<li>D. Binary interaction of MalK and MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9822819" target="_blank">9822819</a>]<br></li>
<li>As a result , the ability of MalT to interact with MalK was possibly unregulated , and the secondary structural motifs involved in MalK recognition were permanently exposed .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>Mutant forms of MalK and MalT defective in signalling are able to interact .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9822819" target="_blank">9822819</a>]<br></li>
<li>This may indicate that the dimeric form of MalK is the one that interacts with MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9529892" target="_blank">9529892</a>]<br></li>
<li>MalK Interacts with DT1 -- The similarity between the action modes of the three negative effectors of MalT suggests that , like MalY and Aes , MalK might interact with DT1 .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>The regulatory domain of MalK also interacts with MalT , inhibiting its activity as a transcriptional activator ( 31 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=16321936" target="_blank">16321936</a>]<br></li>
<li>The N terminus of MalT does not titrate MalK .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=12003949" target="_blank">12003949</a>]<br></li>
<li>The MalT sites in malPp were preciseiy located and their occupation as a function of MaiT concentration was quantified using DNase I and dimethyi sulphate footprinting experiments .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=7830577" target="_blank">7830577</a>]<br></li>
<li>It should be noted that we have presented the simplest model accounting for our present results and that this model relies on the assumption that the complex MalT forms in vitro with malEp-malKp is closely related to the structure actually responsible for transcription-activation in vivo .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2538630" target="_blank">2538630</a>]<br></li>
<li>Some elements of this structure , namely the CRP site 1 , located at − 76.5 , and the distal MalT sites , seem to play a direct role in malEp activation besides their participation in the assembly of the higher-order structure .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9000616" target="_blank">9000616</a>]<br></li>
<li>The mechanism of activation by CRP is clearly different from that occurring at the divergent malEp-malKp promoters , which are simultaneously controlled by an array of three binding sites for CRP , all located at distal positions in between ( 36 ) , and forming a high-order structure responsible for activation , assisting direct activation by the MalT primary regulator .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9573142" target="_blank">9573142</a>]<br></li>
<li>The binding of MalT and CRP to this region is known to result in the formation of a higher-order structure that is responsible for malKp activation .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9000616" target="_blank">9000616</a>]<br></li>
<li>Since we recently purified the MalT protein ( Richet and Raibaud , submitted for publication ) , we reconsidered this problem of induction by studying the activation of a maltose regulon promoter in vitro .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=3298211" target="_blank">3298211</a>]<br></li>
<li>The purification of MalT in an active form and the development of a purified in vitro transcription system recently made the process of transcription-activation by MalT amenable to biochemical analysis ( Richet and Raibaud , 1987 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>The MalT protein , which has been recently purified in an active form , appears to be a monomer in solution ( M , = 102,000 ) ( Richet & Raibaud , 1987 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2538630" target="_blank">2538630</a>]<br></li>
<li>For example , we can not formally exclude the possibility that two different CRP/MalT nucleoprotein structures exist in equilibrium , each one being specifically involved in activation of only one promoter .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2538630" target="_blank">2538630</a>]<br></li>
<li>Two mutated MalT proteins ( corresponding to a mutation in each cluster ) were purified and examined for in vitro activation of the MalT-dependent malPp promoter .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2180908" target="_blank">2180908</a>]<br></li>
				</div></ul><br>
			<label class="collapse_EVO" for="_3"><font size="5px">MalT evolution</font></label>
				<input id="_3" type="checkbox">
				<div class="EVO"><br><ul><li>The protein contained a short stretch of 30 amino acids that was surprisingly homologous to a sequence in MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2670898" target="_blank">2670898</a>]<br></li>
<li>Surprisingly , MalI contained of 30 amino acids a sequence ( 86 to 116 in Fig. 8 ) that exhibit fairly good homology ( 11 amino acids are identical ) to the activator protein of the mal regulon , MalT ( amino acids 751 to 780 in MalT ) ( 14 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2670898" target="_blank">2670898</a>]<br></li>
<li>NarL , FimZ , UhpA and RcsB of subgroup ( c ) also certainly fall into the category of response regulator from the existence of phosphoryl-ation domain , although SdiA and MalT show the similarity to the above four regulatory proteins only in the C-terminal region containing the helix-turn-helix motif .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=8729576" target="_blank">8729576</a>]<br></li>
<li>Members of the UhpA-LuxR family contain a predicted helix-turn-helix domain , and the specific binding of MalT to target sequences in promoter DNA has been demonstrated ( 22 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=1569008" target="_blank">1569008</a>]<br></li>
<li>The C-termi-nal domains of the UhpA family of response regulators contain a highly conserved segment predicted to form a helix-turn-helix motif that is similar to the DNA-binding regions of some transcription factors that are not regulated by protein phosphoryl-ation , such as MalT from E. coli and LuxR from Vibrio fischeri ( 14 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=8999880" target="_blank">8999880</a>]<br></li>
<li>The search for proteins with homology to the putative BglJ protein yielded other members of this family including FimZ , UvrC , MalT , RcsA , NarP , and NarL ( ALTSCHUL et al. 1990 ; STOUTet al. 1991 ; SWENSOaNnd CLEGG1992 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=8725214" target="_blank">8725214</a>]<br></li>
<li>These genes belong to five transcriptional units under the control of a transcriptional activator , the MalT protein ( Richet & Raibaud , 1989 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9884223" target="_blank">9884223</a>]<br></li>
<li>MalT belongs to a class of bacterial transactivators , the MalT or LAL family ( 11 , 42 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=12003949" target="_blank">12003949</a>]<br></li>
<li>Members of this subfamily have an amino-terminal phosphorylation domain characteristic of so-called two-component regulators , such as OmpR , CheY , PhoB , and NtrC , and a carboxyl-terminal domain conserved among many transcriptional activators , including LuxR and MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=1569008" target="_blank">1569008</a>]<br></li>
<li>Keywords : MalK ; MalT ; transcription activator ; ABC transporter ; maltose regulon * Corresponding author Introduction MalT , the dedicated transcriptional activator of the maltose regulon in Escherichia coli , is the prototype of a family of w100 kDa transcriptional activators that belong to the STAND ( signal transduction ATPases with numerous domains ) class of P-loop ATPases .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li>
<li>One such example is the TyrR regulator , which does not belong to the MalT family of transcriptional activators and whose activity is modulated differentially by three ligands : ATP , tyrosine and phenylalanine ( Wilson et al. , 1995 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>In this area , MalT exhibits homology to a number of prokaryotic transcriptional activators ( 280 ) of the UhpA-LuxR family of regulatory proteins ( 260 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9529892" target="_blank">9529892</a>]<br></li>
<li>MalT protein ( 103 kDa ) is the best known member of an emerging family of 100-kDa homologous transcriptional activators ( 9 , 10 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10559195" target="_blank">10559195</a>]<br></li>
<li>MalT ( polypeptide size 103 kDa ) is the best known member of an emerging family of homologous 100 kDa transcriptional activators ( Wubbolts , 1994 ; Peng et al. , 1997 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>MalT ( 103 kDa ) is the best characterized representative of a family of transcriptional activators found both in Gram-positive and Gramnegative bacteria .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15491603" target="_blank">15491603</a>]<br></li>
<li>MalT is the archetype of a family of 100-kDa transcriptional activators found in prokaryotes ( 12 , 13 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>The only feature that MalT shares with members of another family of transcriptional activators , the LuxR family , is a conserved C-terminal domain ( '10 kDa ) that contains * The costs of publication of this article were defrayed in part by the payment of page charges .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10559195" target="_blank">10559195</a>]<br></li>
<li>Besides the MalT family of transcriptional activators , the largest regulators that are structurally well-deﬁned are the NtrC-type or the TyrR-type activators ( about 55 kDa ) , which are members of another family of transcriptional regulators and which are composed of three domains .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15491603" target="_blank">15491603</a>]<br></li>
				</div></ul><br>
			<label class="collapse_RP" for="_4"><font size="5px">Processes regulated by MalT</font></label>
				<input id="_4" type="checkbox">
				<div class="RP"><br><ul><li>23.5 20.0 3.8 16.3 9.1 12.7 Maltose transport MalT , Crp malK lamB malM ibpB ibpA htpG Maltose transport MalT , Crp 18.6 5.3 3.3 39.0 24.4 11.7 32.7 13.3 9.1 24.2 20.2 8.2 2.6 2.1 1.7 4.6 4.1 2.0 48.6 19.2 20.0 52.6 35.9 16.6 s32 Heat shock Heat shock s32 Heat shock chaperone s32 Protease ; chaperone Regulator Regulator ; chaperone Protease Periplasmic clpB 11.5 12.9 17.3 21.0 20.4 14.3 3.3 3.2 1.3 1.8 2.5 2.9 8.0 2.7 2.9 24.5 6.8 5.7 1.7 1.3 yceP/bssS cpxP ( b3913 ) degP ( htrA ) spy CpxR CpxR , H-NS CpxR , BaeSR CpxR CpxR Unknown Unknown ydeH yebE 49.2 44.8 63.1 21.0 30.7 32.2 56.9 33.1 9.5 1.1 1.6 6.1 7.3 7.3 2.6 1.5 1.6 2.0 1.4 1.2 1.3 2.9 Unknown ; signal peptide Putative transporter Regulator ; phage-shock protein Regulator ; phage-shock protein Regulator ; phage-shock protein Inner membrane Sulphurtransferase yncJ ( b1436 ) yhjX pspA pspB pspC pspD pspE 1.6 44.1 1.1 1.6 1.7 1.2 1.2 3.1 165.6 1.8 1.5 2.1 1.2 1.5 PspF , IHF 1.3 1.9 5.0 2.4 4.7 2.7 2.6 1.4 PspF , IHF PhoB RbsR , Crp 37.9 22.0 2.6 1.2 1.8 2.3 0.8 1.1 Inner membrane Unknown Ribose transport Ribose transport Ribose transport Ribose transport Ribose transport Ribose transport pspG ( yjbO ) ytfK rbsD rbsA rbsC rbsB rbsK rbsR 0.7 3.8 1.8 1.0 1.6 1.4 1.2 0.8 0.9 3.0 8.2 5.4 21.3 6.6 9.0 2.8 manX Mannose permease 4.2 2.1 1.1 5.0 manY Mannose permease 3.4 2.6 1.1 5.2 manZ Mannose permease 6.5 5.7 1.0 16.7 NagC , DgsA , Crp a. Genes and operons which are induced 10-fold in three independent experiments are listed with the average fold induction for the three experiments .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=18710431" target="_blank">18710431</a>]<br></li>
<li>Genes transiently induced upon cold shock Wild-type 15 ° C / 37 ° C ratio at 5 h Mutant/wild-type ratio ( 15 ° C , 1 h ) Gene product and/or function Wild-type 15 ° C / 37 ° C ratio at 1 h Gene name and role Genes involved in membrane synthesis/function Aerotaxis receptor Short-chain fatty-acid-transporter aer atoE dctA fabB glnH malE , - F , - K , - M manY manZ nupC rbsA-D sanA trg xylF ybeJ 9.8 6.5 0.14 0.5 1.07 1.1 0.73 0.5 0.28 0.39 0.015 0.8 0.28 0.8 2.1 0.08 4.8 3 0.4 0.5 0.22 0.08 0.1 0 DctA protein 3-Oxoacyl - [ acyl-carrier protein ] synthase I Glutamine-binding protein precursor Maltose transport proteins Phosphotransferase system enzyme II PTS-system , mannose-speciﬁc IID component Nucleoside permease NupC Ribose transport proteins SanA protein Methyl-accepting chemotaxis protein III D-Xylose-binding periplasmic protein precursor Amino acid ABC transporter binding protein 7.8 13 6.1 9.0 -- 10 8.9 6.9 9.3 5.0 -- 10 4.3 9.2 20 6.8 1.75 2.6 1 0.5 -- 2.7 1.9 0.3 1.2 1.5 -- 2 2.1 4.1 3.5 1.8 0.6 0.35 0.1 0.1 0.2 0.01 0.09 0.2 0.5 0.6 0.4 0.5 0.03 -- 0.08 0.01 0.13 0.02 0.14 0.03 0.05 -- 0.09 0.02 0.24 0.03 Genes involved in cell metabolism Alcohol dehydrogenase Glucose-1-phosphatase precursor adhE agp aldA aphA aspA bfr carA cfa cpdB cysK deoA fpr fruB fruK fucU fumA gapA glpK lipA malP malQ malT manX mdh nrdD otsA otsB pgi poxB pykA rbsK srlA 18.8 16 15 16.2 20 5 8.5 8.2 10 7 21.8 4.5 7 6.5 6.3 9.3 13.5 12.8 4.2 20 6.3 12 11.4 3.2 15.2 4.3 2.7 6.1 3.6 7.4 5.1 9.3 0.48 2 1.5 0.44 3 1 0.15 1.16 2 1.27 1.02 0.45 0.16 0.75 0.87 0.79 1.2 0.55 0.02 2.5 0.46 0.72 0.7 0.3 1.58 0.12 0.19 0.15 0.6 0.14 0.34 1.3 3.2 2.9 0.45 0.3 0.01 26 0.8 0.1 0.1 0.9 0.15 0.025 0.33 0.31 0.2 0.2 0.22 0.08 0.3 0.02 0.25 0.75 0.075 0.22 0.03 0 0.22 0.29 0.15 0.15 0.02 0.16 0.37 0 0.21 0.15 0.12 0.13 0.06 0.01 0.005 0.005 Aldehyde dehydrogenase Acid phosphatase Aspartate ammonia-lyase Bacterioferritin Carbamoyl-phosphate synthase small chain Cyclopropane fatty acid synthase Cyclic nucleotide 2 ' phosphodiesterase Cysteine synthase Thymidine phosphorylase Ferredoxin-NADP reductase PTS-system , fructose-speciﬁc IIA/FPR component 1-Phosphofructokinase ( fructose 1-phosphate kinase ) Fucose operon FucU protein Fumarate hydratase Glyceraldehyde-3-phosphate dehydrogenase Glycerol kinase Lipoic acid synthetase ( lip-syn ) Maltodextrin phosphorylase 4-Alpha-glucanotransferase MalT regulatory protein Phosphotransferase system enzyme II Malate dehydrogenase Oxygen-sensitive ribonucleoside-triphosphate reductase Tehalose-6-phosphate synthase Trehalose-phosphatase Glucose-6-phosphate isomerase Pyruvate oxidase Pyruvate kinase Ribokinase Phosphoenolpyruvate-carbohydrate phosphotransferase system , glucitol/sorbitol-speci ﬁc IIBC component Phosphotransferase system enzyme II Sorbitol-6-phosphate 2-dehydrogenase Glucitol operon repressor Phosphotransferase system trehalose permease Trehalose-6-phosphate hydrolase Uridine phosphorylase Pyrimidine-speciﬁc nucleoside hydrolase 0.15 2.1 7.3 1 0.9 3.7 1.6 0.6 3.6 1.6 0.8 0.7 2.7 1 2.3 1 1.7 4 3 4.2 2.4 0.28 1.8 1 0.7 1.7 0.18 0.75 2.9 2.7 0.12 0.03 0.16 0.03 0.18 0.015 0.2 0.01 0.13 0.03 0.24 0.05 0.19 0.25 0.16 0.19 0.025 0.04 0 0.04 srlB srlD srlR treB treC udp ybeK 0.22 0.23 0.06 1 1.1 1.5 0.55 4.4 5.1 0.3 1.5 1.5 0.02 0.4 0.01 0.05 0.02 0.2 2.6 0.7 0.45 0.62 1.6 5.5 6 6 10 10.2 0.08 0 Genes encoding proteins with diverse functions 0.1 0.1 1 1 0.3 0.4 4 9 CspA CspB cspA cspB cspG cspl dps grxB hns hobH htpG kbl mdaA mlc mopA mopB ppiA rimJ sseA 0.07 0.05 0.015 0.06 0.5 0.35 0.4 0.2 0.9 0.67 0.21 0.02 0.24 0.03 0.15 0.8 0.7 0.9 1 2.4 2 1.6 1.8 4 2.5 1.3 0.9 1.7 2.7 1.8 0.5 0.03 1.3 0.4 0.8 2 0.5 0.24 0.06 0.29 0.88 1 0.51 0.74 1.2 6 2 10 4.7 4.8 10 4.5 4.8 11.6 6.8 9.3 8 4.6 6.5 7.6 CspG Cspl DNA-binding protein Dps Glutaredoxin 2 DNA-binding protein H-NS DNA binding protein , replication-origin speciﬁc Heat shock protein C62 .5 2-Amino-3-ketobutyrate coenzyme A ligase Modulator of drug activity A Making large colonies protein GroEL protein GroES protein Peptidyl-prolyl-cis-trans-isomerase A precursor Ribosomal-protein-alanine acetyltransferase Putative thiosulfate sulfurtransferase 0.05 0.01 0.5 0.1 0.15 0.07 0.27 0.005 0.13 0.01 0.18 0.04 0.22 0.06 TABLE 2 .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15466053" target="_blank">15466053</a>]<br></li>
<li>S ... 4.39 5.33 5.59 Isocitrate dehydrogenase ( IDH ) kinase/phosphatase Malate dehydrogenase N.S. 3.49 mdh Methylpentose pathway Fucose isomerase Fucokinase 4.58 3.07 N.S. 11.95 2.35 3.48 fu fu fu cI cK cO Lactaldehyde reductase malF malG malK Maltodextrine pathway Inner membrane protein Maltose transport protein 4.10 2.74 4.62 17.86 8.96 14.50 Maltose/maltodextrin-transport ATP-binding protein Maltose operon periplasmic protein alpha-amylase , periplasmic MalT regulatory protein Maltoporin ( lambda receptor protein ) malM malS malT lamB 2.15 3.14 N.S. 3.44 8.49 4.41 2.85 7.33 alpha-galactosidase ( melibiase ) Melibiose carrier protein ( melibiose permease ) Melibiose operon regulatory protein melA melB D-galactoside pathway 6.27 11.24 3.50 2.80 melR N.S. 2.10 Galactoside transport ATP-binding protein D-galactose binding protein mglA D-galactose pathway 3.23 34.30 mglB 2.46 14.13 Ribose transport system permease Ribokinase L-arabinose-transport ATP binding protein rbsC rbsK araG Pentose pathway 3.46 2.96 2.35 4.05 5.31 2.49 srlA PTS-system , glucitol/sorbitol speciﬁc IIBC component Glucitol operon repressor Tagatose bisphosphate aldolase Putative tagatose 6-phosphate kinase 1 Putative tagatose 6-phosphate kinase 2 PTS enzyme II , galactitol speciﬁc , protein B Hexitol pathway 3.43 3.96 srlR gatY gatZ 2.25 3.16 3.23 4.30 2.18 agaZ 2.76 N.S. ptkB 3.34 8.85 Trehalose 6-phosphate hydrolase treC D-glucoside pathway 8.13 Uronate isomerase ( glucuronate isomerase ) ( uronic isomerase ) Mannonate dehydratase Probable 2-keto-3-deoxygluconate-transport protein Galactoside acetyltransferase 5.64 uxaC Hexuronate pathway 3.45 3.14 5.70 N.S. 2.06 uxuA kdgT 5.94 4.62 lacA Glycerol pathway 5.67 4.59 3.05 2.07 glpF glpX Glycerol diffusion facilitator GlpX protein , may be involved in glycerol-metabolism Glucose-1-phosphatase Acid glucose-1-phosphatase 9.48 4.84 agp Serine metabolism 3.34 3.21 N.S. N.S. sdaB sdaC L-serine deaminase Probable serine transport 135.89 53.18 2.06 5.58 tnaA tnaB Tryptophanase Tryptophan metabolism Low afﬁnity tryptophan permease 30.82 39.96 0.11 0.15 yjcU yjcX Unknown function Hypothetical protein Hypothetical ABC transporter periplasmic binding protein Hypothetical ABC transporter ATP-binding protein Hypothetical transcriptional regulato 46.54 0.19 yjcW 0.18 yjcV 64.09 Genes that were induced by more than 2.0 fold or decreased by more than 50 % are shown .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=12125819" target="_blank">12125819</a>]<br></li>
<li>We also performed Western blot experiments ( see Materials and Methods ) by using a polyclonal MalT antiserum and extracts from different strains ( i.e. , wild type , BSN26 ; hns , BSN27 ; stpA , BSN28 ; and hns-stpA , BSN29 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9829919" target="_blank">9829919</a>]<br></li>
<li>62 , No. 1 Maltose/Maltodextrin System of Escherichia coli : Transport , Metabolism , and Regulation WINFRIED BOOS1 * AND HOWARD SHUMAN2 Department of Biology , University of Konstanz , D-78457 Konstanz , Germany ,1 and Department of Microbiology , Columbia University , College of Physicians & Surgeons , New York , New York 100322 I NTRODUCTION AND SCOPE ... 2 ALTOSE GENES AND THEIR PRODUCTS ... 2 OSITIVE TRANSCRIPTIONAL ACTIVATOR , MalT ... 2 malT , Its Product , and Regulation of Its Expression ... 2 MalT Box ... 2 ALTOSE/MALTODEXTRIN TRANSPORT SYSTEM ... 2 Periplasmic Substrate Recognition Site and Its Interaction with Membrane Components ... 2 Membrane-Spanning Subunits MalF and MalG of the Transport System ... 2 MalK , the Energy-Coupling Protein of the Transport System ... 2 Role of the Lambda Receptor ( Maltoporin ) in the Diffusion of Maltose and Maltodextrins through the Outer Membrane ... 2 NZYMES OF THE MALTOSE SYSTEM ... 2 Amylomaltase ... 2 Maltodextrin Phosphorylase ... 2 Maltodextrin Glucosidase , an Enzyme of Unclear Function ... 2 Role of Glucokinase and Phosphoglucomutase in Maltose/Maltodextrin Metabolism ... 2 Periplasmic a-Amylase ... 2 Maltose Utilization in Other Bacteria ... 2 ONCLASSICAL REGULATORY PHENOMENA ... 2 MalK , the ATP-Hydrolyzing Subunit , as a Sensor for mal Expression ... 2 MalY as a mal Repressor ... 2 Aes as a mal Repressor ... 2 Effect of Phosphorylated PhoP on mal Expression ... 2 NDOGENOUS INDUCER OF THE MALTOSE SYSTEM ... 2 Glycogen as a Source of Maltotriose ... 2 Second Pathway for Maltotriose Formation ... 2 Elevated Expression of the mal Genes during Glucose Starvation ... 2 Role of Glucose in Internal Induction of the Maltose System ... 2 Osmoregulation of the Maltose System ... 2 NTERCONNECTION BETWEEN THE MALTOSE AND TREHALOSE SYSTEMS ... 2 Trehalose as an Inducer of the Maltose System ... 2 Transport of Maltose and Trehalose in the Archaeon Thermococcus litoralis ... 2 INAL CONSIDERATIONS ... 2 CKNOWLEDGMENTS ... 2 EFERENCES ... 2 04 05 05 05 09 10 10 12 13 M P M 14 15 15 16 17 17 17 18 18 18 19 20 20 20 20 21 21 21 21 22 22 23 23 23 23 E N E I F A R INTRODUCTION AND SCOPE Historically , some of the earliest work on Escherichia coli genetics and physiology in the Jacob and Monod groups concentrated on the maltose system , but it was rapidly overshadowed by the spectacular success in understanding the lactose operon .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9529892" target="_blank">9529892</a>]<br></li>
<li>POSITIVE TRANSCRIPTIONAL ACTIVATOR , MalT malT , Its Product , and Regulation of Its Expression MALTOSE GENES AND THEIR PRODUCTS Table 1 summarizes all known mal genes in E. coli .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9529892" target="_blank">9529892</a>]<br></li>
<li>The reaction mixture ( 46 , u ) contained 43 mM Tris acetate ( pH 8.2 ) , 75 mM potassium acetate , 12 mM magnesium acetate , 6.8 mM CaCl2 , 26 mM ammonium acetate , 1.4 mM dithiothreitol ( DTT ) , 0.12 mg of E. coli tRNA per ml , 0.026 mg each of flavin-adenine-dinucleotide , NADP , pyridoxine hydrochloride , and folic acid per ml , 0.011 mg of p-aminobenzoic acid per ml , 21 mM trisodium phosphoenol-pyruvate , 2.2 mM ATP , 0.55 mM each UTP , CTP , and GTP , 1.1 mM cyclic AMP , 0.21 mM each of the amino acids , 1.5 % polyethylene glycol 6000 , 0.3 mg of protein from an S-30 extract , 1 nM plasmid pOM34 , 210 nM purified MalT protein , and various concentrations of maltodextrins .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=3298211" target="_blank">3298211</a>]<br></li>
<li>As observed for the MhpR regulator , CRP also regulates expression of other transcription factors in E. coli such as MelR ( Webster et al. , 1988 ) , MalT ( Chapon & Kolb , 1983 ) , RhaS ( Wickstrum et al. , 2005 ) , MaoB ( Yamashita et al. , 1996 ) , HcaR ( Turlin et al. , 2001 ) , GalS ( Weickert & Adhya , 1993 ) , RpoH ( Kallipolitis & Valentin-Hansen , 1998 ) , BlgG ( Gulati & Mahadevan , 2000 ) , PrpR ( Lee et al. , 2005 ) and Fis ( Nasser et al. , 2001 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=20966094" target="_blank">20966094</a>]<br></li>
<li>The MalT-dependent pulA gene , encoding the lipoprotein pullulanase ( 163 ) , is positioned divergently from a series of genes , also dependent on MalT , that are necessary for the export of pullulanase through the outer membrane ( 193 , 195 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9529892" target="_blank">9529892</a>]<br></li>
<li>glgX amyA Cytoplasmic a-amylase , not MalT dependent , no apparent role in glycogen-degradation .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9529892" target="_blank">9529892</a>]<br></li>
<li>MalT self-associa-tion , which is expected to be crucial for promoter binding , is hence the target of several of the controls to which the activator is subjected , i.e. the inducer , ATP , and ATP-hydrolysis .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10559195" target="_blank">10559195</a>]<br></li>
<li>171 , No. 9 MalI , a Novel Protein Involved in Regulation of the Maltose System of Escherichia coli , Is Highly Homologous to the Repressor Proteins GalR , CytR , and Lacl JOACHIM REIDL , KARIN ROMISCH , MICHAEL EHRMANN , AND WINFRIED BOOS * Department of Biology , University of Konstanz , D-7750 Konstanz , Federal Republic of Germany Received 13 March 1989/Accepted 10 June 1989 The maltose regulon of Escherichia coli comprises several operons that are under common regulatory control of the MalT activator protein .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2670898" target="_blank">2670898</a>]<br></li>
<li>The N Terminus of the Escherichia coli Transcription Activator MalT Is the Domain of Interaction with MalY Anja Schlegel ,1 Olivier Danot ,2 Evelyne Richet ,2 Thomas Ferenci ,3 and Winfried Boos1 * Department of Biology , University of Konstanz , 78457 Konstanz , Germany1 ; Unité de Génétique Moléculaire , Institut Pasteur , FRE CNRS 2364 , 75724 Paris Cedex 15 , France2 ; and Department of Microbiology G08 , University of Sydney , Sydney , New South Wales 2006 , Australia3 Received 26 December 2001/Accepted 1 March 2002 The maltose system of Escherichia coli consists of a number of genes encoding proteins involved in the uptake and metabolism of maltose and maltodextrins .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=12003949" target="_blank">12003949</a>]<br></li>
<li>site 2 ( A ) and site 3 ( D ) as a function ot MalT concentration .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=7830577" target="_blank">7830577</a>]<br></li>
<li>Discussion The search for gain of function mutations in DT3 under conditions of MalT inhibition by MalK revealed a surface-exposed determinant that is involved speciﬁcally in MalT control by MalK .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li>
				<label class="RP_collapse_similarity" for="rp_similarity_16">
Danot , O. , and Raibaud , O. ( 1994 ) Multiple protein-DNA and protein-protein interactions are involved in transcriptional activation by MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=8596446" target="_blank">8596446</a>]<br></label>
<input id="rp_similarity_16", type="checkbox">
<div class="RP_similar">
<li>Danot , O. , and Raibaud , O. ( 1994 ) Multiple protein-DNA and protein ± protein interactions are involved in transcriptional activation by MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>Multiple protein-DNA and proteinprotein interactions are involved in transcriptional activation by MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9529892" target="_blank">9529892</a>]<br></li>
<li>Multiple protein-DNA and protein-protein interactions are involved in transcriptional activation by MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9000616" target="_blank">9000616</a>]<br></li>
<li>Multiple protein -- DNA and protein -- protein interactions are involved in transcriptional activation by MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15491603" target="_blank">15491603</a>, <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></li></div>
<li>Interestingly , in many respects , MalT rather resembles the DnaA protein , the activator of initiation of DNA-replication in E. coli .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>One of these proteins , MalT , a nonresponse regulator class 3 protein , is an ATP-dependent transcriptional activator ( Richet and Raibaud 1989 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=7699720" target="_blank">7699720</a>]<br></li>
<li>The presence of a wild-type malPQ + operon , which encodes enzymes involved in the catabolism of maltodextrins , further increases the concentration of active MalT in a malTp1 malTp7 background ( see below ) , possibly through an effect on the production of maltotriose ( the true inducer ) from maltose .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9000616" target="_blank">9000616</a>]<br></li>
<li>We also examined their role in the regulation of the malT gene , which encodes MalT and which is controlled by cAMP-CRP ( 24 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9829919" target="_blank">9829919</a>]<br></li>
<li>It has also been demonstrated that MalK , a component of the ABC-type transporter for maltose , physically interacts with MalT to downregulate its transcriptional activity in response to the levels of ATP-hydrolysis associated with maltose-transport ( Panagiotidis et al. , 1998 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11157755" target="_blank">11157755</a>]<br></li>
<li>In addition to its role in transport , MalK influences maltose gene-expression , probably by competing with the endogenous inducer for MalT , .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9884223" target="_blank">9884223</a>]<br></li>
<li>Dextrin-metabolizing or synthesizing enzymes affect the level of internal maltotriose , the inducer of the system which is recognized by MalT ; cyclic AMP ( cAMP ) / CAP , as well as the product of the mlc gene , controls the expression of malT itself ; and the levels of MalK , the ATP-hydrolyzing subunit of the transport system , as well as of MalY ( a bC-S lyase ) and of Aes ( an esterase with homology to lipases ) affect the expression of the maltose-transport genes .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9529892" target="_blank">9529892</a>]<br></li>
<li>In contrast to other maltose operon promoters , which are regulated only by MalT : malEp and malKp are also positively controlled by CRP , a pleiotropic regulator involved in the control of carbon source utilization ( De Crombrugghe et al. , 1984 ; Chapon , 1982 ; Richet & Raibaud , 1987 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2538630" target="_blank">2538630</a>]<br></li>
<li>Their activation depends on the synergistic action of MalT , the activator of the maltose regulon ( Schwartz , 1987 ) , and CRP , a global regulator controlling the utilization of carbon sources ( Kolb et al. , 1993 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9000616" target="_blank">9000616</a>]<br></li>
<li>Our results suggest that the H-NS and StpA proteins stimulate MalT translation and hence play a positive role in the control of the maltose regulon .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9829919" target="_blank">9829919</a>]<br></li>
<li>In the case of the maltose regulon , H-NS has been shown to stimulate MalT translation ( 15 ) , and H-NS plays a positive role in the activation of the traJ gene of pRK100 ( 16 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=17827501" target="_blank">17827501</a>]<br></li>
<li>The MalK941 mutant protein has an increased ability to down-modulate MalT activity If MalK is somehow involved in antagonizing the ability of MalT to activate transcription at mal promoters based on the level of maltose-transport into the cell , there must be a mechanism for transmitting information about transport rates to MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9822819" target="_blank">9822819</a>]<br></li>
<li>MalT , the transcriptional activator of the Escherichia coli maltose regulon , binds the MalT-dependent promoters and activates transcription initiation only in the presence of maltotriose and ATP ( or adenylyl imido-diphosphate ( AMP-PNP ) ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10559195" target="_blank">10559195</a>]<br></li>
<li>Keywords : transcription activator ; E. coli ; cryo-EM ; nucleoprotein complex ; multimer * Corresponding author Introduction The transcriptional activator MalT speciﬁcally controls the expression of all of the operons comprising the maltose regulon from Escherichia coli .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15491603" target="_blank">15491603</a>]<br></li>
<li>The model system is the Escherichia coli maltodextrin-transporter , whose ATP-binding cassette component , the MalK protein , down-regulates the activity of MalT , a transcriptional activator that controls the expression of the maltose regulon ( 4 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>The transcriptional activator MalT plays a key role in the regulation of expression of the Escherichia coli maltose regulon that encodes proteins involved in the uptake and catabolism of maltodextrins .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10559195" target="_blank">10559195</a>]<br></li>
<li>Alone or in synergy with CRP ( cAMP receptor protein ) , MalT activates all the operons comprising the Escherichia coli maltose regulon , which encodes proteins involved in the uptake and degradation of maltodextrins ( Boos and Shuman , 1998 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>]<br></li>
<li>In contrast , expression of the malKpromoter of the maltose regulon requires two activator proteins , MalT and the cAMP receptor protein ( CRP ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=8087856" target="_blank">8087856</a>]<br></li>
<li>The activation of these genes depends on the action of the maltose regulon activator MalT and the global activator cyclic AMP receptor protein .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9829919" target="_blank">9829919</a>]<br></li>
<li>The MalT protein is a transcriptional activator essential for the expression of all the genes in the maltose regulon , except the malT gene itself .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9829919" target="_blank">9829919</a>]<br></li>
<li>All mal genes are controlled by MalT , a transcriptional activator that is exclusively activated by maltotriose .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=16321936" target="_blank">16321936</a>]<br></li>
<li>Transcription of the mal genes is under the control of several factors , including a maltose oper-on-speciﬁc activator protein ( MalT ) , two global regulators ( Crp and now Lrp ) , and perhaps also malK .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=7751276" target="_blank">7751276</a>]<br></li>
<li>It could act on the individual mal genes , such as malK or malE , or it could act on the expression of malT , the gene for the activator of all mal genes , thus controlling mal gene-expression by the control of MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9484893" target="_blank">9484893</a>]<br></li>
<li>The plasmids that encode MBP were transformed the day before use into a Am & E strain ( HS3309 ) that contains a m & T promoter mutation that results in a 50-fold overproduction of the positive regulator protein , MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=3050132" target="_blank">3050132</a>]<br></li>
<li>Strain HS3341 , a malT1 ( Con ) strain that carries a malP -- 8lacZ fusion was co-transformed with pairs of plasmids to determine the effects of MalK protein alone ( pMR11 , pBR322 ) , MalT -- BCCP alone ( pCP80 , pACYC184 ) , and MalK and MalT -- BCCP together ( pMR11 , pCP80 ) on the expression of a MalP -- LacZ fusion protein .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9822819" target="_blank">9822819</a>]<br></li>
<li>In the presence of MalT '' ( maZTCmutation ) or without MalQ ( malQ mutation ) , malK expression more or less depends on pH , .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9884223" target="_blank">9884223</a>]<br></li>
<li>Expression of malK-lacZ in BRE1219 with plasmids encoding MalT fragmentsa FIG. 2 .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=12003949" target="_blank">12003949</a>]<br></li>
				</div></ul><br>
			<label class="collapse_SIT" for="_5"><font size="5px">MalT binding site</font></label>
				<input id="_5" type="checkbox">
				<div class="SIT"><br><ul><li>Comparison of the sizes of the footprints obtained with Ep92 and Ep64 ( ~ 32 bp ) and Ep47 ( 18 bp ) suggests the existence of an additional lMalT binding site , poorly recognizable , between positions -47 and -64 ( Fig. 6 ( a ) and data not shown ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2538630" target="_blank">2538630</a>]<br></li>
<li>Indeed , DNase I footprinting done with the -44 / - 152 fragment cloned away from the identified MalT boxes shows that MalT protects against DNase I attack an N 15 bp region extending from positions -44 to -58 ( data not shown ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2538630" target="_blank">2538630</a>]<br></li>
<li>This finding suggests that t ' he two inverted-repeats , which are separat ' ed by 22 base-pairs , may constitute recognition sequences for symmetrical MalT monomers .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=6379197" target="_blank">6379197</a>]<br></li>
<li>After forming a complex with the inducer , MalT recognizes a motif of two direct repeats , common to all mal promoters ( 4 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=1918057" target="_blank">1918057</a>]<br></li>
<li>On the other hand , MalT has to bind to specific double-stranded nucleotide sequences in the promoters that it activates , and , as postulated for at least two of these promoters , MalT monomers probably interact with each other to build up a complex nucleoprotein structure ( 27 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2180908" target="_blank">2180908</a>]<br></li>
<li>Summary The promoters of the Escherichia coll maltose regulon are positively regulated by the MalT protein , which recognizes a short asymmetric nucieotide sequence that is present as severai copies in each promoter of the regulon .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=7830577" target="_blank">7830577</a>]<br></li>
<li>In the presence of maltotriose and ATP , MalT , the activator protein specific for the regulon , binds to a short asymmetrical sequence which is present in several copies in alt the MalT-dependent promoters ( Vidal-lngigiiardi etai , 1991 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=7830577" target="_blank">7830577</a>]<br></li>
<li>In the presence of both effectors , MalT binds to the asymmetric 5 ' - GGAT/GGA nucleotide sequence which is present in several copies in the mal promoters ( 32 ) and , by an unknown mechanism , increases the rate of open complex formation at these promoters ( 30 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2180908" target="_blank">2180908</a>]<br></li>
<li>Instead , the asymmetric hexanucleotide sequence 59-GG A ( G/T ) GA-39 , the so-called MalT box , was identiﬁed centered at bp 237.5 or at 238.5 upstream of the transcriptional start point ( 9 , 10 , 106 , 201 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9529892" target="_blank">9529892</a>]<br></li>
<li>Each MalT binding site corresponds to a 10-base pair asymmetric DNA sequence ( 59-ggGGa ( T/G ) GAgg-39 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10559195" target="_blank">10559195</a>]<br></li>
<li>Transcription activation by 1,2 MalT involves MalT self-association , cooperative 3 binding to several copies of a 10 bp asymmetric recognition motif ( 5 0-ggGGa ( T/G ) GAgg-30 ) that are located in the target promoters , and stimulation 4 -- 6 of open complex formation by RNA polymerase .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15491603" target="_blank">15491603</a>]<br></li>
<li>The analysis of these MalT boxes also led to an extension in the consensus sequence , which is now deﬁned as 59-GGG A ( T/G ) GAGG-39 ( 281 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9529892" target="_blank">9529892</a>]<br></li>
<li>The positions of 26 mutations in MalT along the primary sequence .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=12003949" target="_blank">12003949</a>]<br></li>
<li>This is reminiscent of the regula-pendent genes , the MalT binding site has aproposed consen - tion of the malP-malQ operon in which a CAMPICAP binding sus sequence reading 5 ' - GGGGAT/GGAGG ( 27 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=1544897" target="_blank">1544897</a>]<br></li>
<li>MalT is known to prevent DNase I attack over a stretch of about 16bp centred around a decanucleotide homologous to the consensus sequence GGGGAT / GGAGG .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=7830577" target="_blank">7830577</a>]<br></li>
<li>Moreover , these footprints indicate that MalT binding to one recognition sequence results in the protection from DNase I attack of an N 16 bp stretch centred on the MalT box .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2538630" target="_blank">2538630</a>]<br></li>
<li>Even though they do not exhibit sequence similarity , all three proteins must contain a similar structural motif by which they recognize MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9529892" target="_blank">9529892</a>]<br></li>
<li>An attractive alternative hypothesis is that the homology represents the inducer recognition site , implying that MalI and MalT bind the same sugar .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2670898" target="_blank">2670898</a>]<br></li>
<li>The observation of sequences that are homologous in the three proteins MalK , MalT , and MalI would speak for a common sugar recognition site in these proteins .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2670898" target="_blank">2670898</a>]<br></li>
<li>The fusion proteins may bind to the MalT recognition site and thereby prevent the wt protein from binding .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=3015733" target="_blank">3015733</a>]<br></li>
<li>If , as just proposed , the sequence T - ( ` - C ' - T - ( I-KZZ-C : - A - ( : - G-A constitutes a recognition site for the MalT protein , a similar sequence would be expected t ' o be found at the two other known malT-controlled ma1 promoters ( Bedouelle $ Hofnung , 1982 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=6379197" target="_blank">6379197</a>]<br></li>
<li>A comparison of the sequences at the three malT-controlled ma1 promoters ( Bedouelle et al. , 1982 ) and the mapping of one promoter-down mutation in the malK 1amB operon ( Bedouelle , 1983 ) already led to the suggestion that the G-G-A-G-G-A sequence located in the vicinity of position - 35 both in the malK 1amB and malEFG operons might be part of the interaction site for MalT protein .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=6379197" target="_blank">6379197</a>]<br></li>
<li>As a working hypothesis , we propose that the G-A-G-G-A sequence present in the vicinity of the - 35 position and the inverted-repeat of the sequence located in the vicinity of position - 60 constitute recognition sequences for the MalT protein at the malPQ promoter .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=6379197" target="_blank">6379197</a>]<br></li>
<li>We did not find a MalT recognition sequence around the promoter region of sfsl , either .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2013578" target="_blank">2013578</a>]<br></li>
<li>( e ) MalT binding to malEp-malKp induces DNA bending in the central region A close examination of the central region separating the protected areas reveals a regular pattern of alternately increased and decreased sensitivity to DNase I cleavage , which spans -110 bp on both st , rands ( Figs 4 and 5 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2538630" target="_blank">2538630</a>]<br></li>
<li>A head-to-tail association is consistent with the observation that the motif comprising two directly repeated MalT sites , separated by 3 bp ( sites 2 and 3 in malPp500 ( Figure 5A ) ) , is a recurrent feature in all of the MalT-dependent promoters .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15491603" target="_blank">15491603</a>]<br></li>
<li>Such a model relies , of course , on the premise that several levels of ﬂexibility allow for the simultaneous occupation of the MalT sites that are further apart than tandem sites ( such as sites 3 and 4 in pulAp-pulCp , which are separated by 11 bp ) or that 4 are both further apart and in opposite orientations ( such as sites 1 and 2 in malPp500 , which are separated by 13 bp ( Figure 5A ) ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15491603" target="_blank">15491603</a>]<br></li>
<li>It specifically binds DNA at different sites in the promoters whose activity it controls , recognizing a short , asymmetric motif called the MalT box ( 5 ' - GGAT/GGA -3 ' ) ( Raibaud et al. , 1989 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2524384" target="_blank">2524384</a>]<br></li>
<li>It binds to specific sites in the promoters whose activities it controls , recognizing a short asymmetric motif called the MalT box ( 12 , 43 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2670898" target="_blank">2670898</a>]<br></li>
<li>Discussion Functionai and non-functionai activator-binding sites in maIPp The exact location of the nucieotide sequences to which MalT actually binds in the MalT-dependent promoters is often not easiiy defined , as these sequences sometimes exhibit only 60 % identity with the consensus ( Vidal-Ingigiiardi et ai .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=7830577" target="_blank">7830577</a>]<br></li>
<li>In the presence of ATP and maltotriose , MalT binds to decanucleotide MalT boxes that are found upstream of mal promoters and activates transcription at these sites .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9822819" target="_blank">9822819</a>]<br></li>
<li>MalT binds cooperatively to multiple sites in MalT-dependent promoters ( 22 , 23 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=1569008" target="_blank">1569008</a>]<br></li>
<li>Genetic data strongly suggest that this sequence is part of the MalT binding site ( Bedouelle , 1983 ; Gutierrez & Raibaud , 1984 ; Raibaud et al. , 1985 ) , but direct evidence that MalT binds to the `` MalT box '' is so far lacking .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2538630" target="_blank">2538630</a>]<br></li>
<li>In the presence of these two ligands , MalT binds to a degenerate decanucleotide sequence , 58-GGGGA ( T/G ) GAGG-38 ( T box ) , that is found in various permutations upstream of all mal promoters ( Richet and Raibaud , 1989 ; Vidal-Ingigliardi et al. , 1991 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9822819" target="_blank">9822819</a>]<br></li>
<li>The end points of the malEp upstream deletions malEpD64 and malEpD92 ( Raibaud et al. , 1989 ) are indicated Results Each set of three MalT sites ( 3/4/5 and 3 ' / 4 ' / 5 ' ) forms a functional unit to which MalT binds cooperatively ( Danot & Raibaud , 1994 ; Richet et al. , 1991 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9000616" target="_blank">9000616</a>]<br></li>
<li>The fact that this region iies between sites 2/3 and site 1 in maiPp leads us to speculate that MalT bound to sites 2/3 interacts with the a-subunits , in such a modei , MaiT and RNA poiymerase would form a nucieoprotein complex heid together by several proteinprotein interactions .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=7830577" target="_blank">7830577</a>]<br></li>
<li>To ensure that the occupation of MalT sites 1 and 2 observed with malEp + was not due to a stabilizing effect of RNA polymerase bound at malEp and/or malKp , I veriﬁed that MalT sites 1 and 2 were similarly occupied in the absence of functional − 10 sequences .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9000616" target="_blank">9000616</a>]<br></li>
<li>The occupancy of MalT sites 1 and 2 does not result from stabilization by RNA polymerase bound to malEp because the inactivation of the − 10 element of malEp does not alter the degree of protection of MalT sites 1 and 2 of the malEpKp1 ,2,3 , I3 variant in pop2226 ( Figure 5 ( a ) ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9000616" target="_blank">9000616</a>]<br></li>
<li>In contrast , a synthetic promoter containing the malPp − 35 / − 10 region and two consensus MalT sites located at the same position and in the same orientation as the MalT sites 1 and 2 present in malEp displays a signiﬁcant level of MalT-dependent activity ( Danot & Raibaud , 1993 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9000616" target="_blank">9000616</a>]<br></li>
<li>As 4,26 revealed by DNase I protection experiments , MalT binding to a set of MalT sites often gives rise , at saturating concentrations of the activator , to a regular pattern of alternating clusters of enhanced and diminished DNase I cleavage sites that are separated by 5 bp .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15491603" target="_blank">15491603</a>]<br></li>
				<label class="SIT_collapse_similarity" for="sit_similarity_41">
Two MalT binding sites in direct repeat .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9000616" target="_blank">9000616</a>, <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=1569008" target="_blank">1569008</a>, <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9529892" target="_blank">9529892</a>, <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15491603" target="_blank">15491603</a>, <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15733913" target="_blank">15733913</a>]<br></label>
<input id="sit_similarity_41", type="checkbox">
<div class="SIT_similar">
<li>Richet , E. , and Raibaud , O. ( 1991 ) Two MalT binding sites in direct repeat .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=7830577" target="_blank">7830577</a>]<br></li>
<li>Vidal-Ingigliardi , D. , Richet , E. , and Raibaud , O. ( 1991 ) Two MalT binding sites in direct repeat .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10692154" target="_blank">10692154</a>, <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9484893" target="_blank">9484893</a>, <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9822819" target="_blank">9822819</a>]<br></li></div>
<li>Such a set of MalT binding the polypeptide chain is located at theperiplasmic end of the sites could clearly be identified in the sequence preceding the second P-pleated strand whereas region IV is located within transcriptional start point of malS .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=1544897" target="_blank">1544897</a>]<br></li>
<li>The positions at which the 10 bp MalT sites ( arrowed boxes ) are centered are numbered with respect to the transcription start point ( C1 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15491603" target="_blank">15491603</a>]<br></li>
<li>MalT activates transcription only when bound at the correct sites .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10715008" target="_blank">10715008</a>]<br></li>
<li>The primary activator is MalT which activates malKp when bound to the 3 ' / 4 ' / 5 ' set of sites present in the promoter proximal region .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9000616" target="_blank">9000616</a>]<br></li>
<li>( b ) malEp and malKp eficiency depends on a 240 bp region encompassing multiple MalT and ORP binding sites The in wivo structural analysis of the divergent malEp and malKp promoters reported here shows that , although the situation is not ' quite symmetrical , the upstream functional limit of each promoter lies at ' about position -240 .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2538630" target="_blank">2538630</a>]<br></li>
<li>The -10 region , ttie MalT sites and the CRP site are symbolizecJ by an open box .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=7830577" target="_blank">7830577</a>]<br></li>
<li>The common regulatory region of the malEp and malKp promoters consists of a compact array of binding sites for both activator proteins , MalT and CRP ( 9 ) ( Fig .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=1824723" target="_blank">1824723</a>]<br></li>
<li>The filled arrowed and open boxes , which indicate the positions of the MalT and CRP binding sites , respectively , are numbered as shown on the schematic representation of the wdEp-malKp region ( for the sequence , see Raibaud et al. , 1989 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2016744" target="_blank">2016744</a>]<br></li>
<li>The malEp-malKp region is represented to scale with the Pribnow boxes ( hatched boxes ) , the MalT binding sites ( filled arrowed boxes ) and the CRP binding sites ( open boxes ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2016744" target="_blank">2016744</a>, <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2016744" target="_blank">2016744</a>]<br></li>
<li>Solid large arrow-shaped bullets represent MalT binding sites ( MalT boxes ) , and open rectangles represent cAMP/CAP binding sites .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9529892" target="_blank">9529892</a>]<br></li>
<li>CRP binding to these sites bends the DNA and causes MalT to shift 3 bp downstream to binding sites from which MalT can activate transcription ( 24 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=16166533" target="_blank">16166533</a>]<br></li>
<li>Footprinting experiments show that ' this region encompassesa seriesof effective binding sites for both MalT and CRP .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2538630" target="_blank">2538630</a>]<br></li>
<li>This region comprises two series of MalT binding sites separated by one series of four CRP binding sites ( see Fig. 4 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2016744" target="_blank">2016744</a>]<br></li>
<li>Located between these start sites is a 210-bp regulatory region which comprises two series of MalT boxes ( three MalT boxes , including the repeat , in front of malK , and two MalT boxes , the repeat , in front of malE ) separated by three cAMP/CAP binding sites .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9529892" target="_blank">9529892</a>]<br></li>
<li>For malE , the Crp-binding site is at a nonpermissive position ( 276.5 ) that is separated from the promoter by binding sites for a second activator ( MalT ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9696769" target="_blank">9696769</a>]<br></li>
<li>Beginning at nucleotide 692 a set of three MalT binding sites ( 27 ) can be recognized .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=1544897" target="_blank">1544897</a>]<br></li>
<li>A sequence analysis of the promoter region of mal2 revealed three MalT binding sites , the location and orientation of which is similar to those of malK and malP promoters ( 4 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=1918057" target="_blank">1918057</a>]<br></li>
<li>Altogether these deletions strictly define MalT box 1 as an CLEAVAGE ~ GGACTCTAGTTTCTTTATACGGCAA .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2538630" target="_blank">2538630</a>]<br></li>
<li>B , DMS footprints of MalT bound to malPp .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=7830577" target="_blank">7830577</a>, <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=7830577" target="_blank">7830577</a>]<br></li>
				</ul></div><br>
			<label class="collapse_TU" for="_6"><font size="5px">Transcription unit regulated by MalT</font></label>
				<input id="_6" type="checkbox">
				<div class="TU"><br><ul><li>10.32 maa ( mac , F183a ) 20 , 26 Glucose/maltose transacetylase , not MalT dependent , responsible for exit of maltose and glucose in their acetylated forms .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9529892" target="_blank">9529892</a>]<br></li>
<li>The number , orientation , and spacing of these site DISCUSSION are nearly identical to the MalT boxes found in the malKThe molecular characterization of the malS gene revealed hmB , as well as in the malP-malQ operons .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=1544897" target="_blank">1544897</a>]<br></li>
<li>encoded MBP and has constitutive expression of the Using equation ( 2 ) and the value of Kd , fz , the maltose operon activator , MalT .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=16288781" target="_blank">16288781</a>]<br></li>
<li>E. coli strain HS3309 ( 25 ) was used for expression of periplasmic MBP and MBP-DM from pLH1 ( 26 ) and pLH1-DM ( 27 ) ; HS3309 does not produce chromosomally encoded MBP and has constitutive expression of the maltose operon activator , MalT to drive expression from pLH1 .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=19630440" target="_blank">19630440</a>]<br></li>
<li>The observation that the repression by MalK is relieved both by MalT overexpression and by a class of malT mutations ( malTc ) that confer constitutive expression of the maltose regulon suggested further that MalT is the target of the negative control exerted by MalK ( 6 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15180985" target="_blank">15180985</a>]<br></li>
<li>The expression of malT is under the control of the cyclic AMP-cyclic AMP receptor protein ( cAMP/CAP ) - mediated catabolite repression system , as is the expression of the malE malF maiG and the malK lamB malM operons , whereas the malP malQ operon is not ( only indirectly via the dependence on MalT ) ( 11 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2670898" target="_blank">2670898</a>]<br></li>
<li>The expression of malT is not autoregulated by MalT but is subject to catabolite repression and therefore requires the presence of the cAMP/CAP complex ( 35 , 36 , 65 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9529892" target="_blank">9529892</a>]<br></li>
<li>It is necessary to have both MalT and the mutated form of CRP ( CRP * ) to induce mal gene expression in sfsl-dependent systems .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2013578" target="_blank">2013578</a>]<br></li>
				<label class="TU_collapse_similarity" for="tu_similarity_9">
Overproduction reduces mal gene expression by interaction with MalT and its inactivation .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9529892" target="_blank">9529892</a>]<br></label>
<input id="tu_similarity_9", type="checkbox">
<div class="TU_similar">
<li>Overproduction reduces mal gene expression , presumably by interaction with MalT and its inactivation .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9529892" target="_blank">9529892</a>]<br></li></div>
<li>The induced expression of malK , classes , one made under low osmolarity and the other controlled by MalT ' , was identical to uninduced ex - under high osmolarity .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9884223" target="_blank">9884223</a>]<br></li>
<li>MalT expression is reduced in hns and hns-stpA mutant strains .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9829919" target="_blank">9829919</a>]<br></li>
<li>The expression of the MalT protein is not restored by CRP * in hns and hns-stpA mutant strains .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9829919" target="_blank">9829919</a>]<br></li>
<li>MalT does not control its own expression .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9484893" target="_blank">9484893</a>]<br></li>
<li>The expression of genes under the control of MalT was , however , signiﬁcantly increased ( approximately 5 - to 20-fold ) ( Table 2 and Fig. 1 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=15716448" target="_blank">15716448</a>]<br></li>
<li>The expression of these genes is controlled by the MalT protein , a 103 kDa monomer that binds ATP and maltotriose ( Richet and Raibaud , 1987 ; Dardonville and Raibaud , 1990 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9822819" target="_blank">9822819</a>]<br></li>
<li>The system is positively regulated by MalT , its transcriptional activator .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=12003949" target="_blank">12003949</a>]<br></li>
<li>The expression of these mal genes is controlled by the transcriptional activator MalT ( 58 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9023215" target="_blank">9023215</a>]<br></li>
<li>The expression of mal2 is positively controlled by the presence of MalT , the transcriptional activator of the mal regulon .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=1918057" target="_blank">1918057</a>]<br></li>
<li>Sequential removal of the two distal MalT boxes reduces but does not abolish the expression of malE , whereas the removal of any MalT box abolishes the expression of the malK operon ( 206 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9529892" target="_blank">9529892</a>]<br></li>
<li>Complex mechanisms regulate the expression of this operon ; expression is activated by MalT , which binds to the malEFG promoter in its maltotriose-bound form and by the cAMP receptor protein , which binds in its cAMP bound form .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11350954" target="_blank">11350954</a>]<br></li>
<li>In nutrient broth maltotriose is present , so MalT activates malE expression even though the cAMP receptor protein is not active ( 33 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=11350954" target="_blank">11350954</a>]<br></li>
<li>The malT gene has been cloned ( Raibaud and Schwartz , 1980 ) and sequenced ( Cole and Raibaud , 1986 ) and its product MalT characterized ( Richet and Raibaud , 1987 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9484893" target="_blank">9484893</a>]<br></li>
<li>The malT gene was cloned ( 204 ) and sequenced ( 40 ) , and its product , MalT , was puriﬁed and characterized ( 214 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9529892" target="_blank">9529892</a>]<br></li>
<li>We also examined their role in the regulation of the malT gene , which encodes MalT and which is controlled by cAMP-CRP ( 24 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9829919" target="_blank">9829919</a>]<br></li>
<li>and malKlam & maEM operons are controlled by both MalT and CRP .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2016744" target="_blank">2016744</a>]<br></li>
<li>Besides the outer membrane porins , other genes ( 49 ) -- those encoding the tripeptide permease TppB of Salmonella typhimurium , the outer membrane protease Opr , the PhoA and PhoE proteins of the Pho regulon , and the positive regulator MalT of the maltose operon -- are known to be regulated by EnvZ and OmpR .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=7642497" target="_blank">7642497</a>]<br></li>
<li>POSITIVE TRANSCRIPTIONAL ACTIVATOR , MalT malT , Its Product , and Regulation of Its Expression MALTOSE GENES AND THEIR PRODUCTS Table 1 summarizes all known mal genes in E. coli .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9529892" target="_blank">9529892</a>]<br></li>
<li>Arguing against this hypothesis are the facts that the amyA gene lies outside the known mal gene regions and that its upstream region lacks the MalT box characteristic of the genes of the mal regulon .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=1400215" target="_blank">1400215</a>]<br></li>
<li>Expression of the mal genes is induced by maltose and maltodextrins and is dependent on a specific positive regulator , the MalT protein , as well as on the cyclic AMP-catabolite gene activator protein complex .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=2423504" target="_blank">2423504</a>]<br></li>
<li>Expression of the mal genes is dependent upon the positive transcriptional regulator MalT , and the malT gene is itself negatively regulated by Mlc ( Decker et al. , 1998 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9767573" target="_blank">9767573</a>]<br></li>
<li>malT ( Con ) mutants , which also express the system constitutively ( 3 ) , were class-ically considered to produce a MalT protein able to activate transcription in the absence of inducer .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=3298211" target="_blank">3298211</a>]<br></li>
<li>This motif of MalT-dependent promoter structure with three MalT boxes has also been found by sequence analysis upstream of malS ( 235 ) and malZ ( 267 ) , two MalT-dependent genes encoding maltodextrin-hydrolyzing enzymes in E. coli .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9529892" target="_blank">9529892</a>]<br></li>
<li>However , malZ is also induced at high osmolarity independent of MalT 251 ( 15 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=21421758" target="_blank">21421758</a>]<br></li>
<li>Recently , we found that malZ expression can also occur in the absence of MalT , in particular under conditions of high medium osmolarity .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=9529892" target="_blank">9529892</a>]<br></li>
				</div></ul></div><br>
	</div>
</body>
</html>